BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999;79:1522-30. [PMID: 10188901 DOI: 10.1038/sj.bjc.6690243] [Cited by in Crossref: 937] [Cited by in F6Publishing: 836] [Article Influence: 40.7] [Reference Citation Analysis]
<
Number Citing Articles
1 Song X, Wang L, Chen W, Pan T, Zhu H, Xu J, Jin M, Finley RK, Wu J. Lymphatic mapping and sentinel node biopsy in gastric cancer. Am J Surg. 2004;187:270-273. [PMID: 14769318 DOI: 10.1016/j.amjsurg.2003.11.013] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
2 Visser E, Brenkman H, Verhoeven R, Ruurda J, van Hillegersberg R. Weekday of gastrectomy for cancer in relation to mortality and oncological outcomes – A Dutch population-based cohort study. European Journal of Surgical Oncology (EJSO) 2017;43:1862-8. [DOI: 10.1016/j.ejso.2017.07.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
3 Roig-garcía J, Gironés-vilá J, Garsot-savall E, Puig-costa M, Rodríguez-hermosa J, Codina-cazador A. Gastrectomía por laparoscopia en el cáncer gástrico. Experiencia en una serie de 56 pacientes. Cirugía Española 2008;83:65-70. [DOI: 10.1016/s0009-739x(08)70508-6] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
4 Benjamin A, Merkow RP. Importance of Adequate Lymphadenectomy in Gastrointestinal Cancer. Cancer Treat Res 2016;168:331-43. [PMID: 29206381 DOI: 10.1007/978-3-319-34244-3_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Jansen EP, Boot H, Saunders MP, Crosby TD, Dubbelman R, Bartelink H, Verheij M, Cats A. A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys 2007;69:1424-8. [PMID: 17689023 DOI: 10.1016/j.ijrobp.2007.05.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
6 Wu XS, Wu WG, Li ML, Yang JH, Ding QC, Zhang L, Mu JS, Gu J, Dong P, Lu JH, Liu YB. Impact of being overweight on the surgical outcomes of patients with gastric cancer: A meta-analysis. World J Gastroenterol 2013; 19(28): 4596-4606 [PMID: 23901238 DOI: 10.3748/wjg.v19.i27.4596] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
7 Higashi T, Nakamura F, Saruki N, Sobue T. Establishing a quality measurement system for cancer care in Japan. Jpn J Clin Oncol 2013;43:225-32. [PMID: 23390306 DOI: 10.1093/jjco/hyt001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
8 Patriti A, Ceccarelli G, Ceribelli C, Bartoli A, Spaziani A, Cisano C, Cigliano S, Casciola L. Robot-assisted laparoscopic management of cardia carcinoma according to Siewert recommendations. Int J Med Robotics Comput Assist Surg 2011;7:170-7. [DOI: 10.1002/rcs.385] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
9 Allum WH; European Union Network of Excellence (EUNE) for Gastric Cancer Steering Group. Gastric cancer in Europe. British Journal of Surgery 2008;95:406-8. [DOI: 10.1002/bjs.6197] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
10 Wohnrath DR, Araujo RLC. Positive node-ratio in curative-intent treatment for gastric cancer is a strong independent prognostic factor for 5-year overall survival. J Surg Oncol 2020;121:777-83. [PMID: 31691299 DOI: 10.1002/jso.25755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
11 Kim J, Sun CL, Mailey B, Prendergast C, Artinyan A, Bhatia S, Pigazzi A, Ellenhorn JD. Race and ethnicity correlate with survival in patients with gastric adenocarcinoma. Ann Oncol. 2010;21:152-160. [PMID: 19622590 DOI: 10.1093/annonc/mdp290] [Cited by in Crossref: 90] [Cited by in F6Publishing: 91] [Article Influence: 6.9] [Reference Citation Analysis]
12 Hashimoto T, Kurokawa Y, Mori M, Doki Y. Update on the Treatment of Gastric Cancer. JMA J 2018;1:40-9. [PMID: 33748521 DOI: 10.31662/jmaj.2018-0006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
13 Soon YY, Leong CN, Tey JC, Tham IW, Lu JJ. Postoperative chemo-radiotherapy versus chemotherapy for resected gastric cancer: a systematic review and meta-analysis. J Med Imaging Radiat Oncol 2014;58:483-96. [PMID: 24995607 DOI: 10.1111/1754-9485.12190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
14 Choi YY, An JY, Katai H, Seto Y, Fukagawa T, Okumura Y, Kim DW, Kim HI, Cheong JH, Hyung WJ, Noh SH. A Lymph Node Staging System for Gastric Cancer: A Hybrid Type Based on Topographic and Numeric Systems. PLoS One 2016;11:e0149555. [PMID: 26967161 DOI: 10.1371/journal.pone.0149555] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
15 Lacueva J, Perez-Ramos M, Soto JL, Oliver I, Andrada E, Medrano J, Perez-Vazquez T, Arroyo A, Carrato A, Ferragut JA. Multidrug resistance-associated protein (MRP1) gene is strongly expressed in gastric carcinomas. Analysis by immunohistochemistry and real-time quantitative RT-PCR. Histopathology. 2005;46:389-395. [PMID: 15810950 DOI: 10.1111/j.1365-2559.2005.02100.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
16 Swan R, Miner TJ. Current role of surgical therapy in gastric cancer. World J Gastroenterol 2006; 12(3): 372-379 [PMID: 16489635 DOI: 10.3748/wjg.v12.i3.372] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
17 Rhome RM, Ru M, Moshier E, Mazumdar M, Buckstein MH. Stage-matched survival differences by ethnicity among gastric cancer patients of Asian ancestry treated in the United States. J Surg Oncol 2019;119:737-48. [PMID: 30694524 DOI: 10.1002/jso.25389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Brenkman HJ, Haverkamp L, Ruurda JP, van Hillegersberg R. Worldwide practice in gastric cancer surgery. World J Gastroenterol 2016; 22(15): 4041-4048 [PMID: 27099448 DOI: 10.3748/wjg.v22.i15.4041] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
19 Dikken JL, van de Velde CJ, Coit DG, Shah MA, Verheij M, Cats A. Treatment of resectable gastric cancer. Therap Adv Gastroenterol. 2012;5:49-69. [PMID: 22282708 DOI: 10.1177/1756283x11410771] [Cited by in Crossref: 48] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
20 Msika S, Benhamiche AM, Jouve JL, Rat P, Faivre J. Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer. 2000;36:390-396. [PMID: 10708942 DOI: 10.1016/s0959-8049(99)00308-1] [Cited by in Crossref: 78] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
21 Pretz JL, Wo JY, Mamon HJ, Kachnic LA, Hong TS. Chemoradiation therapy: localized esophageal, gastric, and pancreatic cancer. Surg Oncol Clin N Am 2013;22:511-24. [PMID: 23622077 DOI: 10.1016/j.soc.2013.02.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
22 Vuong B, Graff-baker AN, Dehal A, Stern S, Fujita M, Goldfarb M, Bilchik AJ. Survival Analysis with Extended Lymphadenectomy for Gastric Cancer: Removing Stage Migration from the Equation. The American Surgeon 2017;83:1074-9. [DOI: 10.1177/000313481708301012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
23 Thiels CA, Hanson KT, Habermann EB, Boughey JC, Grotz TE. Integrated cancer networks improve compliance with national guidelines and outcomes for resectable gastric cancer. Cancer 2019;126:1283-94. [DOI: 10.1002/cncr.32660] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
24 Han J, Nie Z, Li P, Shi H, Wang S, Li Q, Zhang R, Qiao Y, Huang K, Fu Z. Comparison of Treatment Modalities for Locally Advanced Gastric Cancer: A Propensity Score Matching Analysis. J Cancer 2020;11:4421-30. [PMID: 32489461 DOI: 10.7150/jca.41082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Danielson H, Kokkola A, Kiviluoto T, Sirén J, Louhimo J, Kivilaakso E, Puolakkainen P. Clinical Outcome after D1 vs D2–3 Gastrectomy for Treatment of Gastric Cancer. Scand J Surg 2007;96:35-40. [DOI: 10.1177/145749690709600107] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
26 Riall TS, Cameron JL, Lillemoe KD, Campbell KA, Sauter PK, Coleman J, Abrams RA, Laheru D, Hruban RH, Yeo CJ. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival. J Gastrointest Surg. 2005;9:1191-1204; discussion 1204-1206. [PMID: 16332474 DOI: 10.1016/j.gassur.2005.08.034] [Cited by in Crossref: 164] [Cited by in F6Publishing: 136] [Article Influence: 10.3] [Reference Citation Analysis]
27 Zhang Z, Huang JY, Wang PL, Hou WB, Yin SC, Xu HM. Should All Stage N3b Patients with Advanced Gastric Cancer Be Considered Equivalent? A 30-Year Single Center Study. J Gastrointest Surg 2019;23:1742-7. [PMID: 30238247 DOI: 10.1007/s11605-018-3945-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
28 Bringeland E, Wasmuth H, Johnsen G, Johnsen T, Juel I, Mjønes P, Uggen P, Ystgaard B, Grønbech J. Outcomes among patients treated for gastric adenocarcinoma during the last decade: Gastric Cancer in the Last Decade. J Surg Oncol 2013;107:752-7. [DOI: 10.1002/jso.23320] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
29 Hosch SB, Scheunemann P, Izbicki JR. Minimal residual disease in non-small-cell lung cancer. Semin Surg Oncol 2001;20:278-81. [PMID: 11747269 DOI: 10.1002/ssu.1045] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
30 Kim Y, Kim KM, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Lee SJ, Kim ST, Lee J, Park JO, Park YS, Lim HY, Kang WK, Park SH. Adjuvant Chemotherapy with or without Concurrent Radiotherapy for Patients with Stage IB Gastric Cancer: a Subgroup Analysis of the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Phase III Trial. J Gastric Cancer 2018;18:348-55. [PMID: 30607298 DOI: 10.5230/jgc.2018.18.e34] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
31 Enzinger PC, Benedetti JK, Meyerhardt JA, McCoy S, Hundahl SA, Macdonald JS, Fuchs CS. Impact of hospital volume on recurrence and survival after surgery for gastric cancer. Ann Surg. 2007;245:426-434. [PMID: 17435550 DOI: 10.1097/01.sla.0000245469.35088.42] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
32 Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen JH, Li AF, Lui WY, Whang-Peng J. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol. 2006;7:309-315. [PMID: 16574546 DOI: 10.1016/s1470-2045(06)70623-4] [Cited by in Crossref: 424] [Cited by in F6Publishing: 191] [Article Influence: 26.5] [Reference Citation Analysis]
33 Meyer HJ, Hölscher AH, Lordick F, Messmann H, Mönig S, Schumacher C, Stahl M, Wilke H, Möhler M. [Current S3 guidelines on surgical treatment of gastric carcinoma]. Chirurg 2012;83:31-7. [PMID: 22127381 DOI: 10.1007/s00104-011-2149-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
34 Meimarakis G, Winter H, Assmann I, Kopp R, Lehn N, Kist M, Stolte M, Jauch KW, Hatz RA. Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol. 2006;7:211-222. [PMID: 16510330 DOI: 10.1016/s1470-2045(06)70586-1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
35 Wagner AD, Schneider PM, Fleig WE. The role of chemotherapy in patients with established gastric cancer. Best Pract Res Clin Gastroenterol 2006;20:789-99. [PMID: 16997160 DOI: 10.1016/j.bpg.2006.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
36 Di Leo A, Marrelli D, Roviello F, Bernini M, Minicozzi A, Giacopuzzi S, Pedrazzani C, Baiocchi LG, de Manzoni G. Lymph node involvement in gastric cancer for different tumor sites and T stage: Italian Research Group for Gastric Cancer (IRGGC) experience. J Gastrointest Surg. 2007;11:1146-1153. [PMID: 17576611 DOI: 10.1007/s11605-006-0062-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
37 Yasuda K, Shiraishi N, Adachi Y, Inomata M, Sato K, Kitano S. Risk factors for complications following resection of large gastric cancer. Br J Surg 2001;88:873-7. [PMID: 11412261 DOI: 10.1046/j.0007-1323.2001.01782.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
38 Douglass HO, Hundahl SA, Macdonald JS, Khatri VP. Gastric cancer: D2 dissection or low Maruyama Index-based surgery--a debate. Surg Oncol Clin N Am. 2007;16:133-155. [PMID: 17336241 DOI: 10.1016/j.soc.2006.10.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
39 Yang SH, Zhang YC, Yang KH, Li YP, He XD, Tian JH, Lv TH, Hui YH, Sharma N. An evidence-based medicine review of lymphadenectomy extent for gastric cancer. Am J Surg. 2009;197:246-251. [PMID: 18722583 DOI: 10.1016/j.amjsurg.2008.05.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
40 Weber SM, Karpeh MS. Randomized Clinical Trials in Gastric Cancer. Surgical Oncology Clinics of North America 2002;11:111-31. [DOI: 10.1016/s1055-3207(03)00077-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
41 Pedrazzani C, Marrelli D, Rampone B, De Stefano A, Corso G, Fotia G, Pinto E, Roviello F. Postoperative Complications and Functional Results After Subtotal Gastrectomy with Billroth II Reconstruction for Primary Gastric Cancer. Dig Dis Sci 2007;52:1757-63. [DOI: 10.1007/s10620-006-9655-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
42 Mansfield PF. Lymphadenectomy for gastric cancer. J Clin Oncol. 2004;22:2759-2761. [PMID: 15199086 DOI: 10.1200/jco.2004.02.995] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
43 Quéro L, Guillerm S, Hennequin C. Neoadjuvant or adjuvant therapy for gastric cancer. World J Gastrointest Oncol 2015; 7(8): 102-110 [PMID: 26306142 DOI: 10.4251/wjgo.v7.i8.102] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
44 Bruixola G, Segura Á, Díaz-Beveridge R, Caballero J, Bennis MH, Palomar L, Giménez A, Mingol F, García-Mora C, Aparicio J. Adjuvant chemoradiation in gastric cancer: long-term outcomes and prognostic factors from a single institution. Tumori 2015;101:517-23. [PMID: 26045120 DOI: 10.5301/tj.5000344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Francescutti V, Choy I, Biertho L, Goldsmith CH, Anvari M. Gastrectomy and esophagogastrectomy for proximal and distal gastric lesions: a comparison of open and laparoscopic procedures. Surg Innov 2009;16:134-9. [PMID: 19468037 DOI: 10.1177/1553350609336738] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
46 Kasakura Y, Mochizuki F, Wakabayashi K, Kochi M, Fujii M, Takayama T. An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution. J Surg Res. 2002;103:252-259. [PMID: 11922742 DOI: 10.1006/jsre.2002.6368] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
47 Patriti A, Ceccarelli G, Bellochi R, Bartoli A, Spaziani A, Di Zitti L, Casciola L. Robot-assisted laparoscopic total and partial gastric resection with D2 lymph node dissection for adenocarcinoma. Surg Endosc 2008;22:2753-60. [PMID: 18813994 DOI: 10.1007/s00464-008-0129-0] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 6.2] [Reference Citation Analysis]
48 Yu W, Yun YK, Whang I, Choi GS. The surgeon's expertise-outcome relationship in gastric cancer surgery. Cancer Res Treat 2005;37:143-7. [PMID: 19956495 DOI: 10.4143/crt.2005.37.3.143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
49 Mocan L. Surgical Management of Gastric Cancer: A Systematic Review. J Clin Med 2021;10:2557. [PMID: 34207898 DOI: 10.3390/jcm10122557] [Reference Citation Analysis]
50 Barreto SG, Sirohi B. Why should we perform a D2 lymphadenectomy in gastric cancer? Future Oncol 2017;13:2009-12. [PMID: 28984466 DOI: 10.2217/fon-2017-0282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
51 Moslim MA, Handorf E, Reddy SS, Greco SH, Farma JM. Partial Gastrectomy is Associated with Improved Overall Survival in Signet-Ring Cell Gastric Cancer. J Surg Res 2021;266:27-34. [PMID: 33975027 DOI: 10.1016/j.jss.2021.04.005] [Reference Citation Analysis]
52 Brar SS, Seevaratnam R, Cardoso R, Law C, Helyer L, Coburn N. A systematic review of spleen and pancreas preservation in extended lymphadenectomy for gastric cancer. Gastric Cancer. 2012;15 Suppl 1:S89-S99. [PMID: 21915699 DOI: 10.1007/s10120-011-0087-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
53 Morgagni P, Tringali D, La Barba G, Vittimberga G, Ercolani G. Historical assumptions of lymphadenectomy. Transl Gastroenterol Hepatol 2016;1:90. [PMID: 28138655 DOI: 10.21037/tgh.2016.11.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
54 Qin HL, Lin CH, Zhang XL. Evaluation of intraoperative radiotherapy for gastric carcinoma with D2 and D3 surgical resection. World J Gastroenterol 2006; 12(43): 7033-7037 [PMID: 17109501 DOI: 10.3748/wjg.v12.i43.7033] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
55 Miki Y, Tokunaga M, Bando E, Tanizawa Y, Kawamura T, Terashima M. Evaluation of postoperative pancreatic fistula after total gastrectomy with D2 lymphadenectomy by ISGPF classification. J Gastrointest Surg. 2011;15:1969-1976. [PMID: 21833745 DOI: 10.1007/s11605-011-1628-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
56 Mingol F, Gallego J, Orduña A, Martinez-Blasco A, Sola-Vera J, Moya P, Morcillo MA, Ruiz JA, Calpena R, Lacueva FJ. Tumor regression and survival after perioperative MAGIC-style chemotherapy in carcinoma of the stomach and gastroesophageal junction. BMC Surg 2015;15:66. [PMID: 25997454 DOI: 10.1186/s12893-015-0054-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
57 Fukunaga T, Hiki N, Kubota T, Nunobe S, Tokunaga M, Nohara K, Sano T, Yamaguchi T. Oncologic Outcomes of Laparoscopy-Assisted Distal Gastrectomy for Gastric Cancer. Ann Surg Oncol 2013;20:2676-82. [DOI: 10.1245/s10434-013-2930-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
58 Biondi A, D'ugo D, Cananzi F, Papa V, Borasi A, Sicoli F, Degiuli M, Doglietto G, Persiani R. Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? European Journal of Surgical Oncology (EJSO) 2015;41:779-86. [DOI: 10.1016/j.ejso.2015.03.227] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
59 Jain VK, Cunningham D, Chau I. Preoperative and Postoperative Chemotherapy for Gastric Cancer. Surgical Oncology Clinics of North America 2012;21:99-112. [DOI: 10.1016/j.soc.2011.09.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
60 Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Di Paola M, Recher A, Ponzano C. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: Five-year results of a randomized prospective trial. Ann Surg. 2005;241:232-237. [PMID: 15650632 DOI: 10.1097/01.sla.0000151892.35922.f2] [Cited by in Crossref: 632] [Cited by in F6Publishing: 554] [Article Influence: 37.2] [Reference Citation Analysis]
61 Orhan O, Eroglu C, Kaplan B, Ucar K, Altinbas M, Ozkan M, Unal D, Yildiz OG, Soyuer S. Whole abdominal field versus standard field radiotherapy plus concomitant and adjuvant chemotherapy for patients with locally advanced gastric cancer. J Radiat Res 2011;52:168-75. [PMID: 21343682 DOI: 10.1269/jrr.10075] [Reference Citation Analysis]
62 Alimoglu O, Atak I, Eren T. Robot-assisted laparoscopic (RAL) surgery for gastric cancer. Int J Med Robot 2014;10:257-62. [PMID: 24375986 DOI: 10.1002/rcs.1566] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
63 Watanabe M, Kinoshita T, Enomoto N, Shibasaki H, Nishida T. Clinical Significance of Splenic Hilar Dissection with Splenectomy in Advanced Proximal Gastric Cancer: An Analysis at a Single Institution in Japan. World J Surg 2016;40:1165-71. [DOI: 10.1007/s00268-015-3362-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
64 Shiraishi N, Sato K, Yasuda K, Inomata M, Kitano S. Multivariate prognostic study on large gastric cancer. J Surg Oncol. 2007;96:14-18. [PMID: 17582596 DOI: 10.1002/jso.20631] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 4.8] [Reference Citation Analysis]
65 McCulloch P. The role of surgery in patients with advanced gastric cancer. Best Pract Res Clin Gastroenterol. 2006;20:767-787. [PMID: 16997159 DOI: 10.1016/j.bpg.2006.03.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
66 Roukos DH. Adjuvant chemoradiotherapy in gastric cancer: Wave goodbye to extensive surgery? Annals of Surgical Oncology 2002;9:220-1. [DOI: 10.1007/bf02573057] [Cited by in Crossref: 64] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
67 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)60617-6] [Cited by in Crossref: 635] [Cited by in F6Publishing: 407] [Article Influence: 48.8] [Reference Citation Analysis]
68 Chen HN, Chen XZ, Zhang WH, Chen XL, Yang K, Liu JP, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK. Necessity of harvesting at least 25 lymph nodes in patients with stage N2-N3 resectable gastric cancer: a 10-year, single-institution cohort study. Medicine (Baltimore) 2015;94:e620. [PMID: 25761190 DOI: 10.1097/MD.0000000000000620] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
69 Deng J, Liang H, Sun D, Pan Y, Liu Y, Wang D. Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis. Langenbecks Arch Surg. 2011;396:615-623. [PMID: 21380618 DOI: 10.1007/s00423-011-0753-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
70 Crookes PF. Gastric cancer. Clin Obstet Gynecol 2002;45:892-903. [PMID: 12370631 DOI: 10.1097/00003081-200209000-00036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
71 Schwarz RE, Smith DD. Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on U.S. population data. J Gastrointest Surg. 2007;11:158-165. [PMID: 17390167 DOI: 10.1007/s11605-006-0018-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
72 Chang JS, Choi Y, Shin J, Kim KH, Keum KC, Kim HS, Koom WS, Park EC. Patterns of Care for Radiotherapy in the Neoadjuvant and Adjuvant Treatment of Gastric Cancer: A Twelve-Year Nationwide Cohort Study in Korea. Cancer Res Treat 2018;50:118-28. [PMID: 28279066 DOI: 10.4143/crt.2016.575] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
73 Kodera Y. The current state of stomach cancer surgery in the world. Jpn J Clin Oncol 2016;46:1062-71. [DOI: 10.1093/jjco/hyw117] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
74 Song W, Chen JH, Zhang XH, Xu JB, He YL, Cai SR, Han FH, Chen CQ. Effect of somatostatin in advanced gastric cancer after D2 radical gastrectomy. World J Gastroenterol 2014; 20(40): 14927-14933 [PMID: 25356053 DOI: 10.3748/wjg.v20.i40.14927] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. The Lancet Oncology 2010;11:439-49. [DOI: 10.1016/s1470-2045(10)70070-x] [Cited by in Crossref: 1005] [Cited by in F6Publishing: 509] [Article Influence: 83.8] [Reference Citation Analysis]
76 Seo KW, Yoon KY. [Individualized surgery for gastric cancer]. Korean J Gastroenterol 2011;57:335-9. [PMID: 21694484 DOI: 10.4166/kjg.2011.57.6.335] [Reference Citation Analysis]
77 Wang X, Wan F, Pan J, Yu G, Chen Y, Wang J. Prognostic value of the ratio of metastatic lymph nodes in gastric cancer: An analysis based on a Chinese population. J Surg Oncol 2009;99:329-34. [DOI: 10.1002/jso.21247] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
78 Sharma A, Radhakrishnan V. Gastric cancer in India. Indian J Med Paediatr Oncol 2021;32:12-6. [DOI: 10.4103/0971-5851.81884] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
79 Komatsu S, Ichikawa D, Nishimura M, Kosuga T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Otsuji E. Evaluation of prognostic value and stage migration effect using positive lymph node ratio in gastric cancer. Eur J Surg Oncol 2017;43:203-9. [PMID: 27595506 DOI: 10.1016/j.ejso.2016.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
80 Hundahl SA. Surgery for gastric cancer: what the trials indicate. Surg Oncol Clin N Am 2012;21:79-97. [PMID: 22098833 DOI: 10.1016/j.soc.2011.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
81 Takahashi T, Saikawa Y, Kitagawa Y. Gastric cancer: current status of diagnosis and treatment. Cancers (Basel). 2013;5:48-63. [PMID: 24216698 DOI: 10.3390/cancers5010048] [Cited by in Crossref: 102] [Cited by in F6Publishing: 105] [Article Influence: 11.3] [Reference Citation Analysis]
82 Lacueva FJ, Oliver I, Costa D, Calpena R. To perform or not D2 extended lymphadenectomy in patients with gastric cancer in the West. Effectiveness and limits. Clin Transl Oncol 2006;8:139-41. [PMID: 16648110 DOI: 10.1007/s12094-006-0001-4] [Reference Citation Analysis]
83 Park SH, Sohn TS, Lee J, Lim DH, Hong ME, Kim K, Sohn I, Jung SH, Choi MG, Lee JH, Bae JM, Kim S, Kim ST, Park JO, Park YS, Lim HY, Kang WK. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses. JCO 2015;33:3130-6. [DOI: 10.1200/jco.2014.58.3930] [Cited by in Crossref: 209] [Cited by in F6Publishing: 126] [Article Influence: 29.9] [Reference Citation Analysis]
84 Strong VE, Yoon SS. Extended lymphadenectomy in gastric cancer is debatable. World J Surg. 2013;37:1773-1777. [PMID: 23649527 DOI: 10.1007/s00268-013-2070-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
85 Davis PA, Sano T. The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions? Crit Rev Oncol Hematol. 2001;40:77-94. [PMID: 11578917 DOI: 10.1016/s1040-8428(00)00131-1] [Cited by in Crossref: 73] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
86 Sasako M, Inoue M, Lin JT, Khor C, Yang HK, Ohtsu A. Gastric Cancer Working Group report. Jpn J Clin Oncol. 2010;40:i28-i37. [PMID: 20870917 DOI: 10.1093/jjco/hyq124] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 6.1] [Reference Citation Analysis]
87 Peeters KC, Hundahl SA, Kranenbarg EK, Hartgrink H, van de Velde CJ. Low Maruyama index surgery for gastric cancer: blinded reanalysis of the Dutch D1-D2 trial. World J Surg. 2005;29:1576-1584. [PMID: 16317484 DOI: 10.1007/s00268-005-7907-9] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 3.5] [Reference Citation Analysis]
88 Jeong O, Park YK, Ryu SY, Kim YJ. Effect of age on surgical outcomes of extended gastrectomy with D2 lymph node dissection in gastric carcinoma: prospective cohort study. Ann Surg Oncol 2010;17:1589-96. [PMID: 20099039 DOI: 10.1245/s10434-010-0916-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
89 Jalaly NY, Valizadeh N, Azizi S, Kamani F, Hassanzadeh M. Sentinel lymph node mapping and biopsy using radioactive tracer in gastric cancer. ANZ J Surg 2014;84:454-8. [PMID: 22988829 DOI: 10.1111/j.1445-2197.2012.06275.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
90 Sauvanet A, Msika S. [Gastric antrum cancer: what intervention?]. Ann Chir 2005;130:483-6. [PMID: 16023610 DOI: 10.1016/j.anchir.2005.06.002] [Reference Citation Analysis]
91 Slim K, Blay JY, Brouquet A, Chatelain D, Comy M, Delpero JR, Denet C, Elias D, Fléjou JF, Fourquier P, Fuks D, Glehen O, Karoui M, Kohneh-Shahri N, Lesurtel M, Mariette C, Mauvais F, Nicolet J, Perniceni T, Piessen G, Regimbeau JM, Rouanet P, sauvanet A, Schmitt G, Vons C, Lasser P, Belghiti J, Berdah S, Champault G, Chiche L, Chipponi J, Chollet P, De Baère T, Déchelotte P, Garcier JM, Gayet B, Gouillat C, Kianmanesh R, Laurent C, Meyer C, Millat B, Msika S, Nordlinger B, Paraf F, Partensky C, Peschaud F, Pocard M, Sastre B, Scoazec JY, Scotté M, Triboulet JP, Trillaud H, Valleur P. [Digestive oncology: surgical practices]. J Chir (Paris) 2009;146 Suppl 2:S11-80. [PMID: 19435621 DOI: 10.1016/S0021-7697(09)72398-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
92 Landheer M, Therasse P, van de Velde C. The importance of quality assurance in surgical oncology. European Journal of Surgical Oncology (EJSO) 2002;28:571-602. [DOI: 10.1053/ejso.2002.1255] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
93 Jiang L, Yang KH, Guan QL, Zhao P, Chen Y, Tian JH. Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis. J Surg Oncol. 2013;107:807-814. [PMID: 23512524 DOI: 10.1002/jso.23325] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
94 Spolverato G, Ejaz A, Kim Y, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Votanopoulos K, Acher AW, Jin LX, Hawkins WG, Schmidt C, Kooby DA, Worhunsky D, Saunders N, Cho CS, Levine EA, Maithel SK, Pawlik TM. Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma. Ann Surg. 2015;262:991-998. [PMID: 25563867 DOI: 10.1097/sla.0000000000001040] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
95 Martiniuc A, Dumitrascu T, Ionescu M, Tudor S, Lacatus M, Herlea V, Vasilescu C. Pancreatic Fistula after D1+/D2 Radical Gastrectomy according to the Updated International Study Group of Pancreatic Surgery Criteria: Risk Factors and Clinical Consequences. Experience of Surgeons with High Caseloads in a Single Surgical Center in Eastern Europe. J Gastric Cancer 2021;21:16-29. [PMID: 33854810 DOI: 10.5230/jgc.2021.21.e3] [Reference Citation Analysis]
96 Peeters KC, van de Velde CJ. Surgical quality assurance in breast, gastric and rectal cancer. J Surg Oncol. 2003;84:107-112. [PMID: 14598352 DOI: 10.1002/jso.10312] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
97 Bilici A, Ustaalioglu BB, Seker M, Kefeli U, Canpolat N, Tekinsoy B, Ozugur S, Gumus M. The role of 18F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making? Eur J Nucl Med Mol Imaging. 2011;38:64-73. [PMID: 20838995 DOI: 10.1007/s00259-010-1611-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
98 Kumar S, Kumar N, Deo S, Bhoriwal S, Mandal A, Sharma A, Pathy S, Das P, Thulkar S, Bhatnagar S. Patterns of Multimodality Management of Gastric Cancer—Single Institutional Experience of 372 Cases From a Tertiary Care Center in North India. Front Oncol 2022;12:877493. [DOI: 10.3389/fonc.2022.877493] [Reference Citation Analysis]
99 Msika S, Kianmanesh R. Le traitement du cancer gastrique. Chirurgie 1999;124:560-7. [DOI: 10.1016/s0001-4001(00)88281-1] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
100 Vural S, Civil O, Kement M, Altuntas YE, Okkabaz N, Gezen C, Haksal M, Gundogan E, Oncel M. Risk factors for early postoperative morbidity and mortality in patients underwent radical surgery for gastric carcinoma: A single center experience. International Journal of Surgery 2013;11:1103-9. [DOI: 10.1016/j.ijsu.2013.09.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
101 He RB, Chen JQ. Pre-operative chemotherapy for gastric cancer. J Int Med Res 2009;37:1259-66. [PMID: 19930831 DOI: 10.1177/147323000903700501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
102 Kim MC, Kim HH, Jung GJ. Surgical outcome of laparoscopy-assisted gastrectomy with extraperigastric lymph node dissection for gastric cancer. Eur J Surg Oncol. 2005;31:401-405. [PMID: 15837047 DOI: 10.1016/j.ejso.2004.11.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
103 Sierra A, Regueira FM, Hernández-Lizoáin JL, Pardo F, Martínez-Gonzalez MA, A-Cienfuegos J. Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol. 2003;10:219-226. [PMID: 12679305 DOI: 10.1245/aso.2003.07.009] [Cited by in Crossref: 67] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
104 Pata G, Solaini L, Roncali S, Pasini M, Ragni F. Impact of obesity on early surgical and oncologic outcomes after total gastrectomy with "over-D1" lymphadenectomy for gastric cancer. World J Surg. 2013;37:1072-1081. [PMID: 23408049 DOI: 10.1007/s00268-013-1942-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
105 Cuschieri A, Talbot IC, Weeden S; MRC Upper GI Cancer Working Party. Influence of pathological tumour variables on long-term survival in resectable gastric cancer. Br J Cancer 2002;86:674-9. [PMID: 11875724 DOI: 10.1038/sj.bjc.6600161] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
106 Gil-rendo A, Hernández-lizoain, Martínez-regueira F, Sierra Martínez A, Rotellar Sastre F, Delgado MC, Azcarate VV, Idoate CP, Álvarez-cienfuegos J. Risk factors related to operative morbidity in patients undergoing gastrectomy for gastric cancer. Clin Transl Oncol 2006;8:354-61. [DOI: 10.1007/s12094-006-0182-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
107 Cady B. THE CHANGING ROLE OF THE SURGICAL ONCOLOGIST. Surgical Clinics of North America 2000;80:459-69. [DOI: 10.1016/s0039-6109(05)70195-x] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
108 Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D;  ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v38-v49. [PMID: 27664260 DOI: 10.1093/annonc/mdw350] [Cited by in Crossref: 609] [Cited by in F6Publishing: 563] [Article Influence: 101.5] [Reference Citation Analysis]
109 Roig J, Gironès J, Garsot E, Puig M, Pujades M, Rodríguez JI, Codina A. Video-assisted surgery in gastric cancer. Clin Transl Oncol 2006;8:213-7. [DOI: 10.1007/s12094-006-0013-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
110 Calpena R, Javier Lacueva F, Oliver I, Cansado P, Pérez F, Costa D, Compañ AF, Teresa Pérez M. Estado actual del tratamiento multidisciplinario del cáncer gástrico avanzado. Cirugía Española 2003;74:69-76. [DOI: 10.1016/s0009-739x(03)72191-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
111 Dassen AE, Lemmens VE, van de Poll-Franse LV, Creemers GJ, Brenninkmeijer SJ, Lips DJ, Vd Wurff AA, Bosscha K, Coebergh JW. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer. 2010;46:1101-1110. [PMID: 20219351 DOI: 10.1016/j.ejca.2010.02.013] [Cited by in Crossref: 98] [Cited by in F6Publishing: 89] [Article Influence: 8.2] [Reference Citation Analysis]
112 de Steur WO, Hartgrink HH, Dikken JL, Putter H, van de Velde CJ. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial. Br J Surg 2015;102:1388-93. [PMID: 26313463 DOI: 10.1002/bjs.9891] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
113 Allum WH. Optimal surgery for gastric cancer: is more always better? Recent Results Cancer Res. 2012;196:215-227. [PMID: 23129377 DOI: 10.1007/978-3-642-31629-6_15] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
114 Khushalani NI. Cancer of the Esophagus and Stomach. Mayo Clinic Proceedings 2008;83:712-22. [DOI: 10.1016/s0025-6196(11)60900-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 1] [Article Influence: 3.1] [Reference Citation Analysis]
115 Akagi T, Shiraishi N, Kitano S. Lymph node metastasis of gastric cancer. Cancers (Basel). 2011;3:2141-2159. [PMID: 24212800 DOI: 10.3390/cancers3022141] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
116 Batista TP, Martins MR. Lymph node dissection for gastric cancer: a critical review. Oncol Rev 2012;6:e12. [PMID: 25992202 DOI: 10.4081/oncol.2012.e12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
117 Lim DH, Kim HS, Park YS, Lee J, Park SH, Lim HY, Ji SH, Park MJ, Yi SY, An JY, Sohn TS, Noh JH, Bae JM, Kim S, Park CK, Kang WK. Metastatic lymph node in gastric cancer; is it a real distant metastasis? BMC Cancer 2010;10:25. [PMID: 20113485 DOI: 10.1186/1471-2407-10-25] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
118 Shiozaki H, Shimodaira Y, Elimova E, Wadhwa R, Sudo K, Harada K, Estrella JS, Das P, Badgwell B, Ajani JA. Evolution of gastric surgery techniques and outcomes. Chin J Cancer 2016;35:69. [PMID: 27460019 DOI: 10.1186/s40880-016-0134-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
119 Joharatnam-Hogan N, Shiu KK, Khan K. Challenges in the treatment of gastric cancer in the older patient. Cancer Treat Rev. 2020;85:101980. [PMID: 32065879 DOI: 10.1016/j.ctrv.2020.101980] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
120 Kauppila JH, Lagergren J. The surgical management of esophago-gastric junctional cancer. Surg Oncol. 2016;25:394-400. [PMID: 27916171 DOI: 10.1016/j.suronc.2016.09.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
121 Sun X, Liu X, Liu J, Chen S, Xu D, Li W, Zhan Y, Li Y, Chen Y, Zhou Z. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer. Chin J Cancer. 2016;35:57. [PMID: 27342313 DOI: 10.1186/s40880-016-0122-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
122 Maehara Y, Kakeji Y, Koga T, Emi Y, Baba H, Akazawa K, Sugimachi K. Therapeutic value of lymph node dissection and the clinical outcome for patients with gastric cancer. Surgery. 2002;131:S85-S91. [PMID: 11821792 DOI: 10.1067/msy.2002.119309] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
123 Alimoğlu O, Atak İ, Eren T, Kılıç A. Robot assisted laparoscopic (RAL) gastrectomy: case series and a review of the literature. Ulus Cerrahi Derg 2013;29:187-91. [PMID: 25931874 DOI: 10.5152/UCD.2013.2045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
124 Kappas AM, Fatouros M, Roukos DH. It Is Still Not the Time to Change Surgical Strategy for Gastric Cancer: In Reply. Ann Surg Oncol 2005;12:194-6. [DOI: 10.1245/aso.2005.11.914] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
125 Feliu-Palà X, Besora-Canal P, Clavería-Puig R, Viñas-Trullen X, Salazar-Terceros D, Fernández-Sallent E. [Laparoscopic gastrectomy in the treatment of gastric cancer]. Cir Esp 2006;79:231-6. [PMID: 16753103 DOI: 10.1016/s0009-739x(06)70858-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
126 Schwarz RE, Kelsen DP. Postoperative Adjuvant Chemoradiation Therapy for Patients With Resected Gastric Cancer: Intergroup 116. JCO 2001;19:1879-80. [DOI: 10.1200/jco.2001.19.6.1879] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
127 Park SH, Son T, Seo WJ, Lee JH, Choi YY, Kim HI, Cheong JH, Noh SH, Hyung WJ. Prognostic Impact of Extended Lymph Node Dissection versus Limited Lymph Node Dissection on pN0 Proximal Advanced Gastric Cancer: a Propensity Score Matching Analysis. J Gastric Cancer 2019;19:212-24. [PMID: 31245166 DOI: 10.5230/jgc.2019.19.e20] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
128 Forshaw MJ, Gossage JA, Ockrim J, Atkinson SW, Mason RC. Left thoracoabdominal esophagogastrectomy: still a valid operation for carcinoma of the distal esophagus and esophagogastric junction. Diseases of the Esophagus 2006;19:340-5. [DOI: 10.1111/j.1442-2050.2006.00593.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
129 van de Velde CJ. Current role of surgery and multimodal treatment in localized gastric cancer. Ann Oncol 2008;19 Suppl 5:v93-8. [PMID: 18611909 DOI: 10.1093/annonc/mdn319] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
130 Ng KK. Is laparoscopy-assisted distal gastrectomy a superior alternative to the open approach? J Surg Res 2011;165:46-8. [PMID: 20934712 DOI: 10.1016/j.jss.2010.08.045] [Reference Citation Analysis]
131 Kirchoff DD, Deutsch GB, Fujita M, Lee DY, Sim MS, Lee JH, Bilchik AJ. Overall Survival Is Impacted by Birthplace and Not Extent of Surgery in Asian Americans with Resectable Gastric Cancer. J Gastrointest Surg 2015;19:1966-73. [PMID: 26307345 DOI: 10.1007/s11605-015-2919-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
132 Kappas AM, Fatouros M, Roukos DH. Is it Time to Change Surgical Strategy for Gastric Cancer in the United States? Ann Surg Oncol 2004;11:727-30. [DOI: 10.1245/aso.2004.05.907] [Cited by in Crossref: 69] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
133 Lo S, Wu C, Shen K, Hsieh M, Lui W. Higher morbidity and mortality after combined total gastrectomy and pancreaticosplenectomy for gastric cancer. World J Surg 2002;26:678-82. [DOI: 10.1007/s00268-001-0289-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
134 Gunderson LL, Tepper JE, Calvo FA, Callister MD. Gastric/GE Junction Cancer. Clinical Radiation Oncology. Elsevier; 2012. pp. 903-33. [DOI: 10.1016/b978-1-4377-1637-5.00045-6] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
135 Hu Y, Yoon SS. Extent of gastrectomy and lymphadenectomy for gastric adenocarcinoma. Surg Oncol 2021;40:101689. [PMID: 34839198 DOI: 10.1016/j.suronc.2021.101689] [Reference Citation Analysis]
136 Khosravi Shahi P, Díaz Muñoz de la Espada VM, García Alfonso P, Encina García S, Izarzugaza Perón Y, Arranz Cozar JL, Hernández Marín B, Pérez Manga G. Management of gastric adenocarcinoma. Clin Transl Oncol 2007;9:438-42. [PMID: 17652057 DOI: 10.1007/s12094-007-0082-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
137 Hundahl SA. Eliminating and suppressing local-regional disease in gastric cancer. J Surg Oncol 2005;90:171-3. [DOI: 10.1002/jso.20224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
138 Skoropad VY, Berdov BA, Zagrebin VM. Preoperative radiotherapy in combination with metronidazole for resectable gastric cancer: long-term results of a phase 2 study. Eur J Surg Oncol. 2003;29:166-170. [PMID: 12633560 DOI: 10.1053/ejso.2002.1324] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
139 Fitzgerald TL. Invited Commentary. J Am Coll Surg 2019;228:891-2. [PMID: 31128671 DOI: 10.1016/j.jamcollsurg.2019.04.009] [Reference Citation Analysis]
140 Popiela T, Kulig J, Kolodziejczyk P, Sierzega M. Long-term results of surgery for early gastric cancer. Br J Surg. 2002;89:1035-1042. [PMID: 12153632 DOI: 10.1046/j.1365-2168.2002.02156.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.0] [Reference Citation Analysis]
141 Kumagai K, Hiki N, Nunobe S, Irino T, Ida S, Ohashi M, Yamaguchi T, Sano T. Metastasis to the lymph nodes along the proper hepatic artery from adenocarcinoma of the stomach. Langenbecks Arch Surg 2016;401:677-85. [PMID: 27086307 DOI: 10.1007/s00423-016-1429-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
142 Gupta V, Raju K, Rao TS, Naidu CK, Goel V, Hariharan N, Nagarajuch R, Madhunarayana B. A Randomized Trial Comparing the Efficacy of Methylene Blue Dye Alone Versus Combination of Methylene Blue Dye and Radioactive Sulfur Colloid in Sentinel Lymph Node Biopsy for Early Stage Breast Cancer Patients. Indian J Surg Oncol 2020;11:216-22. [PMID: 32523266 DOI: 10.1007/s13193-019-01023-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
143 Roviello F, Pedrazzani C, Marrelli D, Di Leo A, Caruso S, Giacopuzzi S, Corso G, de Manzoni G. Super-extended (D3) lymphadenectomy in advanced gastric cancer. Eur J Surg Oncol. 2010;36:439-446. [PMID: 20392590 DOI: 10.1016/j.ejso.2010.03.008] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 4.0] [Reference Citation Analysis]
144 Nusrath S, Rao Thammineedi S, Patnaik SC, Saksena AR. ICG Fluorescence Navigation Surgery in Gastric Cancer: Role and Relevance. Indian J Surg Oncol 2021;12:711-2. [DOI: 10.1007/s13193-021-01411-8] [Reference Citation Analysis]
145 Weitz J, Jaques DP, Brennan M, Karpeh M. Association of splenectomy with postoperative complications in patients with proximal gastric and gastroesophageal junction cancer. Ann Surg Oncol. 2004;11:682-689. [PMID: 15231523 DOI: 10.1245/aso.2004.03.048] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
146 Vickery CW, Blazeby JM, Conroy T, Arraras J, Sezer O, Koller M, Rosemeyer D, Johnson CD, Alderson D;  EORTC Quality of Life Group. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. Eur J Cancer. 2001;37:966-971. [PMID: 11334720 DOI: 10.1016/s0959-8049(00)00417-2] [Cited by in Crossref: 106] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
147 Kavaliauskas P, Maziukas R, Samalavicius NE, Kuliavas J, Lunevicius R. Subtotal gastrectomy with conventional D2 lymphadenectomy for carcinoma of the distal gastric portion: A retrospective cohort study on clinical outcomes. Ann Med Surg (Lond) 2016;6:36-41. [PMID: 27141301 DOI: 10.1016/j.amsu.2016.01.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
148 Cady B. Fundamentals of contemporary surgical oncology: biologic principles and the threshold concept govern treatment and outcomes1 1No competing interests declared. Journal of the American College of Surgeons 2001;192:777-92. [DOI: 10.1016/s1072-7515(01)00856-0] [Cited by in Crossref: 9] [Article Influence: 0.4] [Reference Citation Analysis]
149 McCulloch P, Nita ME, Kazi H, Gama-Rodrigues JJ. WITHDRAWN: Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev. 2012;1:CD001964. [PMID: 22258947 DOI: 10.1002/14651858.cd001964.pub3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
150 Shum H, Rajdev L. Multimodality management of resectable gastric cancer: A review. World J Gastrointest Oncol 2014; 6(10): 393-402 [PMID: 25320655 DOI: 10.4251/wjgo.v6.i10.393] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
151 Roviello F, Marrelli D, Morgagni P, de Manzoni G, di Leo A, Vindigni C, Saragoni L, Tomezzoli A, Kurihara H; Italian Research Group for Gastric Cancer. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: A longitudinal multicenter study. Annals of Surgical Oncology 2002;9:894-900. [DOI: 10.1007/bf02557527] [Cited by in Crossref: 62] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
152 Allum WH, Griffin SM, Watson A, Colin-Jones D; Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland., British Society of Gastroenterology., British Association of Surgical Oncology. Guidelines for the management of oesophageal and gastric cancer. Gut 2002;50 Suppl 5:v1-23. [PMID: 12049068 DOI: 10.1136/gut.50.90005.v1] [Cited by in F6Publishing: 49] [Reference Citation Analysis]
153 Chang JS, Koom WS, Lee Y, Yoon HI, Lee HS. Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: Is radiotherapy necessary after D2-dissection? World J Gastroenterol 2014; 20(36): 12900-12907 [PMID: 25278687 DOI: 10.3748/wjg.v20.i36.12900] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
154 Gretschel S, Christoph F, Bembenek A, Estevez-Schwarz L, Schneider U, Schlag PM. Body mass index does not affect systematic D2 lymph node dissection and postoperative morbidity in gastric cancer patients. Ann Surg Oncol. 2003;10:363-368. [PMID: 12734083 DOI: 10.1245/aso.2003.07.011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
155 Lacueva FJ, Calpena R. Gastric cancer recurrence: clues for future approaches to avoiding an old problem. J Clin Gastroenterol 2001;32:3-4. [PMID: 11154165 DOI: 10.1097/00004836-200101000-00002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
156 Park SR, Kang Y. Perioperative treatments for resectable gastric cancer. J Korean Med Assoc 2015;58:201. [DOI: 10.5124/jkma.2015.58.3.201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
157 Spathis A, Georgoulakis J, Foukas P, Kefala M, Leventakos K, Machairas A, Panayiotides I, Karakitsos P. KRAS and BRAF mutation analysis from liquid-based cytology brushings of colorectal carcinoma in comparison with formalin-fixed, paraffin-embedded tissue. Anticancer Res. 2010;30:1969-1975. [PMID: 20651341 DOI: 10.1097/cad.0b013e328338b6a5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
158 Gholami S, Janson L, Worhunsky DJ, Tran TB, Squires MH 3rd, Jin LX, Spolverato G, Votanopoulos KI, Schmidt C, Weber SM, Bloomston M, Cho CS, Levine EA, Fields RC, Pawlik TM, Maithel SK, Efron B, Norton JA, Poultsides GA. Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative. J Am Coll Surg. 2015;221:291-299. [PMID: 26206635 DOI: 10.1016/j.jamcollsurg.2015.04.024] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 5.9] [Reference Citation Analysis]
159 Brenner B, Shah MA, Karpeh MS, Gonen M, Brennan MF, Coit DG, Klimstra DS, Tang LH, Kelsen DP. A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Ann Oncol. 2006;17:1404-1411. [PMID: 16788003 DOI: 10.1093/annonc/mdl133] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
160 Lee WJ. No therapeutic effect of extended lymph node dissection for gastric cancer. J Clin Oncol 2005;23:1592-3; author reply 1593. [PMID: 15735148 DOI: 10.1200/JCO.2005.05.323] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
161 Stewart C, Chao J, Chen YJ, Lin J, Sullivan MJ, Melstrom L, Hyung WJ, Fong Y, Paz IB, Woo Y. Multimodality management of locally advanced gastric cancer-the timing and extent of surgery. Transl Gastroenterol Hepatol 2019;4:42. [PMID: 31231709 DOI: 10.21037/tgh.2019.05.02] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
162 Marrelli D, Ferrara F, Giacopuzzi S, Morgagni P, Di Leo A, De Franco L, Pedrazzani C, Saragoni L, De Manzoni G, Roviello F. Incidence and Prognostic Value of Metastases to "Posterior" and Para-aortic Lymph Nodes in Resectable Gastric Cancer. Ann Surg Oncol 2017;24:2273-80. [PMID: 28405772 DOI: 10.1245/s10434-017-5857-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
163 Foo M, Leong T. Adjuvant therapy for gastric cancer: Current and future directions. World J Gastroenterol 2014; 20(38): 13718-13727 [PMID: 25320509 DOI: 10.3748/wjg.v20.i38.13718] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
164 Biffi R, Chiappa A, Luca F, Pozzi S, Lo Faso F, Cenciarelli S, Andreoni B. Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients. J Surg Oncol. 2006;93:394-400. [PMID: 16550575 DOI: 10.1002/jso.20495] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
165 Quadri HS, Smaglo BG, Morales SJ, Phillips AC, Martin AD, Chalhoub WM, Haddad NG, Unger KR, Levy AD, Al-Refaie WB. Gastric Adenocarcinoma: A Multimodal Approach.Front Surg. 2017;4:42. [PMID: 28824918 DOI: 10.3389/fsurg.2017.00042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
166 Souza FO, Pereira DV, Santos LH, Antunes L, Chiesa J. Gastric cancer patients treated by a general or gastric cancer surgical team: a comparative study. Arq Gastroenterol 2008;45:28-33. [PMID: 18425225 DOI: 10.1590/s0004-28032008000100006] [Reference Citation Analysis]
167 Okajima W, Komatsu S, Ichikawa D, Kosuga T, Kubota T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Otsuji E. Prognostic impact of the number of retrieved lymph nodes in patients with gastric cancer. J Gastroenterol Hepatol 2016;31:1566-71. [PMID: 26840392 DOI: 10.1111/jgh.13306] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
168 Sturgeon CM, Duffy MJ, Hofmann BR, Lamerz R, Fritsche HA, Gaarenstroom K, Bonfrer J, Ecke TH, Grossman HB, Hayes P, Hoffmann RT, Lerner SP, Löhe F, Louhimo J, Sawczuk I, Taketa K, Diamandis EP; National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem 2010;56:e1-48. [PMID: 20207771 DOI: 10.1373/clinchem.2009.133124] [Cited by in Crossref: 146] [Cited by in F6Publishing: 119] [Article Influence: 12.2] [Reference Citation Analysis]
169 Tokunaga M, Ohyama S, Hiki N, Fukunaga T, Inoue H, Yamada K, Sano T, Yamaguchi T, Nakajima T. Therapeutic value of lymph node dissection in advanced gastric cancer with macroscopic duodenum invasion: is the posterior pancreatic head lymph node dissection beneficial? Ann Surg Oncol. 2009;16:1241-1246. [PMID: 19224285 DOI: 10.1245/s10434-009-0345-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
170 Foo M, Crosby T, Rackley T, Leong T. Role of (chemo)-radiotherapy in resectable gastric cancer. Clin Oncol (R Coll Radiol). 2014;26:541-550. [PMID: 24996375 DOI: 10.1016/j.clon.2014.06.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
171 Jain VK, Cunningham D, Rao S. Chemotherapy for operable gastric cancer: current perspectives. Indian J Surg Oncol. 2011;2:334-342. [PMID: 23204792 DOI: 10.1007/s13193-012-0139-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
172 Lawson JD, Sicklick JK, Fanta PT. Gastric cancer. Curr Probl Cancer. 2011;35:97-127. [PMID: 21635986 DOI: 10.1016/j.currproblcancer.2011.03.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
173 Oehler C, Ciernik IF. Radiation therapy and combined modality treatment of gastrointestinal carcinomas. Cancer Treatment Reviews 2006;32:119-38. [DOI: 10.1016/j.ctrv.2006.01.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
174 Marchet A, Mocellin S, Ambrosi A, de Manzoni G, Di Leo A, Marrelli D, Roviello F, Morgagni P, Saragoni L, Natalini G. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol. 2008;34:159-165. [PMID: 17566691 DOI: 10.1016/j.ejso.2007.04.018] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 5.1] [Reference Citation Analysis]
175 Fujitani K, Ajani JA, Crane CH, Feig BW, Pisters PW, Janjan N, Walsh GL, Swisher SG, Vaporciyan AA, Rice D, Welch A, Baker J, Faust J, Mansfield PF. Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction. Ann Surg Oncol. 2007;14:2010-2017. [PMID: 17342569 DOI: 10.1245/s10434-006-9198-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
176 Díaz Del Arco C, Ortega Medina L, Estrada Muñoz L, García Gómez de Las Heras S, Fernández Aceñero MJ. Pathologic Lymph Node Staging of Gastric Cancer. Am J Clin Pathol 2021:aqab031. [PMID: 34273159 DOI: 10.1093/ajcp/aqab031] [Reference Citation Analysis]
177 Degiuli M, Reddavid R, Tomatis M, Ponti A, Morino M, Sasako M; of the Italian Gastric Cancer Study Group (IGCSG). D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial. Eur J Cancer 2021;150:10-22. [PMID: 33887514 DOI: 10.1016/j.ejca.2021.03.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
178 Lehnert T, Buhl K, Dueck M, Hinz U, Herfarth C. Two-stage radical gastrectomy for perforated gastric cancer. Eur J Surg Oncol. 2000;26:780-784. [PMID: 11087645 DOI: 10.1053/ejso.2000.1003] [Cited by in Crossref: 59] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
179 Sasako M. Gastric cancer eastern experience. Surg Oncol Clin N Am. 2012;21:71-77. [PMID: 22098832 DOI: 10.1016/j.soc.2011.09.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
180 Tamura S, Takeno A, Miki H. Lymph node dissection in curative gastrectomy for advanced gastric cancer. Int J Surg Oncol. 2011;2011:748745. [PMID: 22312521 DOI: 10.1155/2011/748745] [Cited by in Crossref: 9] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
181 Elmessiry MM, El-Fayoumi TA, Fayed HM, Gebaly AA, Mohamed EAE. Operative and Oncological Outcomes After D2 Versus D1 Gastrectomy of Operable Gastric Cancer: an Observational Study. J Gastrointest Cancer 2020. [PMID: 33188500 DOI: 10.1007/s12029-020-00548-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
182 Bolton JS, Teng S. Transthoracic or transhiatal esophagectomy for cancer of the esophagus—does it matter? Surgical Oncology Clinics of North America 2002;11:365-75. [DOI: 10.1016/s1055-3207(02)00012-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
183 McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D. Randomised trials in surgery: problems and possible solutions. BMJ. 2002;324:1448-1451. [PMID: 12065273 DOI: 10.1136/bmj.324.7351.1448] [Cited by in Crossref: 458] [Cited by in F6Publishing: 388] [Article Influence: 22.9] [Reference Citation Analysis]
184 Deng JY, Liang H. Clinical significance of lymph node metastasis in gastric cancer. World J Gastroenterol 2014; 20(14): 3967-3975 [PMID: 24744586 DOI: 10.3748/wjg.v20.i14.3967] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 80] [Article Influence: 10.0] [Reference Citation Analysis]
185 Chittawadagi B, Nayak SK, Ramakrishnan P, Kumar S, Cumar B, Natarajan R, Palanivelu PR, Chinnusamy P. Laparoscopic D2 gastrectomy in advanced gastric cancer: Postoperative outcomes and long-term survival analysis. Asian J Endosc Surg 2021. [PMID: 33605064 DOI: 10.1111/ases.12926] [Reference Citation Analysis]
186 Jin P, Liu H, Ma FH, Ma S, Li Y, Xiong JP, Kang WZ, Hu HT, Tian YT. Retrospective analysis of surgically treated pT4b gastric cancer with pancreatic head invasion . World J Clin Cases 2021; 9(29): 8718-8728 [PMID: 34734050 DOI: 10.12998/wjcc.v9.i29.8718] [Reference Citation Analysis]
187 Pacelli F, Rosa F, Marrelli D, Pedrazzani C, Bossola M, Zoccali M, Marchet A, Di Cosmo M, Roata C, Graziosi L, Cavazzoni E, Covino M, D'Ugo D, Roviello F, Nitti D, Doglietto GB. Do perioperative blood transfusions influence prognosis of gastric cancer patients? Analysis of 927 patients and interactions with splenectomy. Ann Surg Oncol. 2011;18:1615-1623. [PMID: 21240561 DOI: 10.1245/s10434-010-1543-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
188 Passot G, Vaudoyer D, Messager M, Brudvik KW, Kim BJ, Mariette C, Glehen O. Is Extended Lymphadenectomy Needed for Elderly Patients With Gastric Adenocarcinoma? Ann Surg Oncol 2016;23:2391-7. [PMID: 27169773 DOI: 10.1245/s10434-016-5260-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
189 Mocellin S, Nitti D. Lymphadenectomy extent and survival of patients with gastric carcinoma: a systematic review and meta-analysis of time-to-event data from randomized trials. Cancer Treat Rev 2015;41:448-54. [PMID: 25814393 DOI: 10.1016/j.ctrv.2015.03.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
190 Ceelen WP, Hesse U, de Hemptinne B, Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg. 2000;87:1006-1015. [PMID: 10931042 DOI: 10.1046/j.1365-2168.2000.01538.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 3.4] [Reference Citation Analysis]
191 Knab LM, Yang A. Gastric and Small Bowel Tumors. Cancer Treat Res 2016;168:1-16. [PMID: 29206015 DOI: 10.1007/978-3-319-34244-3_1] [Reference Citation Analysis]
192 Suzuki M, Ogata K, Kogure N, Kimura A, Toyomasu Y, Ohno T, Mochiki E, Kuwano H. Curative Resection Following Neoadjuvant Chemotherapy for Advanced Gastric Cancer With Preservation of a Right Gastroepiploic Artery Coronary Artery Bypass Graft: A Case Report. Int Surg 2015;100:1138-43. [PMID: 25563754 DOI: 10.9738/INTSURG-D-14-00156.1] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
193 Catarci M, Montemurro LA, Di Cintio A, Ghinassi S, Coppola L, Pinnarelli L, Belardi A, Koch M, Grassi GB. Lymph node retrieval and examination during the implementation of extended lymph node dissection for gastric cancer in a non-specialized western institution. Updates Surg. 2010;62:89-99. [PMID: 20845010 DOI: 10.1007/s13304-010-0017-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
194 El-Sedfy A, Dixon M, Seevaratnam R, Bocicariu A, Cardoso R, Mahar A, Kiss A, Helyer L, Law C, Coburn NG. Personalized Surgery for Gastric Adenocarcinoma: A Meta-analysis of D1 versus D2 Lymphadenectomy. Ann Surg Oncol. 2015;22:1820-1827. [PMID: 25348779 DOI: 10.1245/s10434-014-4168-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
195 Marrelli D, Roviello F, De Stefano A, Fotia G, Giliberto C, Garosi L, Pinto E. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection. Journal of the American College of Surgeons 2004;198:51-8. [DOI: 10.1016/j.jamcollsurg.2003.08.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
196 Deng J, Zhang R, Pan Y, Wang B, Wu L, Hao X, Liang H. N stages of the seventh edition of TNM Classification are the most intensive variables for predictions of the overall survival of gastric cancer patients who underwent limited lymphadenectomy. Tumour Biol 2014;35:3269-81. [PMID: 24293375 DOI: 10.1007/s13277-013-1428-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
197 Baek SK, Kim SY, Jeong JH, Cho KS, Yoon HJ. Second-line chemotherapy for advanced gastric cancer in Korea. Gastric Cancer 2012;15:345-54. [PMID: 22410800 DOI: 10.1007/s10120-011-0114-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
198 Valentini V, Cellini F. Radiotherapy in gastric cancer: a systematic review of literature and new perspectives. Expert Rev Anticancer Ther 2007;7:1379-93. [PMID: 17944564 DOI: 10.1586/14737140.7.10.1379] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
199 Roukos DH, Kappas AM. Limitations in controlling risk for recurrence after curative surgery for advanced gastric cancer are now well-explained by molecular-based mechanisms. Ann Surg Oncol 2001;8:620-1. [PMID: 11569774 DOI: 10.1007/s10434-001-0620-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
200 Yao JC, Mansfield PF, Pisters PW, Feig BW, Janjan NA, Crane C, Ajani JA. Combined-modality therapy for gastric cancer. Semin Surg Oncol. 2003;21:223-227. [PMID: 14648779 DOI: 10.1002/ssu.10040] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
201 Singh KK, Rohatgi A, Rybinkina I, McCulloch P, Mudan S. Laparoscopic gastrectomy for gastric cancer: early experience among the elderly. Surg Endosc 2008;22:1002-7. [PMID: 17768658 DOI: 10.1007/s00464-007-9561-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
202 An JY, Pak KH, Inaba K, Cheong JH, Hyung WJ, Noh SH. Relevance of lymph node metastasis along the superior mesenteric vein in gastric cancer. Br J Surg. 2011;98:667-672. [PMID: 21294111 DOI: 10.1002/bjs.7414] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
203 Zhao Y, Yu P, Hao Y, Qian F, Tang B, Shi Y, Luo H, Zhang Y. Comparison of outcomes for laparoscopically assisted and open radical distal gastrectomy with lymphadenectomy for advanced gastric cancer. Surg Endosc 2011;25:2960-6. [DOI: 10.1007/s00464-011-1652-y] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 6.2] [Reference Citation Analysis]
204 Merkow RP, Bentrem DJ. Importance of and adherence to lymph node staging standards in gastrointestinal cancer. Surg Oncol Clin N Am 2012;21:407-16, viii. [PMID: 22583990 DOI: 10.1016/j.soc.2012.03.010] [Reference Citation Analysis]
205 Bremers AJ, Rutgers EJ, van de Velde CJ. Cancer surgery: the last 25 years. Cancer Treat Rev. 1999;25:333-353. [PMID: 10644500 DOI: 10.1053/ctrv.1999.0147] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
206 Li P, He HQ, Zhu CM, Ling YH, Hu WM, Zhang XK, Luo RZ, Yun JP, Xie D, Li YF, Cai MY. The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: a large retrospective study from Southern China. BMC Cancer 2015;15:370. [PMID: 25947284 DOI: 10.1186/s12885-015-1370-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
207 Nelson R, Ko EB, Arrington A, Lee W, Kim J, Garcia-Aguilar J, Kim J. Race and correlations between lymph node number and survival for patients with gastric cancer. J Gastrointest Surg. 2013;17:471-481. [PMID: 23288716 DOI: 10.1007/s11605-012-2125-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
208 Woo Y, Goldner B, Ituarte P, Lee B, Melstrom L, Son T, Noh SH, Fong Y, Hyung WJ. Lymphadenectomy with Optimum of 29 Lymph Nodes Retrieved Associated with Improved Survival in Advanced Gastric Cancer: A 25,000-Patient International Database Study. J Am Coll Surg 2017;224:546-55. [PMID: 28017807 DOI: 10.1016/j.jamcollsurg.2016.12.015] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
209 Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Lirici MM, Napolitano C, Piro F. Videolaparoscopic total and subtotal gastrectomy with extended lymph node dissection for gastric cancer. Am J Surg. 2004;188:728-735. [PMID: 15619491 DOI: 10.1016/j.amjsurg.2004.08.040] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
210 Fujita T, Ohta M, Ozaki Y, Takahashi Y, Miyazaki S, Harada T, Iino I, Kikuchi H, Hiramatsu Y, Kamiya K, Konno H. Collateral thermal damage to the pancreas by ultrasonic instruments during lymph node dissection in laparoscopic gastrectomy. Asian J Endosc Surg 2015;8:281-8. [PMID: 25706186 DOI: 10.1111/ases.12177] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
211 Murphy PM, Blackshaw GR, Paris HJ, Edwards P, Barry JD, Lewis WG. Prospective evaluation of nutritional status related to body mass indices and outcomes after modified D2 gastrectomy for carcinoma. Clin Nutr. 2004;23:477-483. [PMID: 15297082 DOI: 10.1016/j.clnu.2003.07.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
212 Cravo M, Fidalgo C, Garrido R, Rodrigues T, Luz G, Palmela C, Santos M, Lopes F, Maio R. Towards curative therapy in gastric cancer: Faraway, so close!. World J Gastroenterol 2015; 21(41): 11609-11620 [PMID: 26556990 DOI: 10.3748/wjg.v21.i41.11609] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
213 Pedrazzani C, de Manzoni G, Marrelli D, Giacopuzzi S, Corso G, Minicozzi AM, Rampone B, Roviello F. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. J Thorac Cardiovasc Surg. 2007;134:378-385. [PMID: 17662776 DOI: 10.1016/j.jtcvs.2007.03.034] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
214 Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth edition American Joint Committee on Cancer staging, proximal disease, and the ?different disease? hypothesis. Cancer 2000;88:921-32. [DOI: 10.1002/(sici)1097-0142(20000215)88:4<921::aid-cncr24>3.0.co;2-s] [Cited by in Crossref: 365] [Article Influence: 16.6] [Reference Citation Analysis]
215 Hawkes E, Chau I, Ilson DH, Cunningham D. Upper Gastrointestinal Malignancies: A New Era in Clinical Colorectal Cancer. Clinical Colorectal Cancer 2009;8:185-9. [DOI: 10.3816/ccc.2009.n.030] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
216 Kassam Z, Lockwood G, O'brien C, Brierley J, Swallow C, Oza A, Siu L, Knox JJ, Wong R, Cummings B, Kim J, Moore M, Ringash J. Conformal radiotherapy in the adjuvant treatment of gastric cancer: Review of 82 cases. Int J Radiat Oncol Biol Phys 2006;65:713-9. [PMID: 16626887 DOI: 10.1016/j.ijrobp.2006.01.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
217 Wang F, Chang Y, Chen T, Hsu J, Kuo C, Lin C, Chen J, Chiang K, Yeh T, Hwang T, Jan Y. Prognostic significance of splenectomy for patients with gastric adenocarcinoma undergoing total gastrectomy: A retrospective cohort study. International Journal of Surgery 2014;12:557-65. [DOI: 10.1016/j.ijsu.2014.04.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
218 Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Noguchi Y. Is D2 lymph node dissection necessary for early gastric cancer? Ann Surg Oncol. 2002;9:401-405. [PMID: 11986193 DOI: 10.1007/bf02573876] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
219 Boff MF, Schirmer CC, Edelweiss MIA, Meurer L. Pesquisa do linfonodo sentinela em câncer gástrico com o corante azul patente. Rev Col Bras Cir 2007;34:367-73. [DOI: 10.1590/s0100-69912007000600003] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
220 Oh DY, Bang YJ. Adjuvant and neoadjuvant therapy for gastric cancer. Curr Treat Options Oncol. 2013;14:311-320. [PMID: 23686725 DOI: 10.1007/s11864-013-0238-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
221 Marchet A, Mocellin S, Ambrosi A, Morgagni P, Garcea D, Marrelli D, Roviello F, de Manzoni G, Minicozzi A, Natalini G, De Santis F, Baiocchi L, Coniglio A, Nitti D; Italian Research Group for Gastric Cancer (IRGGC). The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007;245:543-52. [PMID: 17414602 DOI: 10.1097/01.sla.0000250423.43436.e1] [Cited by in Crossref: 254] [Cited by in F6Publishing: 262] [Article Influence: 16.9] [Reference Citation Analysis]
222 Bugat R. Irinotecan in the treatment of gastric cancer. Ann Oncol 2003;14 Suppl 2:ii37-40. [PMID: 12810456 DOI: 10.1093/annonc/mdg727] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
223 Brar S, Law C, McLeod R, Helyer L, Swallow C, Paszat L, Seevaratnam R, Cardoso R, Dixon M, Mahar A. Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study. J Am Coll Surg. 2013;217:347-57.e1. [PMID: 23664139 DOI: 10.1016/j.jamcollsurg.2013.01.067] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
224 Morkavuk ŞB, Çulcu S, Tez M, Ünal AE. The efficiency of D1(+) lymphadenectomy in signet ring cell carcinoma: comparison of postoperative early and late outcomes between standard lymphadenectomy and D1(+) lymphadenectomy. Libyan J Med 2021;16:1973761. [PMID: 34482797 DOI: 10.1080/19932820.2021.1973761] [Reference Citation Analysis]
225 Seulin P, Carrère N, Bloom E, Pradère B, Tap G, Gouzi JL. [Stomach cancer: have changes in surgical strategy influenced the results? 20-year retrospective study]. Ann Chir 2000;125:131-6. [PMID: 10998798 DOI: 10.1016/s0001-4001(00)00118-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
226 Xiong HQ, Gunderson LL, Yao J, Ajani JA. Chemoradiation for resectable gastric cancer. Lancet Oncol. 2003;4:498-505. [PMID: 12901965 DOI: 10.1016/s1470-2045(03)01170-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
227 Macdonald JS, Hundahl S, Smalley SR, O’dea D, Mitchell EP. Gastric Cancer. In: Blanke CD, Rödel C, Talamonti MS, editors. Gastrointestinal Oncology. Berlin: Springer Berlin Heidelberg; 2011. pp. 101-38. [DOI: 10.1007/978-3-642-13306-0_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
228 Tokunaga M, Hiki N, Fukunaga T, Ohyama S, Yamada K, Yamaguchi T. Better prognosis of T2 gastric cancer with preoperative diagnosis of early gastric cancer. Ann Surg Oncol 2009;16:1514-9. [PMID: 19290492 DOI: 10.1245/s10434-009-0404-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
229 Zhu WG, Xua DF, Pu J, Zong CD, Li T, Tao GZ, Ji FZ, Zhou XL, Han JH, Wang CS. A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection. Radiother Oncol. 2012;104:361-366. [PMID: 22985776 DOI: 10.1016/j.radonc.2012.08.024] [Cited by in Crossref: 87] [Cited by in F6Publishing: 91] [Article Influence: 8.7] [Reference Citation Analysis]
230 Ichikura T, Chochi K, Sugasawa H, Mochizuki H. Modified radical lymphadenectomy (D1.5) for T2-3 gastric cancer. Langenbecks Arch Surg 2005;390:397-402. [PMID: 16041552 DOI: 10.1007/s00423-005-0570-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
231 Hoshi H. Management of Gastric Adenocarcinoma for General Surgeons. Surg Clin North Am 2020;100:523-34. [PMID: 32402298 DOI: 10.1016/j.suc.2020.02.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
232 Macalindong SS, Kim KH, Nam BH, Ryu KW, Kubo N, Kim JY, Eom BW, Yoon HM, Kook MC, Choi IJ, Kim YW. Effect of total number of harvested lymph nodes on survival outcomes after curative resection for gastric adenocarcinoma: findings from an eastern high-volume gastric cancer center. BMC Cancer. 2018;18:73. [PMID: 29329569 DOI: 10.1186/s12885-017-3872-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
233 Roggin KK, Hemmerich J, Posner MC. Extended follow-up after extended lymphadenectomy for gastric cancer: was it worth the wait? Lancet Oncol 2010;11:404-5. [PMID: 20409753 DOI: 10.1016/S1470-2045(10)70098-X] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
234 Songun I, van de Velde CJ. Optimal surgery for advanced gastric cancer. Expert Rev Anticancer Ther 2009;9:1849-58. [PMID: 19954295 DOI: 10.1586/era.09.132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
235 Özer İ, Bostancı EB, Ulaş M, Özoğul Y, Akoğlu M. Changing Trends in Gastric Cancer Surgery. Balkan Med J 2017;34:10-20. [PMID: 28251018 DOI: 10.4274/balkanmedj.2015.1461] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
236 Cui M, Xing JD, Yang W, Ma YY, Yao ZD, Zhang N, Su XQ. D2 dissection in laparoscopic and open gastrectomy for gastric cancer. World J Gastroenterol 2012; 18(8): 833-839 [PMID: 22371644 DOI: 10.3748/wjg.v18.i8.833] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
237 Kundel Y, Levitt ML, Oberman B, Sadezki S, Tichler T, Symon Z, Catane R, Pfeffer R, Brenner B. Adjuvant Chemotherapy and Whole Abdominal Irradiation for Gastric Carcinoma. Tumori 2008;94:469-73. [DOI: 10.1177/030089160809400405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
238 Mihaljevic AL, Friess H, Schuhmacher C. Clinical trials in gastric cancer and the future. J Surg Oncol 2013;107:289-97. [PMID: 22514058 DOI: 10.1002/jso.23120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
239 Zhang YJ, Xiang RC, Li J, Liu Y, Xie SM, An L, Li HL, Mai G. Superior pancreatic lymphadenectomy with portal vein priority via posterior common hepatic artery approach in laparoscopic radical gastrectomy. World J Clin Cases 2022; 10(6): 1834-1842 [DOI: 10.12998/wjcc.v10.i6.1834] [Reference Citation Analysis]
240 Roukos DH, Lorenz M, Karakostas K, Paraschou P, Batsis C, Kappas AM. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study. Br J Cancer 2001;84:1602-9. [PMID: 11401312 DOI: 10.1054/bjoc.2001.1720] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 3.6] [Reference Citation Analysis]
241 Bozzetti F, Andreola S, Bignami P, Sirizzotti G. Prognostic Effects of Lymph Node Micrometastases in Patients Undergoing Curative Gastrectomy for Cancer. Tumori 2000;86:470-1. [DOI: 10.1177/030089160008600607] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
242 Hwang SH, Kim HI, Song JS, Lee MH, Kwon SJ, Kim MG. The Ratio-Based N Staging System Can More Accurately Reflect the Prognosis of T4 Gastric Cancer Patients with D2 Lymphadenectomy Compared with the 7th American Joint Committee on Cancer/Union for International Cancer Control Staging System. J Gastric Cancer 2016;16:207-14. [PMID: 28053806 DOI: 10.5230/jgc.2016.16.4.207] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
243 Lawrence W. Gastric Adenocarcinoma. Curr Treat Options Gastroenterol 2004;7:149-57. [PMID: 15010029 DOI: 10.1007/s11938-004-0036-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
244 Cozzaglio L, Doci R, Celotti S, Roncalli M, Gennari L. Gastric Cancer: Extent of Lymph Node Dissection and Requirements for a Correct Staging. Tumori 2004;90:467-72. [DOI: 10.1177/030089160409000505] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
245 Kang JH, Ryu SY, Jung MR, Jeong O. Comparison of long term survival outcomes between D1+ and D2 lymph node dissection for ≥ pT2 or pN+ gastric carcinoma: A large scale case-control study using propensity score matching. Eur J Surg Oncol 2020;46:1239-46. [PMID: 32331983 DOI: 10.1016/j.ejso.2020.04.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
246 Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004;22:2069-2077. [PMID: 15082726 DOI: 10.1200/jco.2004.08.026] [Cited by in Crossref: 617] [Cited by in F6Publishing: 261] [Article Influence: 34.3] [Reference Citation Analysis]
247 Datta J, Mcmillan MT, Ecker BL, Karakousis GC, Mamtani R, Plastaras JP, Giantonio BJ, Drebin JA, Dempsey DT, Fraker DL, Roses RE. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis. Annals of Surgery 2016;263:298-305. [DOI: 10.1097/sla.0000000000001360] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
248 Dai M, Shi N, Xing C, Liao Q, Zhang T, Chen G, Wu W, Guo J, Liu Z, Zhao Y. Splenic preservation in laparoscopic distal pancreatectomy. British Journal of Surgery 2017;104:452-62. [DOI: 10.1002/bjs.10434] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
249 Jensen EH, Tuttle TM. Preoperative Staging and Postoperative Surveillance for Gastric Cancer. Surgical Oncology Clinics of North America 2007;16:329-42. [DOI: 10.1016/j.soc.2007.03.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
250 Roth AD. Curative treatment of gastric cancer: towards a multidisciplinary approach? Crit Rev Oncol Hematol. 2003;46:59-100. [PMID: 12672518 DOI: 10.1016/S1040-8428(02)00160-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
251 Stabile BE, Smith BR, Weeks DL. Helicobacter pylori infection and surgical disease--part II. Curr Probl Surg 2005;42:796-862. [PMID: 16344044 DOI: 10.1067/j.cpsurg.2005.08.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
252 Uslu A, Bati H, Postaci H, Nart A, Eliyatkin N, Yetis H, Corumlu B, Aykas A, Zengel B. Impact of histopathology on the outcome of D1/D2 gastrectomies with R0 resection. Digestion 2012;86:67-73. [PMID: 22777320 DOI: 10.1159/000338298] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
253 Zhao L, Niu P, Zhao D, Chen Y. Regional and racial disparity in proximal gastric cancer survival outcomes 1996-2016: Results from SEER and China National Cancer Center database. Cancer Med 2021;10:4923-38. [PMID: 34105890 DOI: 10.1002/cam4.4033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
254 Li P, He XD, Tian JH, Yang KH, Jiang L. Meta-analysis of total gastrectomy and splenectomy in advanced gastric cancer. Shijie Huaren Xiaohua Zazhi 2009; 17(12): 1241-1246 [DOI: 10.11569/wcjd.v17.i12.1241] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
255 Karavokyros I, Michalinos A. Favoring D2-Lymphadenectomy in Gastric Cancer. Front Surg 2018;5:42. [PMID: 29930941 DOI: 10.3389/fsurg.2018.00042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
256 Cummings D, Wong J, Palm R, Hoffe S, Almhanna K, Vignesh S. Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors. Cancers (Basel) 2021;13:582. [PMID: 33540736 DOI: 10.3390/cancers13030582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
257 Choi SH, Seo MA, Hwang HK, Kang CM, Lee WJ. Is it worthwhile to preserve adult spleen in laparoscopic distal pancreatectomy? Perioperative and patient-reported outcome analysis. Surg Endosc. 2012;26:3149-3156. [PMID: 22580876 DOI: 10.1007/s00464-012-2306-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
258 Wohnrath DR, Araujo RLC. D2 lymphadenectomy for gastric cancer as an independent prognostic factor of 10-year overall survival. Eur J Surg Oncol 2019;45:446-53. [PMID: 30392746 DOI: 10.1016/j.ejso.2018.10.538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
259 Scartozzi M, Galizia E, Graziano F, Catalano V, Berardi R, Baldelli AM, Testa E, Mari D, Silva RR, Cascinu S. Over-DI dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients. Br J Cancer 2005;92:1051-4. [PMID: 15770210 DOI: 10.1038/sj.bjc.6602468] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
260 Cohen DJ, Newman E, Iqbal S, Chang RY, Potmesil M, Ryan T, Donahue B, Chandra A, Liu M, Utate M, Hiotis S, Pachter LH, Hochster H, Muggia F. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma. Ann Surg Oncol 2012;19:478-85. [PMID: 21769462 DOI: 10.1245/s10434-011-1940-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
261 Kodera Y, Sasako M, Yamamoto S, Sano T, Nashimoto A, Kurita A; Gastric Cancer Surgery Study Group of Japan Clinical Oncology Group. Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg. 2005;92:1103-1109. [PMID: 16106493 DOI: 10.1002/bjs.4979] [Cited by in Crossref: 140] [Cited by in F6Publishing: 134] [Article Influence: 8.2] [Reference Citation Analysis]
262 Glehen O, Peyrat P, Beaujard AC, Chapet O, Romestaing P, Sentenac I, Francois Y, Vignal J, Gérard JP, Gilly FN. Pattern of failures in gastric cancer patients with lymph node involvement treated by surgery, intraoperative and external beam radiotherapy. Radiother Oncol. 2003;67:171-175. [PMID: 12812847 DOI: 10.1016/s0167-8140(02)00344-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
263 Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S. Gastric adenocarcinoma. Nat Rev Dis Primers. 2017;3:17036. [PMID: 28569272 DOI: 10.1038/nrdp.2017.36] [Cited by in Crossref: 178] [Cited by in F6Publishing: 184] [Article Influence: 35.6] [Reference Citation Analysis]
264 Merrett ND. Multimodality treatment of potentially curative gastric cancer: Geographical variations and future prospects. World J Gastroenterol 2014; 20(36): 12892-12899 [PMID: 25278686 DOI: 10.3748/wjg.v20.i36.12892] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
265 Menges M, Hoehler T. Neoadjuvant Therapy of Gastric Cancer: A Decisive Step Forward. Gastrointest Tumors 2014;1:99-104. [PMID: 26675677 DOI: 10.1159/000362577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
266 Akhondi-Meybodi M, Ghane M, Akhondi-Meybodi S, Dashti G. Five-year Survival Rate for Gastric Cancer in Yazd Province, Central Iran, from 2001 to 2008. Middle East J Dig Dis 2017;9:39-48. [PMID: 28316765 DOI: 10.15171/mejdd.2016.50] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
267 An JY, Cheong JH, Hyung WJ, Noh SH. Recent evolution of surgical treatment for gastric cancer in Korea. J Gastric Cancer. 2011;11:1-6. [PMID: 22076195 DOI: 10.5230/jgc.2011.11.1.1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
268 Montgomery M, Fukuhara S, Karpeh M, Brower S. Evidence-based review of the management of early gastric cancer. Gastroenterol Rep (Oxf) 2013;1:105-12. [PMID: 24759815 DOI: 10.1093/gastro/got016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
269 Leissner J. [Lymphadenectomy for bladder cancer. Diagnostic and prognostic significance as well as therapeutic benefit]. Urologe A 2005;44:638-44. [PMID: 15871006 DOI: 10.1007/s00120-005-0827-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
270 Patel SH, Kooby DA. Gastric adenocarcinoma surgery and adjuvant therapy. Surg Clin North Am 2011;91:1039-77. [PMID: 21889029 DOI: 10.1016/j.suc.2011.06.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
271 Chen S, Li YF, Feng XY, Zhou ZW, Yuan XH, Chen YB. Significance of palliative gastrectomy for late-stage gastric cancer patients. J Surg Oncol. 2012;106:862-871. [PMID: 22648960 DOI: 10.1002/jso.23158] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
272 Hohenberger P, Gretschel S. Gastric cancer. Lancet. 2003;362:305-315. [PMID: 12892963 DOI: 10.1016/s0140-6736(03)13975-x] [Cited by in Crossref: 430] [Cited by in F6Publishing: 215] [Article Influence: 22.6] [Reference Citation Analysis]
273 Schumacher SE, Shim BY, Corso G, Ryu MH, Kang YK, Roviello F, Saksena G, Peng S, Shivdasani RA, Bass AJ, Beroukhim R. Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients. PLoS One 2017;12:e0176045. [PMID: 28426752 DOI: 10.1371/journal.pone.0176045] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
274 Tóth D, Plósz J, Török M. Clinical significance of lymphadenectomy in patients with gastric cancer. World J Gastrointest Oncol 2016; 8(2): 136-146 [PMID: 26909128 DOI: 10.4251/wjgo.v8.i2.136] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
275 Terashima M. The 140 years' journey of gastric cancer surgery: From the two hands of Billroth to the multiple hands of the robot. Ann Gastroenterol Surg 2021;5:270-7. [PMID: 34095716 DOI: 10.1002/ags3.12442] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
276 Bang Y, Kim Y, Yang H, Chung HC, Park Y, Lee KH, Lee K, Kim YH, Noh S, Cho JY, Mok YJ, Kim YH, Ji J, Yeh T, Button P, Sirzén F, Noh SH. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. The Lancet 2012;379:315-21. [DOI: 10.1016/s0140-6736(11)61873-4] [Cited by in Crossref: 866] [Cited by in F6Publishing: 538] [Article Influence: 86.6] [Reference Citation Analysis]
277 Labianca R, Sburlati P, Quadri A, Garassino M. Perioperative or postoperative therapy for resectable gastric cancer? Annals of Oncology 2008;19:v99-v102. [DOI: 10.1093/annonc/mdn320] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
278 Coit D. Adjuvant Therapy for Gastric Cancer. Journal of the American College of Surgeons 2007;205:S54-8. [DOI: 10.1016/j.jamcollsurg.2007.06.329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
279 Hughes BGM, Yip D, Chao M, Gibbs P, Carroll S, Goldstein D, Burmeister B, Karapetis C. Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: an Australian multicentre experience. ANZ J Surg 2004;74:951-6. [DOI: 10.1111/j.1445-1433.2004.03218.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
280 Wang YN, Chang SY, Hwang JM, Chang YK, Kao WY, Wan HL, Tzeng IS, Wu CC. Evaluating the benefit of adjuvant radiotherapy after extensive lymph node dissection for gastric cancer: a single-institute retrospective study. Tzu Chi Med J 2021;33:288-93. [PMID: 34386368 DOI: 10.4103/tcmj.tcmj_230_20] [Reference Citation Analysis]
281 Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol. 2005;54:209-241. [PMID: 15890270 DOI: 10.1016/j.critrevonc.2005.01.002] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
282 Ozmen M, Zulfikaroglu B, Kece C, Aslar A, Ozalp N, Koc M. Factors Influencing Mortality in Spontaneous Gastric Tumour Perforations. J Int Med Res 2002;30:180-4. [DOI: 10.1177/147323000203000211] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
283 Moehler M, Schimanski CC, Gockel I, Junginger T, Galle PR. (Neo)adjuvant strategies of advanced gastric carcinoma: time for a change? Dig Dis 2004;22:345-50. [PMID: 15812158 DOI: 10.1159/000083597] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
284 Rausei S, Galli F, Lianos G, Rosa F, Cossu A, Biondi A, Martignoni F, Cananzi FCM, Fumagalli U, Alfieri S, Persiani R, Quagliuolo V, D'Ugo D, Rosati R. How Should We Measure the Quality of Lymphadenectomy for Gastric Cancer? Anatomical Versus Numerical Criterion. J Gastrointest Cancer 2020;51:887-92. [PMID: 31691087 DOI: 10.1007/s12029-019-00321-x] [Reference Citation Analysis]
285 Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK, Coleman J, Abrams RA, Hruban RH. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236:355-366; discussion 366-368. [PMID: 12192322 DOI: 10.1097/01.sla.0000027272.08464.0b] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
286 Chen FF, Huang DD, Lu JX, Zhou CJ, Zhuang CL, Wang SL, Shen X, Yu Z, Chen XL. Feasibility of Total Gastrectomy with D2 Lymphadenectomy for Gastric Cancer and Predictive Factors for Its Short- and Long-Term Outcomes. J Gastrointest Surg 2016;20:521-30. [PMID: 26691150 DOI: 10.1007/s11605-015-3059-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
287 Goto H, Yasuda T, Oshikiri T, Kanaji S, Kawasaki K, Imanishi T, Oyama M, Kakinoki K, Ohara T, Sendo H, Fujino Y, Tominaga M, Kakeji Y. Comparing the short-term outcomes of laparoscopic distal gastrectomy with D1+ and D2 lymph node dissection for gastric cancer: LDG with D1 and D2 lymph node dissection. Asian J Endosc Surg 2016;9:116-21. [DOI: 10.1111/ases.12269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
288 Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK, Coleman J, Abrams RA, Hruban RH. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002;236:355-66; discussion 366-8. [PMID: 12192322 DOI: 10.1097/00000658-200209000-00012] [Cited by in Crossref: 562] [Cited by in F6Publishing: 458] [Article Influence: 28.1] [Reference Citation Analysis]
289 Lin GT, Chen QY, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Huang CM. Lymph Node Noncompliance Affects the Long-Term Prognosis of Patients with Gastric Cancer after Laparoscopic Total Gastrectomy. J Gastrointest Surg 2020;24:540-50. [PMID: 30937713 DOI: 10.1007/s11605-019-04199-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
290 House MG, Brennan MF. Neoadjuvant therapy for gastric cancer. Adv Surg. 2008;42:151-168. [PMID: 18953815 DOI: 10.1016/j.yasu.2008.04.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
291 Mortensen MB, Fristrup C, Ainsworth A, Nielsen HO, Pless T, Hovendal C. Combined pretherapeutic endoscopic and laparoscopic ultrasonography may predict survival of patients with upper gastrointestinal tract cancer. Surg Endosc. 2011;25:804-812. [PMID: 20676688 DOI: 10.1007/s00464-010-1258-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
292 Pramesh C, Kulkarni NN, Mistry RC, Badwe RA. Lymphadenectomy in cancer: time for a paradigm shift? The Lancet Oncology 2006;7:450-1. [DOI: 10.1016/s1470-2045(06)70706-9] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
293 Dittmar Y, Schüle S, Koch A, Rauchfuss F, Scheuerlein H, Settmacher U. Predictive factors for survival and recurrence rate in patients with node-negative gastric cancer—a European single-centre experience. Langenbecks Arch Surg 2015;400:27-35. [DOI: 10.1007/s00423-014-1226-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
294 Roukos DH. Extended (D2) Lymph Node Dissection for Gastric Cancer: Do Patients Benefit? Ann Surg Oncol 2000;7:253-5. [DOI: 10.1007/s10434-000-0253-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 52] [Article Influence: 3.0] [Reference Citation Analysis]
295 Pemberton L, Coote J, Perry L, Khoo VS, Saunders MP. Adjuvant chemoradiotherapy for gastric carcinoma: dosimetric implications of conventional gastric bed irradiation and toxicity. Clin Oncol (R Coll Radiol). 2006;18:663-668. [PMID: 17100151 DOI: 10.1016/j.clon.2006.06.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
296 Mickevicius A, Ignatavicius P, Markelis R, Parseliunas A, Butkute D, Kiudelis M, Endzinas Z, Maleckas A, Dambrauskas Z. Trends and results in treatment of gastric cancer over last two decades at single East European centre: a cohort study. BMC Surg 2014;14:98. [PMID: 25428767 DOI: 10.1186/1471-2482-14-98] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
297 Jiang Y, Kimchi ET, Montero AJ, Staveley-O’Carroll KF, Ajani JA. Upper gastrointestinal tumors: current status and future perspectives. Expert Rev Anticancer Ther. 2008;8:975-991. [PMID: 18533807 DOI: 10.1586/14737140.8.6.975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
298 Choi YY, An JY, Cho I, Kwon IG, Kang DR, Hyung WJ, Noh SH. The assessment of the oncological safety margin of insufficient lymph node dissection in pT2 (pm) gastric cancer. Yonsei Med J. 2014;55:61-69. [PMID: 24339288 DOI: 10.3349/ymj.2014.55.1.61] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
299 Chen S, Zhao BW, Li YF, Feng XY, Sun XW, Li W, Zhou ZW, Zhan YQ, Qian CN, Chen YB. The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients. PLoS One. 2012;7:e49424. [PMID: 23166665 DOI: 10.1371/journal.pone.0049424.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
300 Sasagawa T, Solano H, Vega W, Mena F. The effectiveness of extended lymph node dissection for gastric cancer performed in Costa Rica under the supervision of a Japanese surgeon: a comparison with surgical results in Japan. Am J Surg. 2008;195:53-60. [PMID: 18082543 DOI: 10.1016/j.amjsurg.2007.01.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
301 RC 2nd, Jaques DP, Brennan MF, Karpeh M. Extended local resection for advanced gastric cancer: increased survival versus increased morbidity. Ann Surg. 2002;236:159-165. [PMID: 12170020 DOI: 10.1097/00000658-200208000-00003] [Cited by in Crossref: 148] [Cited by in F6Publishing: 130] [Article Influence: 7.4] [Reference Citation Analysis]
302 Roukos DH, Paraschou P, Lorenz M. Distal Gastric Cancer and Extensive Surgery: A New Evaluation Method Based on the Study of the Status of Residual Lymph Nodes After Limited Surgery. Ann Surg Oncol 2000;7:719-26. [DOI: 10.1007/s10434-000-0719-0] [Cited by in Crossref: 73] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
303 Lustosa SA, Saconato H, Atallah AN, Lopes Filho Gde J, Matos D. Impact of extended lymphadenectomy on morbidity, mortality, recurrence and 5-year survival after gastrectomy for cancer. Meta-analysis of randomized clinical trials. Acta Cir Bras. 2008;23:520-530. [PMID: 19030751 DOI: 10.1590/s0102-86502008000600009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
304 Luna A, Rebasa P, Montmany S, Navarro S. Learning curve for d2 Lymphadenectomy in gastric cancer. ISRN Surg. 2013;2013:508719. [PMID: 23844296 DOI: 10.1155/2013/508719] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
305 Aytaç E, Aslan F, Çicek B, Erdamar S, Gürses B, Güven K, Falay O, Karahasanoğlu T, Selçukbiricik F, Selek U, Atalar B, Balık E, Tözün N, Rozanes İ, Arıcan A, Hamzaoğlu İ, Baca B, Molinas Mandel N, Saruç M, Göksel S, Demir G, Ağaoğlu F, Yakıcıer C, Özbek U, Özben V, Özyar E, Güner AL, Er Ö, Kaban K, Bölükbaşı Y, Buğra D, Group Tİ. Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group. Turk J Gastroenterol 2019;30:584-98. [PMID: 30541724 DOI: 10.5152/tjg.2018.18737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
306 Iyer P, Moslim M, Farma JM, Denlinger CS. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl Gastroenterol Hepatol 2020;5:52. [PMID: 33073047 DOI: 10.21037/tgh.2020.01.02] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
307 Papenfuss WA, Kukar M, Oxenberg J, Attwood K, Nurkin S, Malhotra U, Wilkinson NW. Morbidity and mortality associated with gastrectomy for gastric cancer. Ann Surg Oncol. 2014;21:3008-3014. [PMID: 24700300 DOI: 10.1245/s10434-014-3664-z] [Cited by in Crossref: 121] [Cited by in F6Publishing: 114] [Article Influence: 15.1] [Reference Citation Analysis]
308 Shin K, Park SJ, Lee J, Park CH, Song KY, Lee HH, Seo HS, Jung YJ, Park JM, Lee SH, Roh SY, Kim IH. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage. BMC Cancer 2019;19:1232. [PMID: 31852475 DOI: 10.1186/s12885-019-6433-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
309 Chan WL, Lam KO, Lee VHF, Davidson M, So TH, Li JS, Chau I, Kwong DLW. Gastric Cancer - From Aetiology to Management: Differences Between the East and the West. Clin Oncol (R Coll Radiol). 2019;31:570-577. [PMID: 31178345 DOI: 10.1016/j.clon.2019.05.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
310 Park SH, Huh H, Choi SI, Kim JH, Jang YJ, Park JM, Kwon OK, Jung MR, Jeong O, Lee CM, Min JS, Kim JJ, An L, Yang KS, Park S, Lee IO; Deep Neuromuscular Block on Oncologic Quality of Laparoscopic Surgery in Obese Gastric Cancer Patients (DEBLOQS_GC) Study Group. Impact of the Deep Neuromuscular Block on Oncologic Quality of Laparoscopic Surgery in Obese Gastric Cancer Patients: A Randomized Clinical Trial. J Am Coll Surg 2022;234:326-39. [PMID: 35213496 DOI: 10.1097/XCS.0000000000000061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
311 Suh Y, Yang H. Screening and Early Detection of Gastric Cancer. Surgical Clinics of North America 2015;95:1053-66. [DOI: 10.1016/j.suc.2015.05.012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
312 Park SH, Kim DY, Heo JS, Lim DH, Park CK, Lee KW, Choi SH, Sohn TS, Kim S, Noh JH. Postoperative chemoradiotherapy for gastric cancer. Ann Oncol. 2003;14:1373-1377. [PMID: 12954575 DOI: 10.1093/annonc/mdg366] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
313 Hundahl SA. Surgical quality in trials of adjuvant cancer therapy. J Surg Oncol 2002;80:177-80. [DOI: 10.1002/jso.10123] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
314 Bozzetti F. Principles of Surgical Radicality in the Treatment of Gastric Cancer. Surgical Oncology Clinics of North America 2001;10:833-54. [DOI: 10.1016/s1055-3207(18)30035-8] [Cited by in Crossref: 15] [Article Influence: 0.7] [Reference Citation Analysis]
315 Buffart TE, Carvalho B, van Grieken NC, van Wieringen WN, Tijssen M, Kranenbarg EM, Verheul HM, Grabsch HI, Ylstra B, van de Velde CJ, Meijer GA. Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer. Oncologist 2012;17:653-62. [PMID: 22531355 DOI: 10.1634/theoncologist.2010-0379] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
316 Tanizawa Y, Terashima M. Lymph node dissection in the resection of gastric cancer: review of existing evidence. Gastric Cancer. 2010;13:137-148. [PMID: 20820982 DOI: 10.1007/s10120-010-0560-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
317 Zhang H, Liu C, Wu D, Meng Y, Song R, Lu P, Wang S. Does D3 surgery offer a better survival outcome compared to D1 surgery for gastric cancer A result based on a hospital population of two decades as taking D2 surgery for reference. BMC Cancer. 2010;10:308. [PMID: 20565910 DOI: 10.1186/1471-2407-10-308] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
318 Zhang T, Han Z, Chandoo A, Huang X, Sun X, Ye L, Hu C, Xue X, Huang Y, Shen X, Chang W, Lin X. Low periostin expression predicts poor survival in intestinal type gastric cancer patients. Cancer Manag Res 2019;11:25-36. [PMID: 30588108 DOI: 10.2147/CMAR.S175596] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
319 Hur H, Lee SR, Xuan Y, Kim YB, Lim YA, Cho YK, Han SU. The Effects of Helicobacter pylori on the prognosis of patients with curatively resected gastric cancers in a population with high infection rate. J Korean Surg Soc 2012;83:203-11. [PMID: 23091792 DOI: 10.4174/jkss.2012.83.4.203] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
320 Stillman MD, Yoon SS. Open and minimally invasive gastrectomy in Eastern and Western patient populations: A review of the literature and reasons for differences in outcomes. J Surg Oncol 2022. [PMID: 35416303 DOI: 10.1002/jso.26887] [Reference Citation Analysis]
321 Ruspi L, Galli F, Pappalardo V, Inversini D, Martignoni F, Boni L, Dionigi G, Rausei S. Lymphadenectomy in elderly/high risk patients: should it be different? Transl Gastroenterol Hepatol 2017;2:5. [PMID: 28217755 DOI: 10.21037/tgh.2016.12.07] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
322 Hundahl SA. Evidence-based recommendations for local-regional control of gastric cancer. Cancer Invest 2005;23:352-62. [PMID: 16100947 DOI: 10.1081/cnv-58885] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
323 Kasakura Y, Fujii M, Mochizuki F, Kochi M, Kaiga T. Is there a benefit of pancreaticosplenectomy with gastrectomy for advanced gastric cancer? Am J Surg. 2000;179:237-242. [PMID: 10827328 DOI: 10.1016/s0002-9610(00)00293-2] [Cited by in Crossref: 53] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
324 Zhang CD, Zong L, Ning FL, Zeng XT, Dai DQ. Modified vs. standard D2 lymphadenectomy in distal subtotal gastrectomy for locally advanced gastric cancer patients under 70 years of age. Oncol Lett 2018;15:375-85. [PMID: 29391883 DOI: 10.3892/ol.2017.7277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
325 Ohtsu A, Yoshida S, Saijo N. Disparities in gastric cancer chemotherapy between the East and West. J Clin Oncol. 2006;24:2188-2196. [PMID: 16682738 DOI: 10.1200/jco.2006.05.9758] [Cited by in Crossref: 138] [Cited by in F6Publishing: 63] [Article Influence: 8.6] [Reference Citation Analysis]
326 Scaringi S, Kianmanesh R, Sabate JM, Facchiano E, Jouet P, Coffin B, Parmentier G, Hay JM, Flamant Y, Msika S. Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience. Eur J Surg Oncol. 2008;34:1246-1252. [PMID: 18222622 DOI: 10.1016/j.ejso.2007.12.003] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 5.0] [Reference Citation Analysis]
327 Jansen EP, Boot H, Verheij M, van de Velde CJ. Optimal locoregional treatment in gastric cancer. J Clin Oncol. 2005;23:4509-4517. [PMID: 16002841 DOI: 10.1200/JCO.2005.21.196] [Cited by in Crossref: 70] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]
328 Marano L, Marrelli D, Roviello F. Focus on research: Nodal dissection for gastric cancer - A dilemma worthy of King Solomon! Eur J Surg Oncol 2016;42:1623-4. [PMID: 27554248 DOI: 10.1016/j.ejso.2016.07.143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
329 Mogal H, Fields R, Maithel SK, Votanopoulos K. In Patients with Localized and Resectable Gastric Cancer, What is the Optimal Extent of Lymph Node Dissection-D1 Versus D2 Versus D3? Ann Surg Oncol. 2019;26:2912-2932. [PMID: 31076930 DOI: 10.1245/s10434-019-07417-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
330 Kobayakawa M, Kojima Y. Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies. Onco Targets Ther. 2011;4:193-201. [PMID: 22162925 DOI: 10.2147/ott.s19059] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
331 Miura S, Kodera Y, Fujiwara M, Ito S, Mochizuki Y, Yamamura Y, Hibi K, Ito K, Akiyama S, Nakao A. Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: a critical reappraisal from the viewpoint of lymph node retrieval. J Am Coll Surg 2004;198:933-8. [PMID: 15194075 DOI: 10.1016/j.jamcollsurg.2004.01.021] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 4.1] [Reference Citation Analysis]
332 Kusano T, Shiraishi N, Shiroshita H, Etoh T, Inomata M, Kitano S. Poor prognosis of advanced gastric cancer with metastatic suprapancreatic lymph nodes. Ann Surg Oncol. 2013;20:2290-2295. [PMID: 23299769 DOI: 10.1245/s10434-012-2839-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
333 Smith BR, Stabile BE. Aggressive D2 Lymphadenectomy is Required for Accurate Pathologic Staging of Gastric Adenocarcinoma. The American Surgeon 2006;72:849-52. [DOI: 10.1177/000313480607201001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
334 Ibrahim M, Gilbert K. Management of gastric cancer in Indian population. Transl Gastroenterol Hepatol 2017;2:64. [PMID: 28905005 DOI: 10.21037/tgh.2017.07.02] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
335 Wong J, Rahman S, Saeed N, Lin HY, Almhanna K, Shridhar R, Hoffe S, Meredith KL. Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience. J Gastrointest Surg. 2013;17:2059-2066. [PMID: 24129828 DOI: 10.1007/s11605-013-2380-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
336 Fugazzola P, Ansaloni L, Sartelli M, Catena F, Cicuttin E, Leandro G, De' Angelis GL, Gaiani F, Di Mario F, Tomasoni M, Coccolini F. Advanced gastric cancer: the value of surgery. Acta Biomed 2018;89:110-6. [PMID: 30561428 DOI: 10.23750/abm.v89i8-S.7897] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
337 Bouliaris K, Rachiotis G, Diamantis A, Christodoulidis G, Polychronopoulou E, Tepetes K. Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system. European Journal of Surgical Oncology (EJSO) 2017;43:1350-6. [DOI: 10.1016/j.ejso.2017.03.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
338 Helyer LK, O'Brien C, Coburn NG, Swallow CJ. Surgeons' knowledge of quality indicators for gastric cancer surgery. Gastric Cancer 2007;10:205-14. [PMID: 18095075 DOI: 10.1007/s10120-007-0435-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
339 Benevento I, Bulzonetti N, De Felice F, Musio D, Vergine M, Tombolini V. The role of different adjuvant therapies in locally advanced gastric adenocarcinoma. Oncotarget 2018;9:34022-9. [PMID: 30338043 DOI: 10.18632/oncotarget.26106] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
340 Kim SM, Cho J, Kang D, Oh SJ, Kim AR, Sohn TS, Noh JH, Kim S. A Randomized Controlled Trial of Vagus Nerve-preserving Distal Gastrectomy Versus Conventional Distal Gastrectomy for Postoperative Quality of Life in Early Stage Gastric Cancer Patients. Ann Surg 2016;263:1079-84. [PMID: 26727095 DOI: 10.1097/SLA.0000000000001565] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
341 Knab LM, Belotte J, Munshi HG, Bentrem DJ. Comparative Effectiveness in Esophagogastric Cancer. In: Bilimoria KY, Minami CA, Mahvi DM, editors. Comparative Effectiveness in Surgical Oncology. Cham: Springer International Publishing; 2015. pp. 121-42. [DOI: 10.1007/978-3-319-12553-4_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
342 Nitti D, Mocellin S, Marchet A, Pilati P, Lise M. Recent advances in conventional and molecular prognostic factors for gastric carcinoma. Surg Oncol Clin N Am 2008;17:467-83, vii. [PMID: 18486878 DOI: 10.1016/j.soc.2008.02.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
343 Kunisaki C, Shimada H, Nomura M, Matsuda G, Otsuka Y, Ono H, Akiyama H. Surgical outcome in patients with gastric adenocarcinoma in the upper third of the stomach. Surgery. 2005;137:165-171. [PMID: 15674196 DOI: 10.1016/j.surg.2004.06.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
344 Hoeppner J. Chirurgische Strategie in der multimodalen Behandlung des Magen- und Ösophaguskarzinoms. Chirurg 2017;88:1005-9. [DOI: 10.1007/s00104-017-0545-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
345 Gallo A, Cha C. Updates on esophageal and gastric cancers. World J Gastroenterol 2006; 12(20): 3237-3242 [PMID: 16718845 DOI: 10.3748/wjg.v12.i20.3237] [Cited by in CrossRef: 79] [Cited by in F6Publishing: 74] [Article Influence: 4.9] [Reference Citation Analysis]
346 Bollschweiler EH, Mönig SP, Hensler K, Baldus SE, Maruyama K, Hölscher AH. Artificial neural network for prediction of lymph node metastases in gastric cancer: a phase II diagnostic study. Ann Surg Oncol. 2004;11:506-511. [PMID: 15123460 DOI: 10.1245/aso.2004.04.018] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
347 Abdelfatah MM, Gochanour EM. Fiducial placement for recurrent gastric cancer. Arab J Gastroenterol 2019;20:56-8. [PMID: 30745013 DOI: 10.1016/j.ajg.2019.01.007] [Reference Citation Analysis]
348 Kim MC, Kim SY, Kim KW. Laparoscopic Reinforcement Suture (LARS) on Staple Line of Duodenal Stump Using Barbed Suture in Laparoscopic Gastrectomy for Gastric Cancer: a Prospective Single Arm Phase II Study. J Gastric Cancer 2017;17:354-62. [PMID: 29302375 DOI: 10.5230/jgc.2017.17.e40] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
349 Chong G, Tebbutt NC. Perioperative therapy for resectable gastric cancer: what does the future hold? Asia Pac J Clin Oncol 2011;7:93-5. [PMID: 21585687 DOI: 10.1111/j.1743-7563.2011.01386.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
350 Chen XZ, Hu JK, Zhou ZG, Rui YY, Yang K, Wang L, Zhang B, Chen ZX, Chen JP. Meta-analysis of effectiveness and safety of D2 plus para-aortic lymphadenectomy for resectable gastric cancer. J Am Coll Surg. 2010;210:100-105. [PMID: 20123339 DOI: 10.1016/j.jamcollsurg.2009.09.033] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
351 Quiros RM, Bui CL. Multidisciplinary approach to esophageal and gastric cancer. Surg Clin North Am 2009;89:79-96, viii. [PMID: 19186232 DOI: 10.1016/j.suc.2008.09.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
352 Wu CW, Chiou JM, Ko FS, Lo SS, Chen JH, Lui WY, Whang-Peng J. Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial. Br J Cancer 2008;98:54-9. [PMID: 18182977 DOI: 10.1038/sj.bjc.6604097] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
353 Hartgrink HH, van de Velde CJ. Status of extended lymph node dissection: Locoregional control is the only way to survive gastric cancer. J Surg Oncol 2005;90:153-65. [DOI: 10.1002/jso.20222] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
354 Verlato G, Roviello F, Marchet A, Giacopuzzi S, Marrelli D, Nitti D, de Manzoni G. Indexes of surgical quality in gastric cancer surgery: experience of an Italian network. Ann Surg Oncol. 2009;16:594-602. [PMID: 19118437 DOI: 10.1245/s10434-008-0271-x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
355 Sasako M. Surgery and adjuvant chemotherapy. Int J Clin Oncol. 2008;13:193-195. [PMID: 18553226 DOI: 10.1007/s10147-008-0791-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
356 Roukos DH. Early-stage gastric cancer: a highly treatable disease. Ann Surg Oncol 2004;11:127-9. [PMID: 14761914 DOI: 10.1245/aso.2004.11.903] [Cited by in Crossref: 68] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
357 Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, Coit DG, Brennan MF. Lymphadenectomy for Adenocarcinoma of the Gastroesophageal Junction (GEJ): Impact of Adequate Staging on Outcome. Ann Surg Oncol 2007;14:306-16. [DOI: 10.1245/s10434-006-9166-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 3.4] [Reference Citation Analysis]
358 Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage. Ann Surg Oncol. 2007;14:317-328. [PMID: 17094022 DOI: 10.1245/s10434-006-9218-2] [Cited by in Crossref: 155] [Cited by in F6Publishing: 161] [Article Influence: 9.7] [Reference Citation Analysis]
359 Fuchs CS, Niedzwiecki D, Mamon HJ, Tepper JE, Ye X, Swanson RS, Enzinger PC, Haller DG, Dragovich T, Alberts SR, Bjarnason GA, Willett CG, Gunderson LL, Goldberg RM, Venook AP, Ilson D, O'Reilly E, Ciombor K, Berg DJ, Meyerhardt J, Mayer RJ. Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance). J Clin Oncol. 2017;35:3671-3677. [PMID: 28976791 DOI: 10.1200/jco.2017.74.2130] [Cited by in Crossref: 62] [Cited by in F6Publishing: 21] [Article Influence: 12.4] [Reference Citation Analysis]
360 Tsirlis TD, Papastratis G, Masselou K, Tsigris C, Papachristodoulou A, Kostakis A, Nikiteas NI. Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance? World J Gastroenterol 2008; 14(17): 2691-2701 [PMID: 18461654 DOI: 10.3748/wjg.14.2691] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
361 Wenguang W, Xuefeng W, Zhiping Z, Xiangsong W, Jianwei W, Songgang L, Yingbin L. Three-step method for lymphadenectomy in gastric cancer surgery: a single institution experience of 120 patients. J Am Coll Surg 2011;212:200-8. [PMID: 21276533 DOI: 10.1016/j.jamcollsurg.2010.09.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
362 Symeonidis D, Tepetes K. Techniques and Current Role of Sentinel Lymph Node (SLN) Concept in Gastric Cancer Surgery. Front Surg. 2018;5:77. [PMID: 30723718 DOI: 10.3389/fsurg.2018.00077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
363 Zulfikaroglu B, Koc M, Ozmen MM, Kucuk NO, Ozalp N, Aras G. Intraoperative lymphatic mapping and sentinel lymph node biopsy using radioactive tracer in gastric cancer. Surgery. 2005;138:899-904. [PMID: 16291391 DOI: 10.1016/j.surg.2005.04.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
364 Pareekutty NM, Kadam S, Ankalkoti B, Balasubramanian S, Anilkumar B. Gastrectomy with D2 Lymphadenectomy for Carcinoma of the Stomach in a Stand-alone Cancer Centre in Rural India. Indian J Surg Oncol 2020;11:256-62. [PMID: 32523272 DOI: 10.1007/s13193-020-01059-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
365 Machin D. On the evolution of statistical methods as applied to clinical trials. J Intern Med 2004;255:521-8. [DOI: 10.1111/j.1365-2796.2004.01319.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
366 Collard M, Marchese T, Guedj N, Cauchy F, Chassaing C, Ronot M, Dokmak S, Soubrane O, Sauvanet A. Is Routine Splenectomy Justified for All Left-Sided Pancreatic Cancers? Ann Surg Oncol. 2019;26:1071-1078. [PMID: 30607766 DOI: 10.1245/s10434-018-07123-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
367 Wei HB, Wei B, Qi CL, Chen TF, Huang Y, Zheng ZH, Huang JL, Fang JF. Laparoscopic versus open gastrectomy with D2 lymph node dissection for gastric cancer: a meta-analysis. Surg Laparosc Endosc Percutan Tech 2011;21:383-90. [PMID: 22146158 DOI: 10.1097/SLE.0b013e31822d02dc] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
368 Goodman KA. Refining the Role for Adjuvant Radiotherapy in Gastric Cancer: Risk Stratification Is Key. J Clin Oncol 2015;33:3082-4. [PMID: 25559799 DOI: 10.1200/JCO.2014.59.1941] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
369 Jaworski R, Bollschweiler E, Holscher AH, Monig SP, Skokowski J, Zielinski J, Swierblewski M, Kopacz A, Jaskiewicz J. Prognostic relevance of demographics and surgical practice for patients with gastric cancer in two centers: in Poland versus Germany. Gastric Cancer 2011;14:234-41. [PMID: 21442179 DOI: 10.1007/s10120-011-0036-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
370 Huang CM, Lin JX, Zheng CH, Li P, Xie JW, Lin BJ, Lu HS. Prognostic impact of dissected lymph node count on patients with node-negative gastric cancer. World J Gastroenterol 2009; 15(31): 3926-3930 [PMID: 19701974 DOI: 10.3748/wjg.15.3926] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
371 Marano L, Polom K, Patriti A, Roviello G, Falco G, Stracqualursi A, De Luca R, Petrioli R, Martinotti M, Generali D, Marrelli D, Di Martino N, Roviello F. Surgical management of advanced gastric cancer: An evolving issue. Eur J Surg Oncol. 2016;42:18-27. [PMID: 26632080 DOI: 10.1016/j.ejso.2015.10.016] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
372 Spanknebel KA, Brennan MF. Is D2 lymphadenectomy for gastric cancer a staging tool or a therapeutic intervention? Surg Oncol Clin N Am. 2002;11:415-30, xii. [PMID: 12424860 DOI: 10.1016/s1055-3207(02)00008-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
373 Jiang N, Deng JY, Ding XW, Ke B, Liu N, Liang H. Node-extranodal soft tissue stage based on extranodal metastasis is associated with poor prognosis of patients with gastric cancer. J Surg Res 2014;192:90-7. [PMID: 24953988 DOI: 10.1016/j.jss.2014.05.053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
374 Stumpf PK, Amini A, Jones BL, Koshy M, Sher DJ, Lieu CH, Schefter TE, Goodman KA, Rusthoven CG. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis. Cancer. 2017;123:3402-3409. [PMID: 28513823 DOI: 10.1002/cncr.30748] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
375 Mönig SP, Collet PH, Baldus SE, Schmackpfeffer K, Schröder W, Thiele J, Dienes HP, Hölscher AH. Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus. J Surg Oncol. 2001;76:89-92. [PMID: 11223832 DOI: 10.1002/1096-9098(200102)76:2%3C89::AID-JSO1016%3E3.0.CO;2-I] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
376 Deng J, Liang H. D2 lymphadenectomy in gastric cancer surgery. Clin Oncol Cancer Res 2009;6:162-8. [DOI: 10.1007/s11805-009-0162-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
377 Degiuli M, Sasako M, Ponti A, Calvo F. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 2004;90:1727-32. [PMID: 15150592 DOI: 10.1038/sj.bjc.6601761] [Cited by in Crossref: 131] [Cited by in F6Publishing: 126] [Article Influence: 7.3] [Reference Citation Analysis]
378 Khedmat H, Panahian M, Mashahdian M, Rajabpour MV, Zendehdel K. Prognostic factors and survival in stomach cancer - analysis of 15 years of data from a referral hospital in iran and evaluation of international variation. Onkologie 2011;34:178-82. [PMID: 21447975 DOI: 10.1159/000327007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
379 Mariette C, Piessen G, Vons C. [Not Available]. J Chir (Paris) 2008;145S4:12S21-9. [PMID: 22793981 DOI: 10.1016/S0021-7697(08)74718-5] [Reference Citation Analysis]
380 Hallet J, Labidi S, Bouchard-Fortier A, Clairoux A, Gagné JP. Oncologic specimen from laparoscopic assisted gastrectomy for gastric adenocarcinoma is comparable to D1-open surgery: the experience of a Canadian centre. Can J Surg 2013;56:249-55. [PMID: 23883495 DOI: 10.1503/cjs.002612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
381 Slagter AE, Vollebergh MA, Jansen EPM, van Sandick JW, Cats A, van Grieken NCT, Verheij M. Towards Personalization in the Curative Treatment of Gastric Cancer. Front Oncol. 2020;10:614907. [PMID: 33330111 DOI: 10.3389/fonc.2020.614907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
382 Chen QY, Lin GT, Zhong Q, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Huang CM. Laparoscopic total gastrectomy for upper-middle advanced gastric cancer: analysis based on lymph node noncompliance. Gastric Cancer 2020;23:184-94. [PMID: 31300914 DOI: 10.1007/s10120-019-00986-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
383 Buergy D, Lohr F, Baack T, Siebenlist K, Haneder S, Michaely H, Wenz F, Boda-Heggemann J. Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy. Radiat Oncol. 2012;7:192. [PMID: 23157945 DOI: 10.1186/1748-717x-7-192] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
384 Giacopuzzi S, Bencivenga M, Cipollari C, Weindelmayer J, de Manzoni G. Lymphadenectomy: how to do it? Transl Gastroenterol Hepatol 2017;2:28. [PMID: 28447063 DOI: 10.21037/tgh.2017.03.09] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
385 Fukunaga S, Nagami Y, Shiba M, Ominami M, Tanigawa T, Yamagami H, Tanaka H, Muguruma K, Watanabe T, Tominaga K, Fujiwara Y, Ohira M, Hirakawa K, Arakawa T. Long-term prognosis of expanded-indication differentiated-type early gastric cancer treated with endoscopic submucosal dissection or surgery using propensity score analysis. Gastrointest Endosc. 2017;85:143-152. [PMID: 27365265 DOI: 10.1016/j.gie.2016.06.049] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 9.7] [Reference Citation Analysis]
386 Günther K, Horbach T, Merkel S, Meyer M, Schnell U, Klein P, Hohenberger W. D3 lymph node dissection in gastric cancer: evaluation of postoperative mortality and complications. Surg Today 2000;30:700-5. [PMID: 10955732 DOI: 10.1007/s005950070080] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
387 Rajdev L. Treatment options for surgically resectable gastric cancer. Curr Treat Options Oncol. 2010;11:14-23. [PMID: 20358316 DOI: 10.1007/s11864-010-0117-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
388 Biffi R, Botteri E, Cenciarelli S, Luca F, Pozzi S, Valvo M, Sonzogni A, Chiappa A, Leal Ghezzi T, Rotmensz N, Bagnardi V, Andreoni B. Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection. European Journal of Surgical Oncology (EJSO) 2011;37:305-11. [DOI: 10.1016/j.ejso.2011.01.013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
389 Roviello F, Rossi S, Marrelli D, De Manzoni G, Pedrazzani C, Morgagni P, Corso G, Pinto E. Perforated gastric carcinoma: a report of 10 cases and review of the literature. World J Surg Oncol 2006;4:19. [PMID: 16573818 DOI: 10.1186/1477-7819-4-19] [Cited by in Crossref: 56] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
390 Portanova M, Vargas F, Lombardi E, Mena V, Carbajal R, Palacios N, Orrego J. Results of specialization in the surgical treatment of gastric cancer in Peru. Gastric Cancer 2007;10:92-7. [DOI: 10.1007/s10120-007-0413-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
391 Ahmad SA, Xia BT, Bailey CE, Abbott DE, Helmink BA, Daly MC, Thota R, Schlegal C, Winer LK, Ahmad SA, Al Humaidi AH, Parikh AA. An update on gastric cancer. Curr Probl Surg 2016;53:449-90. [PMID: 27671911 DOI: 10.1067/j.cpsurg.2016.08.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
392 Hur H, Park CH. [Surgical treatment of gastric carcinoma]. Korean J Gastroenterol 2009;54:83-98. [PMID: 19696536 DOI: 10.4166/kjg.2009.54.2.83] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
393 Nanthakumaran S, Fernandes E, Thompson AM, Rapson T, Gilbert FJ, Park KG. Morbidity and mortality rates following gastric cancer surgery and contiguous organ removal, a population based study. Eur J Surg Oncol 2005;31:1141-4. [PMID: 16111855 DOI: 10.1016/j.ejso.2005.03.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
394 Ueno T, Iida M, Yoshino S, Takeda S, Kubota H, Higashida M, Oka Y, Tsuruta A, Matsumoto H, Nagano H. East Versus West: Differences in Surgical Management in Asia Compared with Europe and North America. Surg Clin North Am. 2017;97:453-466. [PMID: 28325197 DOI: 10.1016/j.suc.2016.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
395 Sasako M. D2 nodal dissection. Operative Techniques in General Surgery 2003;5:36-49. [DOI: 10.1053/otgn.2003.35357] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
396 Tee MC, Pirozzi N, Brahmbhatt RD, Raman S, Franko J. Oncologic and surgical outcomes for gastric cancer patients undergoing gastrectomy differ by race in the United States. Eur J Surg Oncol 2020;46:1941-7. [PMID: 32466860 DOI: 10.1016/j.ejso.2020.05.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
397 Tóth D, Kincses Z, Plósz J, Török M, Kovács I, Kiss C, Damjanovich L. Value of sentinel lymph node mapping using a blue dye-only method in gastric cancer: a single-center experience from North-East Hungary. Gastric Cancer. 2011;14:360-364. [PMID: 21538019 DOI: 10.1007/s10120-011-0048-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
398 Menges M, Hoehler T. Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction. J Cancer Res Clin Oncol 2009;135:29-38. [PMID: 18523800 DOI: 10.1007/s00432-008-0425-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
399 Cady B. COMMENTARY ON `MULTIDISCIPLINARY APPROACH TO ESOPHAGEAL AND GASTRIC CANCER' BY STEIN ET AL. Surgical Clinics of North America 2000;80:683-6. [DOI: 10.1016/s0039-6109(05)70206-1] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
400 Degiuli M, Sasako M, Ponti A; Italian Gastric Cancer Study Group. Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg. 2010;97:643-649. [PMID: 20186890 DOI: 10.1002/bjs.6936] [Cited by in Crossref: 187] [Cited by in F6Publishing: 176] [Article Influence: 15.6] [Reference Citation Analysis]
401 Yuan SQ, Chen YT, Huang ZP. Equipping the 8th Edition American Joint Committee on Cancer Staging for Gastric Cancer with the 15-Node Minimum: a Population-Based Study Using Recursive Partitioning Analysis. J Gastrointest Surg 2017;21:1591-8. [PMID: 28752402 DOI: 10.1007/s11605-017-3504-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
402 Smalley SR, Gunderson L, Tepper J, Martenson JA, Minsky B, Willett C, Rich T. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys. 2002;52:283-293. [PMID: 11872272 DOI: 10.1016/s0360-3016(01)02646-3] [Cited by in Crossref: 125] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
403 Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M, Scaglione D, Andreone D, Ponti A, Calvo F. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol. 2004;30:303-308. [PMID: 15028313 DOI: 10.1016/j.ejso.2003.11.020] [Cited by in Crossref: 181] [Cited by in F6Publishing: 162] [Article Influence: 10.1] [Reference Citation Analysis]
404 Anderson C, Ellenhorn J, Hellan M, Pigazzi A. Pilot series of robot-assisted laparoscopic subtotal gastrectomy with extended lymphadenectomy for gastric cancer. Surg Endosc. 2007;21:1662-1666. [PMID: 17345142 DOI: 10.1007/s00464-007-9266-0] [Cited by in Crossref: 84] [Cited by in F6Publishing: 67] [Article Influence: 5.6] [Reference Citation Analysis]
405 Swisher SG, Pisters PWT, Komaki R, Lahoti S, Ajani JA. Gastroesophageal junction adenocarcinoma. Curr Treat Options in Oncol 2000;1:387-98. [DOI: 10.1007/s11864-000-0066-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
406 Mariette C, Piessen G, Vons C. [Not Available]. J Chir (Paris) 2008;145:12S21-9. [PMID: 22794068 DOI: 10.1016/S0021-7697(08)45005-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
407 Li GZ, Doherty GM, Wang J. Surgical Management of Gastric Cancer: A Review. JAMA Surg 2022. [PMID: 35319717 DOI: 10.1001/jamasurg.2022.0182] [Reference Citation Analysis]
408 Takeuchi H, Kitagawa Y. Is lymphadenectomy a predictor or savior for patients with gastric cancer? Ann Surg Oncol. 2010;17:1257-1258. [PMID: 20140527 DOI: 10.1245/s10434-010-0942-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
409 Lemmens VE, Dassen AE, van der Wurff AA, Coebergh JW, Bosscha K. Lymph node examination among patients with gastric cancer: variation between departments of pathology and prognostic impact of lymph node ratio. Eur J Surg Oncol. 2011;37:488-496. [PMID: 21444177 DOI: 10.1016/j.ejso.2011.03.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
410 Kosuga T, Ichikawa D, Okamoto K, Komatsu S, Shiozaki A, Fujiwara H, Otsuji E. Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients. Gastric Cancer. 2011;14:172-177. [PMID: 21331530 DOI: 10.1007/s10120-011-0028-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
411 Gosselin-Tardif A, Lie J, Nicolau I, Molina JC, Cools-Lartigue J, Feldman L, Spicer J, Mueller C, Ferri L. Gastrectomy with Extended Lymphadenectomy: a North American Perspective. J Gastrointest Surg 2018;22:414-20. [PMID: 29124550 DOI: 10.1007/s11605-017-3633-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
412 Panzeri F, Marchegiani G, Malleo G, Malpaga A, Maggino L, Marchese T, Salvia R, Bassi C, Butturini G. Distal pancreatectomy associated with multivisceral resection: results from a single centre experience. Langenbecks Arch Surg 2017;402:457-64. [DOI: 10.1007/s00423-016-1514-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
413 Hartgrink HH. Improving outcome for scirrhous gastric cancer. Gastric Cancer 2009;12:3-5. [PMID: 19390926 DOI: 10.1007/s10120-009-0501-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
414 Hayashi T, Yoshikawa T, Kamiya A, Date K, Wada T, Otsuki S, Yamagata Y, Katai H, Nishida T. Is splenectomy for dissecting splenic hilar lymph nodes justified for scirrhous gastric cancer? Gastric Cancer 2020;23:922-6. [PMID: 32211994 DOI: 10.1007/s10120-020-01063-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
415 Wang W, Zhang X, Shen C, Zhi X, Wang B, Xu Z. Laparoscopic versus open total gastrectomy for gastric cancer: an updated meta-analysis. PLoS One. 2014;9:e88753. [PMID: 24558421 DOI: 10.1371/journal.pone.0088753] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
416 de Bree E, Charalampakis V, Melissas J, Tsiftsis DD. The extent of lymph node dissection for gastric cancer: a critical appraisal. J Surg Oncol. 2010;102:552-562. [PMID: 20976727 DOI: 10.1002/jso.21646] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
417 Okholm C, Svendsen LB, Achiam MP. Status and prognosis of lymph node metastasis in patients with cardia cancer - a systematic review. Surg Oncol. 2014;23:140-146. [PMID: 24953457 DOI: 10.1016/j.suronc.2014.06.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
418 Zheng L, Zhang C, Wang D, Xue Q, Liu X, Zhou KJ, Liu H, Li G. Laparoscopic spleen-preserving hilar lymph node dissection through pre-pancreatic and retro-pancreatic approach in patients with gastric cancer. Cancer Cell Int 2016;16:52. [PMID: 27366114 DOI: 10.1186/s12935-016-0312-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
419 Mafune K. Surgery for Advanced Gastric Cancer. In: Kaminishi M, Takubo K, Mafune K, editors. The Diversity of Gastric Carcinoma. Tokyo: Springer-Verlag; 2005. pp. 271-86. [DOI: 10.1007/4-431-27713-7_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
420 Kasakura Y, Phan A, Ajani J. Adjuvant therapy for resected gastric carcinoma. Surg Oncol Clin N Am. 2002;11:431-444, xii-xiii. [PMID: 12424861 DOI: 10.1016/s1055-3207(02)00009-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
421 Blakely AM, Miner TJ. Surgical considerations in the treatment of gastric cancer. Gastroenterol Clin North Am. 2013;42:337-357. [PMID: 23639644 DOI: 10.1016/j.gtc.2013.01.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
422 Yang Y, Zheng J, Li Y. Comparison of 4 lymph node staging systems for the prognostic prediction of esophagogastric junction adenocarcinoma with ≤15 retrieved lymph nodes. Eur J Surg Oncol 2021:S0748-7983(21)00942-2. [PMID: 34876328 DOI: 10.1016/j.ejso.2021.11.133] [Reference Citation Analysis]
423 Chen J, Bu Z, Ji J. Surgical treatment of gastric cancer: Current status and future directions. Chin J Cancer Res 2021;33:159-67. [PMID: 34158736 DOI: 10.21147/j.issn.1000-9604.2021.02.04] [Reference Citation Analysis]
424 Parast L, Cai T, Tian L. Evaluating surrogate marker information using censored data. Stat Med 2017;36:1767-82. [PMID: 28088843 DOI: 10.1002/sim.7220] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
425 Oñate-Ocaña LF, Aiello-Crocifoglio V, Mondragón-Sánchez R, Ruiz-Molina JM. Survival benefit of D2 lympadenectomy in patients with gastric adenocarcinoma. Ann Surg Oncol 2000;7:210-7. [PMID: 10791852 DOI: 10.1007/BF02523656] [Cited by in Crossref: 42] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
426 Martínez-Lago N, Vieito-Villar M, Vidal-Insua Y, Padin-Iruegas ME, Vazquez-Rivera F, Candamio-Folgar S, Lopez-Lopez R. Adjuvant treatment with infusional 5-fluorouracil in high risk adenocarcinoma of the stomach or gastroesophageal junction. Clin Transl Oncol 2015;17:856-61. [PMID: 26133519 DOI: 10.1007/s12094-015-1314-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
427 Kovoor PA, Hwang J. Treatment of resectable gastric cancer: current standards of care. Expert Rev Anticancer Ther 2009;9:135-42. [PMID: 19105713 DOI: 10.1586/14737140.9.1.135] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
428 Zhu X, Li J. Gastric carcinoma in China: Current status and future perspectives (Review). Oncol Lett 2010;1:407-12. [PMID: 22966316 DOI: 10.3892/ol_00000071] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
429 Yu C, Xue P, Zhang L, Pan R, Cai Z, He Z, Sun J, Zheng M. Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer. World J Surg Oncol 2018;16:174. [PMID: 30134903 DOI: 10.1186/s12957-018-1475-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
430 Huscher CG, Mingoli A, Sgarzini G, Brachini G, Binda B, Di Paola M, Ponzano C. Totally laparoscopic total and subtotal gastrectomy with extended lymph node dissection for early and advanced gastric cancer: early and long-term results of a 100-patient series. Am J Surg. 2007;194:839-844; discussion 844. [PMID: 18005781 DOI: 10.1016/j.amjsurg.2007.08.037] [Cited by in Crossref: 84] [Cited by in F6Publishing: 78] [Article Influence: 5.6] [Reference Citation Analysis]
431 Kiyokawa T, Fukagawa T. Recent trends from the results of clinical trials on gastric cancer surgery. Cancer Commun (Lond) 2019;39:11. [PMID: 30917873 DOI: 10.1186/s40880-019-0360-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
432 Chipponi J, Huguier M, Pezet D, Basso N, Hay JM, Quandalle P, Jaeck D, Fagniez PL, Gainant A. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. Am J Surg. 2004;187:440-445. [PMID: 15006580 DOI: 10.1016/j.amjsurg.2003.12.014] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
433 Gretschel S, Estevez-Schwarz L, Hünerbein M, Schneider U, Schlag PM. Gastric cancer surgery in elderly patients. World J Surg. 2006;30:1468-1474. [PMID: 16850149 DOI: 10.1007/s00268-005-0633-5] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 4.0] [Reference Citation Analysis]
434 Pernot S, Voron T, Perkins G, Lagorce-Pages C, Berger A, Taieb J. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol 2015; 21(40): 11428-11438 [PMID: 26523107 DOI: 10.3748/wjg.v21.i40.11428] [Cited by in CrossRef: 104] [Cited by in F6Publishing: 100] [Article Influence: 14.9] [Reference Citation Analysis]
435 Muratore A, Zimmitti G, Lo Tesoriere R, Mellano A, Massucco P, Capussotti L. Low rates of loco-regional recurrence following extended lymph node dissection for gastric cancer. Eur J Surg Oncol. 2009;35:588-592. [PMID: 19162429 DOI: 10.1016/j.ejso.2008.12.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
436 van der Geld YG, Senan S, van Sörnsen de Koste JR, Verbakel WF, Slotman BJ, Lagerwaard FJ. A Four-Dimensional CT-Based Evaluation of Techniques for Gastric Irradiation. International Journal of Radiation Oncology*Biology*Physics 2007;69:903-9. [DOI: 10.1016/j.ijrobp.2007.06.062] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
437 Flanagan MA, Leitman IM. Radical gastrectomy with para-aortic lymphadenectomy for carcinoma? The controversy continues. Commentary on Risk factors for metastasis to para-aortic lymph nodes in gastric cancer: a single institution study in China. Journal of Surgical Research. J Surg Res 2013;185:e11-3. [PMID: 23036515 DOI: 10.1016/j.jss.2012.09.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
438 Chen S, Zhao BW, Li YF, Feng XY, Sun XW, Li W, Zhou ZW, Zhan YQ, Qian CN, Chen YB. The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients. PLoS One 2012;7:e49424. [PMID: 23166665 DOI: 10.1371/journal.pone.0049424] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
439 Altman AM, Sheka AC, Marmor S, Lou E, Reynolds M, Hui JYC, Tuttle TM, Jensen EH, Denbo JW. The addition of chemoradiation to adjuvant chemotherapy is associated with improved survival in lymph node-positive gastric cancer. Surg Oncol 2020;34:134-9. [PMID: 32891318 DOI: 10.1016/j.suronc.2020.04.010] [Reference Citation Analysis]
440 Mirkin KA, Hollenbeak CS, Wong J. Greater Lymph Node Retrieval Improves Survival in Node-Negative Resected Gastric Cancer in the United States. J Gastric Cancer 2017;17:306-18. [PMID: 29302371 DOI: 10.5230/jgc.2017.17.e35] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
441 Maduekwe UN, Lauwers GY, Fernandez-Del-Castillo C, Berger DL, Ferguson CM, Rattner DW, Yoon SS. New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma. Ann Surg Oncol. 2010;17:1267-1277. [PMID: 20099040 DOI: 10.1245/s10434-010-0914-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
442 Dulucq JL, Wintringer P, Stabilini C, Solinas L, Perissat J, Mahajna A. Laparoscopic and open gastric resections for malignant lesions: a prospective comparative study. Surg Endosc 2005;19:933-8. [PMID: 15920691 DOI: 10.1007/s00464-004-2172-9] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 4.8] [Reference Citation Analysis]
443 Khushalani N. Cancer of the esophagus and stomach. Mayo Clin Proc. 2008;83:712-722. [PMID: 18533089 DOI: 10.4065/83.6.712] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
444 Persiani R, Rausei S, Antonacci V, Biondi A, Casella F, Ciccoritti L, D’ugo D. Metastatic Lymph Node Ratio: A New Staging System for Gastric Cancer. World J Surg 2009;33:2106-11. [DOI: 10.1007/s00268-009-0157-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
445 Hicks SJ. Gastric cancer: diagnosis, risk factors, treatment and life issues. British Journal of Nursing 2001;10:529-36. [DOI: 10.12968/bjon.2001.10.8.5317] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
446 Deng J, Liang H, Wang D, Sun D, Pan Y, Liu Y. Investigation of the recurrence patterns of gastric cancer following a curative resection. Surg Today. 2011;41:210-215. [PMID: 21264756 DOI: 10.1007/s00595-009-4251-y] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 5.3] [Reference Citation Analysis]
447 Calero A, Escrig-Sos J, Mingol F, Arroyo A, Martinez-Ramos D, de Juan M, Salvador-Sanchis JL, Garcia-Granero E, Calpena R, Lacueva FJ. Usefulness of the log odds of positive lymph nodes to predict and discriminate prognosis in gastric carcinomas. J Gastrointest Surg 2015;19:813-20. [PMID: 25560183 DOI: 10.1007/s11605-014-2728-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
448 Moehler M, Galle PR, Gockel I, Junginger T, Schmidberger H. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of gastric cancer. Best Pract Res Clin Gastroenterol 2007;21:965-81. [PMID: 18070698 DOI: 10.1016/j.bpg.2007.10.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
449 Pultrum BB, van Bastelaar J, Schreurs LMA, van Dullemen HM, Groen H, Nijsten MWN, van Dam GM, Plukker JTHM. Impact of splenectomy on surgical outcome in patients with cancer of the distal esophagus and gastro-esophageal junction. Dis Esophagus 2008;21:334-9. [DOI: 10.1111/j.1442-2050.2007.00762.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
450 Marrelli D, De Franco L, Iudici L, Polom K, Roviello F. Lymphadenectomy: state of the art. Transl Gastroenterol Hepatol 2017;2:3. [PMID: 28217753 DOI: 10.21037/tgh.2017.01.01] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
451 Moslim MA, Minarich MJ, Deng M, Handorf E, Greco SH, Reddy SS, Farma JM. Treatment at an Academic Cancer Center Confers Better Survival by Stage for Signet-Ring Cell and Non-signet-Ring Cell Gastric Cancer. Ann Surg Oncol 2021;28:4423-32. [PMID: 33393048 DOI: 10.1245/s10434-020-09424-3] [Reference Citation Analysis]
452 Biondi A, Persiani R, Cananzi F, Zoccali M, Vigorita V, Tufo A, D’Ugo D. R0 resection in the treatment of gastric cancer: Room for improvement. World J Gastroenterol 2010; 16(27): 3358-3370 [PMID: 20632437 DOI: 10.3748/wjg.v16.i27.3358] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
453 Liu X, Liu Z, Lin E, Chen Y, Sun X, Zhou Z. A cumulative score based on preoperative fibrinogen and the neutrophil-lymphocyte ratio to predict outcomes in resectable gastric cancer. Cancer Manag Res 2018;10:3007-14. [PMID: 30214295 DOI: 10.2147/CMAR.S174656] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
454 Faria GR, Pinto-de-Sousa J, Preto JR, Sousa HS, Barbosa JA, Costa-Maia J. Three decades of clinical-pathological trends in gastric cancer: prospective data from a Portuguese hospital. Int J Surg. 2013;11:472-476. [PMID: 23602895 DOI: 10.1016/j.ijsu.2013.04.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
455 Ramos MFKP, Pereira MA, Dias AR, Yagi OK, Zaidan EP, Ribeiro-Júnior U, Zilberstein B, Cecconello I. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions. Eur J Surg Oncol 2019;45:460-5. [PMID: 30497814 DOI: 10.1016/j.ejso.2018.11.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
456 Rausei S, Dionigi G, Rovera F, Boni L, Valerii C, Giavarini L, Frattini F, Dionigi R. A decade in gastric cancer curative surgery: Evidence of progress (1999-2009). World J Gastrointest Surg 2012; 4(3): 45-54 [PMID: 22530078 DOI: 10.4240/wjgs.v4.i3.45] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
457 Sasako M, Saka M, Fukagawa T, Katai H, Sano T. Surgical treatment of advanced gastric cancer: Japanese perspective. Dig Surg. 2007;24:101-107. [PMID: 17446702 DOI: 10.1159/000101896] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
458 Lamb P, Sivashanmugam T, White M, Irving M, Wayman J, Raimes S. Gastric cancer surgery--a balance of risk and radicality. Ann R Coll Surg Engl 2008;90:235-42. [PMID: 18430340 DOI: 10.1308/003588408X261546] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
459 Songun I, van de Velde CJ. How does extended lymphadenectomy influence practical care for patients with gastric cancer? Nat Rev Clin Oncol 2009;6:66-7. [DOI: 10.1038/ncponc1300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
460 Ozmen MM, Zulfikaroglu B, Kucuk NO, Ozalp N, Aras G, Koseoglu T, Koç M. Lymphoscintigraphy in detection of the regional lymph node involvement in gastric cancer. Ann R Coll Surg Engl 2006;88:632-8. [PMID: 17132310 DOI: 10.1308/003588406X149200] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
461 Cuschieri A. Laparoscopic gastric resection. Surg Clin North Am. 2000;80:1269-1284, viii. [PMID: 10987035 DOI: 10.1016/s0039-6109(05)70224-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
462 Wilkinson NW, Howe J, Gay G, Patel-Parekh L, Scott-Conner C, Donohue J. Differences in the pattern of presentation and treatment of proximal and distal gastric cancer: results of the 2001 gastric patient care evaluation. Ann Surg Oncol. 2008;15:1644-1650. [PMID: 18392661 DOI: 10.1245/s10434-008-9877-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
463 Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23:7114-7124. [PMID: 16192595 DOI: 10.1200/jco.2005.14.621] [Cited by in Crossref: 325] [Cited by in F6Publishing: 159] [Article Influence: 19.1] [Reference Citation Analysis]
464 Glaoui M, Naciri S, Ghanem S, Belkouchi A, Errihani H. [The surgical treatment of adenocarcinoma of the gastroesophageal junction: Moroccan experience through a series of 149 cases]. Pan Afr Med J 2011;8:35. [PMID: 22121443 DOI: 10.4314/pamj.v8i1.71150] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
465 Sugase T, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Hiramatsu K, Koh M, Saito Y, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Hanazaki K, Mori M, Doki Y, Naka T. Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer. Oncotarget 2018;9:32917-28. [PMID: 30250639 DOI: 10.18632/oncotarget.25952] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
466 Malmström P. Lymph node staging in prostatic carcinoma revisited. Acta Oncologica 2009;44:593-8. [DOI: 10.1080/02841860510029626] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
467 Van Cutsem E, Dicato M, Geva R, Arber N, Bang Y, Benson A, Cervantes A, Diaz-Rubio E, Ducreux M, Glynne-Jones R. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol. 2011;22 Suppl 5:v1-v9. [PMID: 21633049 DOI: 10.1093/annonc/mdr284] [Cited by in Crossref: 80] [Cited by in F6Publishing: 74] [Article Influence: 7.3] [Reference Citation Analysis]
468 Ilson DH. Current Progress in the Adjuvant Treatment of Gastric Cancer. Surgical Oncology Clinics of North America 2017;26:225-39. [DOI: 10.1016/j.soc.2016.10.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
469 Fayers PM, Cuschieri A, Fielding J, Craven J, Uscinska B, Freedman LS. Sample size calculation for clinical trials: the impact of clinician beliefs. Br J Cancer 2000;82:213-9. [PMID: 10638992 DOI: 10.1054/bjoc.1999.0902] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
470 Bencivenga M, Torroni L, Verlato G, Mengardo V, Sacco M, Allum WH, de Manzoni G. Lymphadenectomy for gastric cancer at European specialist centres. Eur J Surg Oncol 2021;47:1048-54. [PMID: 33092970 DOI: 10.1016/j.ejso.2020.10.013] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
471 Kodera Y. The beginning of a new era: East meets West more comfortably regarding lymphadenectomy for gastric cancer — Japan will finally drop the surgery-alone arm in its pursuit of a multimodal treatment strategy. Gastric Cancer 2007;10:69-74. [DOI: 10.1007/s10120-007-0423-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
472 Kim TH, Park SR, Ryu KW, Kim Y, Bae J, Lee JH, Choi IJ, Kim Y, Kim DY. Phase 3 Trial of Postoperative Chemotherapy Alone Versus Chemoradiation Therapy in Stage III-IV Gastric Cancer Treated With R0 Gastrectomy and D2 Lymph Node Dissection. International Journal of Radiation Oncology*Biology*Physics 2012;84:e585-92. [DOI: 10.1016/j.ijrobp.2012.07.2378] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 6.4] [Reference Citation Analysis]
473 Shridhar R, Dombi GW, Weber J, Hoffe SE, Meredith K, Konski A. Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis. Am J Clin Oncol. 2012;35:216-221. [PMID: 21378540 DOI: 10.1097/coc.0b013e31820dbf08] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
474 Melville A, Morris E, Forman D, Eastwood A. Management of upper gastrointestinal cancers. Qual Health Care 2001;10:57-64. [PMID: 11239144 DOI: 10.1136/qhc.10.1.57] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
475 Povoski SP, Neff RL, Mojzisik CM, O'Malley DM, Hinkle GH, Hall NC, Murrey DA Jr, Knopp MV, Martin EW Jr. A comprehensive overview of radioguided surgery using gamma detection probe technology. World J Surg Oncol 2009;7:11. [PMID: 19173715 DOI: 10.1186/1477-7819-7-11] [Cited by in Crossref: 151] [Cited by in F6Publishing: 98] [Article Influence: 11.6] [Reference Citation Analysis]
476 Harlow SP, Krag DN, Julian TB, Ashikaga T, Weaver DL, Feldman SA, Klimberg VS, Kusminsky R, Moffat FL Jr, Noyes RD, Beitsch PD. Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer. Ann Surg 2005;241:48-54. [PMID: 15621990 DOI: 10.1097/01.sla.0000149429.39656.94] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 3.8] [Reference Citation Analysis]
477 Zhang YX, Yang K. Significance of nodal dissection and nodal positivity in gastric cancer. Transl Gastroenterol Hepatol 2020;5:17. [PMID: 32258521 DOI: 10.21037/tgh.2019.09.13] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
478 Park DJ, Lee HJ, Kim HH, Yang HK, Lee KU, Choe KJ. Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg. 2005;92:1099-1102. [PMID: 15931657 DOI: 10.1002/bjs.4952] [Cited by in Crossref: 182] [Cited by in F6Publishing: 162] [Article Influence: 10.7] [Reference Citation Analysis]
479 Cabral F, Ramos P, Monteiro C, Casaca R, Pinto I, Abecasis N. Impact of perioperative chemotherapy on postoperative morbidity after gastrectomy for gastric cancer. Cir Esp 2021;99:521-6. [PMID: 33293027 DOI: 10.1016/j.ciresp.2020.09.006] [Reference Citation Analysis]
480 Maezawa Y, Aoyama T, Yamada T, Kano K, Hayashi T, Sato T, Oshima T, Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T. Priority of lymph node dissection for proximal gastric cancer invading the greater curvature. Gastric Cancer 2018;21:569-72. [DOI: 10.1007/s10120-017-0775-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
481 Maehara Y, Kakeji Y, Oda S, Takahashi I, Akazawa K, Sugimachi K. Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer. Br J Cancer. 2000;83:986-991. [PMID: 10993643 DOI: 10.1054/bjoc.2000.1427] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 3.1] [Reference Citation Analysis]
482 Liu CG, Lu P, Lu Y, Jin F, Xu HM, Wang SB, Chen JQ. Distribution of solitary lymph nodes in primary gastric cancer: A retrospective study and clinical implications. World J Gastroenterol 2007; 13(35): 4776-4780 [PMID: 17729400 DOI: 10.3748/wjg.v13.i35.4776] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
483 Pelc Z, Skórzewska M, Rawicz-Pruszyński K, Polkowski WP. Lymph Node Involvement in Advanced Gastric Cancer in the Era of Multimodal Treatment-Oncological and Surgical Perspective. Cancers (Basel) 2021;13:2509. [PMID: 34065596 DOI: 10.3390/cancers13102509] [Reference Citation Analysis]
484 Mack LA. D1 versus D2 lymphadenectomy and volume versus training: ongoing debate in gastric cancer surgery. J Surg Oncol 2006;93:345-6. [PMID: 16550554 DOI: 10.1002/jso.20496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
485 Hundahl SA, Macdonald JS, Benedetti J, Fitzsimmons T; Southwest Oncology Group and the Gastric Intergroup. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol. 2002;9:278-286. [PMID: 11923135 DOI: 10.1007/bf02573066] [Cited by in Crossref: 157] [Cited by in F6Publishing: 51] [Article Influence: 7.9] [Reference Citation Analysis]
486 Leelawat K, Engprasert S, Tujinda S, Suthippintawong C, Enjoji M, Nakashima M, Watanabe T, Leardkamolkarn V. Receptor-binding cancer antigen expressed on SiSo cells can be detected in metastatic lymph nodes from gastrointestinal cancers. World J Gastroenterol 2005; 11(38): 6014-6017 [PMID: 16273616 DOI: 10.3748/wjg.v11.i38.6014] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
487 Mcculloch P. How I do it: D2 gastrectomy. European Journal of Surgical Oncology (EJSO) 2002;28:738-43. [DOI: 10.1053/ejso.2002.1343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
488 Liu YY, Fang WL, Wang F, Hsu JT, Tsai CY, Liu KH, Yeh CN, Chen TC, Wu RC, Chiu CT, Yeh TS. Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?-Time to Embrace a New Digit. Oncologist 2017;22:97-106. [PMID: 27789777 DOI: 10.1634/theoncologist.2016-0239] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
489 Ashraf N, Hoffe S, Kim R. Adjuvant treatment for gastric cancer: chemotherapy versus radiation. Oncologist 2013;18:1013-21. [PMID: 23966224 DOI: 10.1634/theoncologist.2012-0462] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
490 Liu C, Qi L, Feng QX, Sun SW, Zhang YD, Liu XS. Performance of a machine learning-based decision model to help clinicians decide the extent of lymphadenectomy (D1 vs. D2) in gastric cancer before surgical resection. Abdom Radiol (NY) 2019;44:3019-29. [PMID: 31201432 DOI: 10.1007/s00261-019-02098-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
491 Kooby DA. Is Extended Lymphadenectomy Needed for Elderly Patients with Gastric Adenocarcinoma? Ann Surg Oncol 2016;23:2373-4. [PMID: 27207094 DOI: 10.1245/s10434-016-5261-9] [Reference Citation Analysis]
492 Meng C, Yin H, Sun Z, Zhou J, Chen S, Bai C, Zhao L. Adjuvant Chemotherapy with Docetaxel, Cisplatin, and Continuous-Infusion 5-Fluorouracil for Gastric Cancer: A Phase II Study. Transl Oncol 2014;7:277-83. [PMID: 24704535 DOI: 10.1016/j.tranon.2014.02.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
493 Yoney A, Bati Y, Akboru H, Isikli L, Unsal M. A retrospective comparison of concurrent 5-fluorouracil or oral UFT in postoperative chemoradiation for gastric adenocarcinoma. Cancer Radiother. 2010;14:19-23. [PMID: 19963423 DOI: 10.1016/j.canrad.2009.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
494 Bickenbach K, Strong VE. Comparisons of Gastric Cancer Treatments: East vs. West. J Gastric Cancer. 2012;12:55-62. [PMID: 22792517 DOI: 10.5230/jgc.2012.12.2.55] [Cited by in Crossref: 80] [Cited by in F6Publishing: 85] [Article Influence: 8.0] [Reference Citation Analysis]
495 Panin SI, Postolov MP, Kovalenko NV, Beburishvili AG, Fedorov AV, Bykov AV. [Distal subtotal gastrectomy and gastreectomy in surgical treatment of patients with gastric cancer: a systematic review and meta-analysis]. Khirurgiia (Mosk) 2020;:93-100. [PMID: 33210514 DOI: 10.17116/hirurgia202011193] [Reference Citation Analysis]
496 Graziosi L, Marino E, Cavazzoni E, Donini A. Prognostic value of the seventh AJCC/UICC TNM classification of non-cardia gastric cancer. World J Surg Oncol 2013;11:103. [PMID: 23687939 DOI: 10.1186/1477-7819-11-103] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
497 Kong SH, Lee HJ, Ahn HS, Kim JW, Kim WH, Lee KU, Yang HK. Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging. Ann Surg. 2012;255:50-58. [PMID: 21577089 DOI: 10.1097/sla.0b013e31821d4d75] [Cited by in Crossref: 94] [Cited by in F6Publishing: 45] [Article Influence: 9.4] [Reference Citation Analysis]
498 de Gara CJ, Hanson J, Hamilton S. A population-based study of tumor-node relationship, resection margins, and surgeon volume on gastric cancer survival. Am J Surg. 2003;186:23-27. [PMID: 12842743 DOI: 10.1016/s0002-9610(03)00116-8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
499 Xu DZ, Geng QR, Long ZJ, Zhan YQ, Li W, Zhou ZW, Chen YB, Sun XW, Chen G, Liu Q. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol. 2009;16:319-326. [PMID: 19050970 DOI: 10.1245/s10434-008-0240-4] [Cited by in Crossref: 72] [Cited by in F6Publishing: 79] [Article Influence: 5.1] [Reference Citation Analysis]
500 Tokunaga M, Hiki N, Fukunaga T, Nohara K, Katayama H, Akashi Y, Ohyama S, Yamaguchi T. Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection Following Standardization—A Preliminary Study. J Gastrointest Surg 2009;13:1058-63. [DOI: 10.1007/s11605-009-0840-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
501 Gretschel S, Bembenek A, Ulmer Ch, Hünerbein M, Markwardt J, Schneider U, Schlag PM. Prediction of gastric cancer lymph node status by sentinel lymph node biopsy and the Maruyama computer model. Eur J Surg Oncol. 2005;31:393-400. [PMID: 15837046 DOI: 10.1016/j.ejso.2004.11.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
502 Han Y, Zhu Z, You Q, Granito A. The Survival Relationship between Preoperative Inflammation Markers and Patients with Special Pathological Types of Gastric Cancer. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-10. [DOI: 10.1155/2022/5715898] [Reference Citation Analysis]
503 Zielinski J, Jaworski R, Pawlaczyk R, Swierblewski M, Kabata P, Jaskiewicz J, Rogowski J. Simultaneous surgery for critical aortic stenosis and gastric cancer: A case report. World J Gastroenterol 2010; 16(9): 1161-1164 [PMID: 20205291 DOI: 10.3748/wjg.v16.i9.1161] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
504 Lee JH, Kim KM, Cheong JH, Noh SH. Current management and future strategies of gastric cancer. Yonsei Med J 2012;53:248-57. [PMID: 22318810 DOI: 10.3349/ymj.2012.53.2.248] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
505 den Dulk M, Verheij M, Cats A, Jansen EPM, Hartgrink HH, van de Velde CJH. The Essentials of Locoregional Control in the Treatment of Gastric Cancer. Scand J Surg 2006;95:236-42. [DOI: 10.1177/145749690609500405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
506 Seevaratnam R, Bocicariu A, Cardoso R, Yohanathan L, Dixon M, Law C, Helyer L, Coburn NG. How many lymph nodes should be assessed in patients with gastric cancer? Gastric Cancer. 2012;15 Suppl 1:S70-S88. [PMID: 22895615 DOI: 10.1007/s10120-012-0169-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 55] [Article Influence: 4.7] [Reference Citation Analysis]
507 Wong J, Jackson P. Gastric cancer surgery: an American perspective on the current options and standards. Curr Treat Options Oncol. 2011;12:72-84. [PMID: 21274666 DOI: 10.1007/s11864-010-0136-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
508 Roviello F, Rossi S, Marrelli D, Pedrazzani C, Corso G, Vindigni C, Morgagni P, Saragoni L, de Manzoni G, Tomezzoli A. Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol. 2006;94:275-280; discussion 274. [PMID: 16917863 DOI: 10.1002/jso.20566] [Cited by in Crossref: 101] [Cited by in F6Publishing: 97] [Article Influence: 6.3] [Reference Citation Analysis]
509 Yuasa N, Nimura Y. Survival after surgical treatment of early gastric cancer, surgical techniques, and long-term survival. Langenbecks Arch Surg. 2005;390:286-293. [PMID: 15133674 DOI: 10.1007/s00423-004-0482-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
510 Dikken JL, van Sandick JW, Maurits Swellengrebel HA, Lind PA, Putter H, Jansen EP, Boot H, van Grieken NC, van de Velde CJ, Verheij M. Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS). BMC Cancer. 2011;11:329. [PMID: 21810227 DOI: 10.1186/1471-2047.11-329] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
511 Thomson IG, Gotley DC, Barbour AP, Martin I, Jayasuria N, Thomas J, Smithers BM. Treatment results of curative gastric resection from a specialist Australian unit: low volume with satisfactory outcomes. Gastric Cancer. 2014;17:152-160. [PMID: 23474836 DOI: 10.1007/s10120-013-0240-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
512 Coccolini F, Montori G, Ceresoli M, Cima S, Valli MC, Nita GE, Heyer A, Catena F, Ansaloni L. Advanced gastric cancer: What we know and what we still have to learn. World J Gastroenterol 2016; 22(3): 1139-1159 [PMID: 26811653 DOI: 10.3748/wjg.v22.i3.1139] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
513 Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Critical Reviews in Oncology/Hematology 2009;71:127-64. [DOI: 10.1016/j.critrevonc.2009.01.004] [Cited by in Crossref: 266] [Cited by in F6Publishing: 262] [Article Influence: 20.5] [Reference Citation Analysis]
514 Jiang Y, Ajani JA. Multidisciplinary management of gastric cancer. Curr Opin Gastroenterol 2010;26:640-6. [PMID: 20827183 DOI: 10.1097/MOG.0b013e32833efd9b] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
515 Chandran S, Vaughan R, Efthymiou M, Sia J, Hamilton C. A pilot study of EUS-guided fiducial insertion for the multidisciplinary management of gastric cancer. Endosc Int Open 2014;2:E153-9. [PMID: 26134962 DOI: 10.1055/s-0034-1377523] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
516 Faiz Z, Hayashi T, Yoshikawa T. Lymph node dissection for gastric cancer: Establishment of D2 and the current position of splenectomy in Europe and Japan. Eur J Surg Oncol 2021;47:2233-6. [PMID: 33910779 DOI: 10.1016/j.ejso.2021.04.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
517 Memon MA, Khan S, Yunus RM, Barr R, Memon B. Meta-analysis of laparoscopic and open distal gastrectomy for gastric carcinoma. Surg Endosc 2008;22:1781-9. [DOI: 10.1007/s00464-008-9925-9] [Cited by in Crossref: 135] [Cited by in F6Publishing: 121] [Article Influence: 9.6] [Reference Citation Analysis]
518 Choi YY, Noh SH, Cheong JH. Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine. Yonsei Med J 2015;56:1177-85. [PMID: 26256958 DOI: 10.3349/ymj.2015.56.5.1177] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
519 Kodera Y, Fujiwara M, Koike M, Nakao A. Chemotherapy as a component of multimodal therapy for gastric carcinoma. World J Gastroenterol 2006; 12(13): 2000-2005 [PMID: 16610047 DOI: 10.3748/wjg.v12.i13.2000] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
520 Grossmann EM, Longo WE, Virgo KS, Johnson FE, Oprian CA, Henderson W, Daley J, Khuri SF. Morbidity and mortality of gastrectomy for cancer in Department of Veterans Affairs Medical Centers. Surgery. 2002;131:484-490. [PMID: 12019399 DOI: 10.1067/msy.2002.123806] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 2.4] [Reference Citation Analysis]
521 Scatizzi M, Kröning KC, Lenzi E, Moraldi L, Cantafio S, Feroci F. Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer: a case-control study. Updates Surg. 2011;63:17-23. [PMID: 21286896 DOI: 10.1007/s13304-011-0043-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
522 Alline M, Bertrand MM, Colombo PE, Mourregot A, Rouanet P. [Lymph node dissection: what for? From esophagus to rectum: surgical and lymph node related prognostic factors]. Bull Cancer. 2014;101:368-372. [PMID: 24793629 DOI: 10.1684/bdc.2014.1929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
523 Glehen O, Traverse-Glehen A, Peyrat P, François Y, Gérard JP, Vignal J, Gilly FN. [Stomach adenocarcinoma. Evolution of surgical treatment in a series of 350 cases]. Ann Chir. 2000;125:744-751. [PMID: 11105346 DOI: 10.1016/s0003-3944(00)00268-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
524 Date R, Panesar K. D2 gastrectomy - a safe operation in experienced hands*: Total Gastrectomy for Gastric Cancer. International Journal of Clinical Practice 2005;59:672-4. [DOI: 10.1111/j.1742-1241.2004.00413.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
525 Kim S, Kim JS, Jeong HY, Noh SM, Kim KW, Cho MJ. Retrospective analysis of treatment outcomes after postoperative chemoradiotherapy in advanced gastric cancer. Radiat Oncol J. 2011;29:252-259. [PMID: 22984678 DOI: 10.3857/roj.2011.29.4.252] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
526 Saito H, Kono Y, Murakami Y, Shishido Y, Kuroda H, Matsunaga T, Fukumoto Y, Osaki T, Ashida K, Fujiwara Y. Therapeutic Value of Lymph Node Dissection Along the Superior Mesenteric Vein and the Posterior Surface of the Pancreatic Head in Gastric Cancer Located in the Lower Third of the Stomach. Yonago Acta Med. 2018;61:175-181. [PMID: 30275748 DOI: 10.33160/yam.2018.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
527 Liu XX, Jiang ZW, Chen P, Zhao Y, Pan HF, Li JS. Full robot-assisted gastrectomy with intracorporeal robot-sewn anastomosis produces satisfying outcomes. World J Gastroenterol 2013; 19(38): 6427-6437 [PMID: 24151361 DOI: 10.3748/wjg.v19.i38.6427] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
528 Biffi R, Fazio N, Luca F, Chiappa A, Andreoni B, Zampino MG, Roth A, Schuller JC, Fiori G, Orsi F, Bonomo G, Crosta C, Huber O. Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer. World J Gastroenterol 2010; 16(7): 868-874 [PMID: 20143466 DOI: 10.3748/wjg.v16.i7.868] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
529 Wilson D, Hiller L, Geh JI. Review of second-line chemotherapy for advanced gastric adenocarcinoma. Clin Oncol (R Coll Radiol). 2005;17:81-90. [PMID: 15830569 DOI: 10.1016/j.clon.2004.10.006] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
530 Martinez-Ramos D, Calero A, Escrig-Sos J, Mingol F, Daroca-Jose JM, Sauri M, Arroyo A, Salvador-Sanchis JL, de Juan M, Calpena R, Lacueva FJ. Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes. Eur J Surg Oncol 2014;40:358-65. [PMID: 24075824 DOI: 10.1016/j.ejso.2013.08.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
531 Jansen EP, Boot H, Dubbelman R, Bartelink H, Cats A, Verheij M. Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy. Br J Cancer 2007;97:712-6. [PMID: 17848909 DOI: 10.1038/sj.bjc.6603965] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
532 Kostić Z, Cuk V, Ignjatović M, Usaj-Knezević S. [Early complications following radical surgical treatment of patients with gastric adenocarcinoma]. Vojnosanit Pregl 2006;63:249-56. [PMID: 16605190 DOI: 10.2298/vsp0603249k] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
533 Li ZY, Shan F, Zhang LH, Bu ZD, Wu AW, Wu XJ, Zong XL, Wu Q, Ren H, Ji JF. Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer. World J Surg Oncol. 2011;9:110. [PMID: 21942969 DOI: 10.1186/1477-7819-9-110] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
534 Lam S, Tan E, Menezes A, Martin D, Gallagher J, Storey D, Sandroussi C. A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching. World J Surg Oncol 2018;16:136. [PMID: 29986713 DOI: 10.1186/s12957-018-1422-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
535 Minarich MJ, Schwarz RE. A Simplified Two-Step Technique for Extended Lymphadenectomy During Resection of Gastroesophageal Malignancy: Early Results Compared to En Bloc Dissection. J Gastrointest Surg 2019;23:393-401. [PMID: 30603860 DOI: 10.1007/s11605-018-4056-7] [Reference Citation Analysis]
536 McCulloch P, Nita ME, Kazi H, Gama-Rodrigues J. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev. 2003;CD001964. [PMID: 14583942 DOI: 10.1002/14651858.cd001964.pub2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
537 Kus T, Kose F, Aktas G, Arslan UY, Sedef AM, Cinkir HY, Dirikoc M, Akkus G, Ozdemir NY. Survival analysis according to lymph nodes dissection and adjuvant therapy types in gastric cancer: A retrospective multicenter cohort study. Journal of Oncological Sciences 2019;5:80-4. [DOI: 10.1016/j.jons.2019.09.004] [Reference Citation Analysis]
538 Coburn NG, Swallow CJ, Kiss A, Law C. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer. 2006;107:2143-2151. [PMID: 17001662 DOI: 10.1002/cncr.22229] [Cited by in Crossref: 124] [Cited by in F6Publishing: 132] [Article Influence: 7.8] [Reference Citation Analysis]
539 Pang W, Lou N, Jin C, Hu C, Arvine C, Zhu G, Shen X. Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer. Eur J Gastroenterol Hepatol 2016;28:493-502. [PMID: 26854795 DOI: 10.1097/MEG.0000000000000563] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
540 Jung YJ, Seo HS, Kim JH, Park CH, Lee HH. The Relevance of Serosal Exposure Without Nodal Metastasis in Resectional Gastric Cancer. Ann Surg Oncol 2019;26:1772-8. [PMID: 30767177 DOI: 10.1245/s10434-019-07221-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
541 Geh JI, Glynne-Jones R, Kwok QS, Banerji U, Livingstone JI, Townsend ER, Harrison RA, Mitchell IC. Preoperative ECF chemotherapy in gastro-oesophageal adenocarcinoma. Clin Oncol (R Coll Radiol) 2000;12:182-7. [PMID: 10942336 DOI: 10.1053/clon.2000.9147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.0] [Reference Citation Analysis]
542 Taneja C, Cady B. Decreasing role of lymphatic system surgery in surgical oncology. J Surg Oncol 2005;89:61-6. [DOI: 10.1002/jso.20198] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
543 Yura M, Yoshikawa T, Otsuki S, Yamagata Y, Morita S, Katai H, Nishida T. The Therapeutic Survival Benefit of Splenic Hilar Nodal Dissection for Advanced Proximal Gastric Cancer Invading the Greater Curvature. Ann Surg Oncol 2019;26:829-35. [DOI: 10.1245/s10434-018-07122-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
544 Roukos DH, Kappas AM. Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2005;2:98-107. [PMID: 16264882 DOI: 10.1038/ncponc0099] [Cited by in Crossref: 118] [Cited by in F6Publishing: 105] [Article Influence: 6.9] [Reference Citation Analysis]
545 Misleh JG, Santoro P, Strasser JF, Bennett JJ. Multidisciplinary Management of Gastric Cancer. Surgical Oncology Clinics of North America 2013;22:247-64. [DOI: 10.1016/j.soc.2012.12.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
546 Douglass HO. Gastric cancer: D2 all over again. Ann Surg Oncol 2003;10:206-7. [PMID: 12679301 DOI: 10.1245/aso.2003.01.015] [Reference Citation Analysis]
547 Kim C, Mulder K, Spratlin J. How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer. Oncologist. 2014;19:1046-1055. [PMID: 25142842 DOI: 10.1634/theoncologist.2014-0006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
548 Phillips JD, Nagle AP, Soper NJ. Laparoscopic gastrectomy for cancer. Surg Oncol Clin N Am 2013;22:39-57, v-vi. [PMID: 23158084 DOI: 10.1016/j.soc.2012.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
549 Heemskerk VH, Lentze F, Hulsewé KW, Hoofwijk TG. Gastric carcinoma: review of the results of treatment in a community teaching hospital. World J Surg Oncol 2007;5:81. [PMID: 17659085 DOI: 10.1186/1477-7819-5-81] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
550 Badgwell B, Das P, Ajani J. Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy. J Hematol Oncol 2017;10:149. [PMID: 28810883 DOI: 10.1186/s13045-017-0517-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
551 Sun W, Deng J, Zhang N, Liu H, Liu J, Gu P, Du Y, Wu Z, He W, Wang P, Liang H. Prognostic impact of D2-plus lymphadenectomy and optimal extent of lymphadenectomy in advanced gastric antral carcinoma: Propensity score matching analysis. Chin J Cancer Res 2020;32:51-61. [PMID: 32194305 DOI: 10.21147/j.issn.1000-9604.2020.01.07] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
552 Markar SR, Karthikesalingam A, Jackson D, Hanna GB. Long-term survival after gastrectomy for cancer in randomized, controlled oncological trials: comparison between West and East. Ann Surg Oncol. 2013;20:2328-2338. [PMID: 23340695 DOI: 10.1245/s10434-012-2862-9] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.6] [Reference Citation Analysis]
553 Mansour JC, Coit DG. Appropriate Treatment for Patients with Gastric Adenocarcinoma. Ann Surg Oncol 2008;15:1798-9. [DOI: 10.1245/s10434-008-9854-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
554 Hundahl SA. Surgical quality control in gastric cancer trials. Surg Oncol Clin N Am 2002;11:445-58. [PMID: 12424862 DOI: 10.1016/s1055-3207(02)00014-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
555 Tóth D, Török M, Kincses Z, Damjanovich L. Prospective, comparative study for the evaluation of lymph node involvement in gastric cancer: Maruyama computer program versus sentinel lymph node biopsy. Gastric Cancer. 2013;16:201-207. [PMID: 22740059 DOI: 10.1007/s10120-012-0170-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
556 Etoh T, Inomata M, Shiraishi N, Kitano S. Revisional surgery after gastrectomy for gastric cancer: review of the literature. Surg Laparosc Endosc Percutan Tech. 2010;20:332-337. [PMID: 20975505 DOI: 10.1097/sle.0b013e3181f39ff1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
557 Jung JY, Ryu MH, Ryoo BY, Han B, Cho JW, Lim MS, Lim H, Kang HS, Kim MJ, Ha HI, Song H, Kim JH, Kim HS, Kang YK, Zang DY. Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1. Gastroenterol Res Pract 2016;2016:6857625. [PMID: 26839542 DOI: 10.1155/2016/6857625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
558 Lee J, Lim DH, Kim S, Park SH, Park JO, Park YS, Lim HY, Choi MG, Sohn TS, Noh JH, Bae JM, Ahn YC, Sohn I, Jung SH, Park CK, Kim KM, Kang WK. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol. 2012;30:268-273. [PMID: 22184384 DOI: 10.1200/jco.2011.39.1953] [Cited by in Crossref: 433] [Cited by in F6Publishing: 249] [Article Influence: 39.4] [Reference Citation Analysis]
559 Van Laethem JL, Demols A. Adjuvant therapy in gastric and cardia cancer: should we irradiate? Curr Opin Oncol 2006;18:381-5. [PMID: 16721135 DOI: 10.1097/01.cco.0000228746.95035.6c] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
560 Roggin KK, Posner MC. D3 or not D3... that is not the question. Lancet Oncol. 2006;7:279-280. [PMID: 16574543 DOI: 10.1016/s1470-2045(06)70628-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
561 Dikken JL, van Sandick JW, Maurits Swellengrebel HA, Lind PA, Putter H, Jansen EP, Boot H, van Grieken NC, van de Velde CJ, Verheij M, Cats A. Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS). BMC Cancer 2011;11:329. [PMID: 21810227 DOI: 10.1186/1471-2407-11-329] [Cited by in Crossref: 136] [Cited by in F6Publishing: 137] [Article Influence: 12.4] [Reference Citation Analysis]
562 Krijnen P, den Dulk M, Meershoek-Klein Kranenbarg E, Jansen-Landheer ML, van de Velde CJ. Improved survival after resectable non-cardia gastric cancer in The Netherlands: the importance of surgical training and quality control. Eur J Surg Oncol. 2009;35:715-720. [PMID: 19144490 DOI: 10.1016/j.ejso.2008.12.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
563 Bollschweiler E, Lubke T, Monig SP, Holscher AH. Evaluation of POSSUM scoring system in patients with gastric cancer undergoing D2-gastrectomy. BMC Surg 2005;5:8. [PMID: 15831104 DOI: 10.1186/1471-2482-5-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
564 Rausei S, Ruspi L, Rosa F, Morgagni P, Marrelli D, Cossu A, Cananzi FC, Lomonaco R, Coniglio A, Biondi A, Cipollari C, Graziosi L, Fumagalli U, Casella F, Bertoli P, di Leo A, Alfieri S, Vittimberga G, Roviello F, Orsenigo E, Quagliuolo V, Montemurro S, Baiocchi G, Persiani R, Bencivenga M, Donini A, Rosati R, Sansonetti A, Ansaloni L, Zanoni A, Galli F, Dionigi G; Italian Research Group for Gastric Cancer (IRGGC). Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study. Eur J Surg Oncol 2016;42:1881-9. [PMID: 27266816 DOI: 10.1016/j.ejso.2016.05.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
565 Coburn N, Cosby R, Klein L, Knight G, Malthaner R, Mamazza J, Mercer CD, Ringash J. Staging and surgical approaches in gastric cancer: A systematic review. Cancer Treatment Reviews 2018;63:104-15. [DOI: 10.1016/j.ctrv.2017.12.006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 10.5] [Reference Citation Analysis]
566 Allum WH, Smyth EC, Blazeby JM, Grabsch HI, Griffin SM, Rowley S, Cafferty FH, Langley RE, Cunningham D. Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro-oesophageal junction. Br J Surg 2019;106:1204-15. [PMID: 31268180 DOI: 10.1002/bjs.11184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
567 Santoro R, Ettorre GM, Santoro E. Subtotal gastrectomy for gastric cancer. World J Gastroenterol 2014; 20(38): 13667-13680 [PMID: 25320505 DOI: 10.3748/wjg.v20.i38.13667] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
568 Curtis JL, Burns RC, Wang L, Mahour GH, Ford HR. Primary gastric tumors of infancy and childhood: 54-year experience at a single institution. Journal of Pediatric Surgery 2008;43:1487-93. [DOI: 10.1016/j.jpedsurg.2007.11.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
569 Michel P, Di Fiore F. [Adjuvant chemotherapy for gastric carcinoma]. Gastroenterol Clin Biol 2006;30:96-101. [PMID: 16514386 DOI: 10.1016/s0399-8320(06)73120-7] [Reference Citation Analysis]
570 Elimova E, Mizrak Kaya D, Harada K, Ajani JA. Potentially Curable Cancers of the Esophagus and Stomach. Mayo Clin Proc 2016;91:1307-18. [PMID: 27594190 DOI: 10.1016/j.mayocp.2016.07.018] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
571 Ferri L. Extended Lymphadenectomy in Gastric Cancer Is Crucial. World J Surg 2013;37:1768-72. [DOI: 10.1007/s00268-013-2069-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
572 Correia T, Amaro P, Sofia C. Tratamento de deiscência cirúrgica grave com sistema «Over-the-scope clip». GE Jornal Português de Gastrenterologia 2013;20:261-5. [DOI: 10.1016/j.jpg.2013.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
573 Van Cutsem E, Dicato M, Arber N, Benson A, Cunningham D, Diaz-Rubio E, Glimelius B, Goldberg R, Haller D, Haustermans K, Koo-Kang Y, Labianca R, Lang I, Minsky B, Nordlinger B, Roth A, Rougier P, Schmoll HJ, Sobrero A, Tabernero J, Szawlowski A, van de Velde C. The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005. Ann Oncol 2006;17 Suppl 6:vi13-8. [PMID: 16809641 DOI: 10.1093/annonc/mdl976] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
574 Shi Y, Zhou Y. The role of surgery in the treatment of gastric cancer. J Surg Oncol. 2010;101:687-692. [PMID: 20512944 DOI: 10.1002/jso.21455] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
575 Memon MA, Subramanya MS, Khan S, Hossain MB, Osland E, Memon B. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg. 2011;253:900-911. [PMID: 21394009 DOI: 10.1097/sla.0b013e318212bff6] [Cited by in Crossref: 82] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
576 Skoropad V, Berdov B, Zagrebin V. Concentrated preoperative radiotherapy for resectable gastric cancer: 20-years follow-up of a randomized trial. J Surg Oncol. 2002;80:72-78. [PMID: 12173383 DOI: 10.1002/jso.10102] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 2.5] [Reference Citation Analysis]
577 Skoropad VY, Berdov BA, Mardynski YS, Titova LN. A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery alone in resectable gastric cancer. Eur J Surg Oncol. 2000;26:773-779. [PMID: 11087644 DOI: 10.1053/ejso.2000.1002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 2.9] [Reference Citation Analysis]
578 Guzman EA, Pigazzi A, Lee B, Soriano PA, Nelson RA, Benjamin Paz I, Trisal V, Kim J, Ellenhorn JD. Totally laparoscopic gastric resection with extended lymphadenectomy for gastric adenocarcinoma. Ann Surg Oncol. 2009;16:2218-2223. [PMID: 19444523 DOI: 10.1245/s10434-009-0508-3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
579 Degiuli M, Sasako M, Ponti A, Vendrame A, Tomatis M, Mazza C, Borasi A, Capussotti L, Fronda G, Morino M; Italian Gastric Cancer Study Group. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg 2014;101:23-31. [PMID: 24375296 DOI: 10.1002/bjs.9345] [Cited by in Crossref: 159] [Cited by in F6Publishing: 149] [Article Influence: 19.9] [Reference Citation Analysis]
580 Wong J, Rahman S, Saeed N, Lin HY, Almhanna K, Shridhar R, Hoffe S, Meredith KL. Effect of body mass index in patients undergoing resection for gastric cancer: a single center US experience. J Gastrointest Surg 2014;18:505-11. [PMID: 24443204 DOI: 10.1007/s11605-014-2455-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
581 Arcangeli G, Saracino B, Arcangeli G, Angelini F, Marchetti P, Tirindelli Danesi D. Postoperative adjuvant chemoradiation in completely resected locally advanced gastric cancer. International Journal of Radiation Oncology*Biology*Physics 2002;54:1069-75. [DOI: 10.1016/s0360-3016(02)03026-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
582 Morita S, Fukagawa T, Fujiwara H, Katai H. The clinical significance of para-aortic nodal dissection for advanced gastric cancer. Eur J Surg Oncol. 2016;42:1448-1454. [PMID: 26876636 DOI: 10.1016/j.ejso.2016.01.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
583 Ryun Park S. Management of gastric cancer: East vs west. Current Problems in Cancer 2015;39:315-41. [DOI: 10.1016/j.currproblcancer.2015.10.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
584 Coburn N, Seevaratnam R, Paszat L, Helyer L, Law C, Swallow C, Cardosa R, Mahar A, Lourenco LG, Dixon M. Optimal management of gastric cancer: results from an international RAND/UCLA expert panel. Ann Surg. 2014;259:102-108. [PMID: 23478525 DOI: 10.1097/sla.0b013e318288dd2b] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
585 Martin DJ, Church NG, Kennedy CW, Falk GL. Does systematic 2-field lymphadenectomy for esophageal malignancy offer a survival advantage? Results from 178 consecutive patients. Dis Esophagus. 2008;21:612-618. [PMID: 18459992 DOI: 10.1111/j.1442-2050.2008.00826.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
586 Procopiuc L, Tudor Ş, Mănuc M, Diculescu M, Vasilescu C. Robot-assisted surgery for gastric cancer. World J Gastrointest Oncol 2016; 8(1): 8-17 [PMID: 26798433 DOI: 10.4251/wjgo.v8.i1.8] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
587 Jeromen A, Oblak I, Anderluh F, Velenik V, Vidmar MS, Ratoša I. Results of postoperative radiochemotherapy of the patients with resectable gastroesophageal junction adenocarcinoma in Slovenia. Radiol Oncol 2012;46:337-45. [PMID: 23412351 DOI: 10.2478/v10019-012-0049-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
588 Lambert R, Guilloux A, Oshima A, Pompe-Kirn V, Bray F, Parkin M, Ajiki W, Tsukuma H. Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer. 2002;97:811-818. [PMID: 11857360 DOI: 10.1002/ijc.10150] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 3.8] [Reference Citation Analysis]
589 Sasako M. Progress in the treatment of gastric cancer in Japan over the last 50 years. Ann Gastroenterol Surg 2020;4:21-9. [PMID: 32021955 DOI: 10.1002/ags3.12306] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
590 Costa ML, de Cássia Braga Ribeiro K, Machado MA, Costa AC, Montagnini AL. Prognostic score in gastric cancer: the importance of a conjoint analysis of clinical, pathologic, and therapeutic factors. Ann Surg Oncol 2006;13:843-50. [PMID: 16614885 DOI: 10.1245/ASO.2006.05.040] [Cited by in Crossref: 34] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
591 Aoyama T, Yoshikawa T. Adjuvant therapy for locally advanced gastric cancer. Surg Today. 2017;47:1295-1302. [PMID: 28251375 DOI: 10.1007/s00595-017-1493-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
592 Lim DH. Postoperative adjuvant radiotherapy for patients with gastric adenocarcinoma. J Gastric Cancer 2012;12:205-9. [PMID: 23346491 DOI: 10.5230/jgc.2012.12.4.205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
593 Kodera Y, Schwarz RE, Nakao A. Extended lymph node dissection in gastric carcinoma. Journal of the American College of Surgeons 2002;195:855-64. [DOI: 10.1016/s1072-7515(02)01496-5] [Cited by in Crossref: 57] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
594 Doekhie FS, Mesker WE, van Krieken JH, Kok NF, Hartgrink HH, Kranenbarg EK, Putter H, Kuppen PJ, Tanke HJ, Tollenaar RA. Clinical relevance of occult tumor cells in lymph nodes from gastric cancer patients. Am J Surg Pathol. 2005;29:1135-1144. [PMID: 16096401 DOI: 10.1097/01.pas.0000160439.38770.cb] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
595 Lee WJ. It is still not the time to change surgical strategy for gastric cancer. Ann Surg Oncol 2005;12:194; author reply 194-6. [PMID: 15827803 DOI: 10.1245/ASO.2005.10.908] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
596 Reddavid R, Sofia S, Chiaro P, Colli F, Trapani R, Esposito L, Solej M, Degiuli M. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake? World J Gastroenterol 2018; 24(2): 274-289 [PMID: 29375213 DOI: 10.3748/wjg.v24.i2.274] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 26] [Article Influence: 9.5] [Reference Citation Analysis]
597 Chen QY, Zhong Q, Liu ZY, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Li P, Zheng CH, Huang CM. Does Noncompliance in Lymph Node Dissection Affect Oncological Efficacy in Gastric Cancer Patients Undergoing Radical Gastrectomy? Ann Surg Oncol 2019;26:1759-71. [PMID: 30756329 DOI: 10.1245/s10434-019-07217-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
598 Schwarz RE. Spleen-preserving splenic hilar lymphadenectomy at the time of gastrectomy for cancer: technical feasibility and early results. J Surg Oncol. 2002;79:73-76. [PMID: 11754382 DOI: 10.1002/jso.10036] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
599 Roukos DH, Kappas AM. Targeting the optimal extent of lymph node dissection for gastric cancer. J Surg Oncol 2002;81:59-62; discussion 62. [PMID: 12355403 DOI: 10.1002/jso.10153] [Cited by in Crossref: 70] [Cited by in F6Publishing: 52] [Article Influence: 3.5] [Reference Citation Analysis]
600 Nienhüser H, Schmidt T. Gastric cancer lymph node resection-the more the merrier? Transl Gastroenterol Hepatol 2018;3:1. [PMID: 29441366 DOI: 10.21037/tgh.2017.12.08] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
601 de Manzoni G, Di Leo A, Pedrazzani C, Castaldini G, Borzellino G, Veraldi G, Cordiano C. Intraoperative US staging of T in gastric cancer: Final results of a blind prospective study. J Surg Oncol 2001;78:158-61. [DOI: 10.1002/jso.1141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
602 Kim TU, Kim S, Lee NK, Kim HJ, Han GJ, Lee JW, Baek HJ, Jeon TY, Kim HS, Park DY. Prognostic Value of Computed Tomography–Detected Extramural Venous Invasion to Predict Disease-Free Survival in Patients With Gastric Cancer: . Journal of Computer Assisted Tomography 2017;41:430-6. [DOI: 10.1097/rct.0000000000000543] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
603 Surenkok S, Beyzadeoglu M, Oysul K, Ozyigit G, Ataergin S, Arpaci F, Ozet A. The Management of Gastric Adenocarcinoma with Postoperative Chemoirradiation. A non-randomized comparison of oral UFT and 5-FU. Tumori 2008;94:70-4. [DOI: 10.1177/030089160809400113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
604 Dulucq JL, Wintringer P, Perissat J, Mahajna A. Completely laparoscopic total and partial gastrectomy for benign and malignant diseases: a single institute's prospective analysis. J Am Coll Surg. 2005;200:191-197. [PMID: 15664093 DOI: 10.1016/j.jamcollsurg.2004.10.004] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 3.6] [Reference Citation Analysis]
605 Lacueva J, Gallego J, Díaz-González JA. Updating controversies on the multidisciplinary management of gastric cancer. Clin Transl Oncol. 2010;12:677-685. [PMID: 20947482 DOI: 10.1007/s12094-010-0577-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
606 Menges M. Gastric cancer: Where is the place for the surgeon, the oncologist and the endoscopist today? World J Gastrointest Oncol 2011; 3(1): 10-13 [PMID: 21267398 DOI: 10.4251/wjgo.v3.i1.10] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
607 Magnusson J. Stomach cancer. Curr Surg 2006;63:96-100; quiz 100-1. [PMID: 16520108 DOI: 10.1016/j.cursur.2005.10.005] [Reference Citation Analysis]
608 Nitti D, Marchet A, Olivieri M, Ambrosi A, Mencarelli R, Belluco C, Lise M. Ratio Between Metastatic and Examined Lymph Nodes Is an Independent Prognostic Factor After D2 Resection for Gastric Cancer: Analysis of a Large European Monoinstitutional Experience. Ann Surg Oncol 2003;10:1077-85. [DOI: 10.1245/aso.2003.03.520] [Cited by in Crossref: 136] [Cited by in F6Publishing: 61] [Article Influence: 7.2] [Reference Citation Analysis]
609 Verlato G, Giacopuzzi S, Bencivenga M, Morgagni P, Manzoni GD. Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer. World J Gastroenterol 2014; 20(36): 12883-12891 [PMID: 25278685 DOI: 10.3748/wjg.v20.i36.12883] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
610 Garg PK, Jakhetiya A, Sharma J, Ray MD, Pandey D. Lymphadenectomy in gastric cancer: Contentious issues. World J Gastrointest Surg 2016; 8(4): 294-300 [PMID: 27152135 DOI: 10.4240/wjgs.v8.i4.294] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
611 Solsky I, In H. Surgical Treatment for Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:581-605. [PMID: 34053640 DOI: 10.1016/j.giec.2021.04.001] [Reference Citation Analysis]
612 Goto H, Tokunaga M, Sugisawa N, Tanizawa Y, Bando E, Kawamura T, Niihara M, Tsubosa Y, Terashima M. Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction. Gastric Cancer. 2013;16:590-595. [PMID: 23179369 DOI: 10.1007/s10120-012-0214-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
613 Lui SA, Tan WB, Tai BC, Yong WP, Mu YS, Ti TK, Shabbir A, So J. Predictors of survival outcome following radical gastrectomy for gastric cancer. ANZ J Surg 2019;89:84-9. [PMID: 30690932 DOI: 10.1111/ans.15011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
614 Mita K, Ito H, Fukumoto M, Murabayashi R, Koizumi K, Hayashi T. An adequate perioperative management and strategy for gastric cancer after coronary artery bypass using the right gastroepiploic artery. Surg Today. 2013;43:284-288. [PMID: 22706786 DOI: 10.1007/s00595-012-0224-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
615 Brenkman HJF, Goense L, Brosens LA, Haj Mohammad N, Vleggaar FP, Ruurda JP, van Hillegersberg R. A High Lymph Node Yield is Associated with Prolonged Survival in Elderly Patients Undergoing Curative Gastrectomy for Cancer: A Dutch Population-Based Cohort Study. Ann Surg Oncol 2017;24:2213-23. [PMID: 28247154 DOI: 10.1245/s10434-017-5815-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
616 Upchurch E, Griffiths S, Lloyd GR, Isabelle M, Kendall C, Barr H. Developments in optical imaging for gastrointestinal surgery. Future Oncol 2017;13:2363-82. [PMID: 29121775 DOI: 10.2217/fon-2017-0181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
617 Klein Kranenbarg E, Hermans J, van Krieken JH, van de Velde CJ. Evaluation of the 5th edition of the TNM classification for gastric cancer: improved prognostic value. Br J Cancer 2001;84:64-71. [PMID: 11139315 DOI: 10.1054/bjoc.2000.1548] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 1.9] [Reference Citation Analysis]
618 Zhang Y, Tian S. Does D2 plus para-aortic nodal dissection surgery offer a better survival outcome compared to D2 surgery only for gastric cancer consistently? A definite result based on a hospital population of nearly two decades. Scand J Surg. 2013;102:251-257. [PMID: 24056132 DOI: 10.1177/1457496913491343] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
619 Zhou ML, Kang M, Li GC, Guo XM, Zhang Z. Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis. World J Surg Oncol 2016;14:209. [PMID: 27502921 DOI: 10.1186/s12957-016-0957-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
620 Xu D, Huang Y, Geng Q, Guan Y, Li Y, Wang W, Yuan S, Sun X, Chen Y, Li W, Zhou Z, Zhan Y. Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system. PLoS One 2012;7:e38681. [PMID: 22723875 DOI: 10.1371/journal.pone.0038681] [Cited by in Crossref: 28] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
621 Mocellin S, McCulloch P, Kazi H, Gama-Rodrigues JJ, Yuan Y, Nitti D. Extent of lymph node dissection for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2015;:CD001964. [PMID: 26267122 DOI: 10.1002/14651858.CD001964.pub4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
622 Young JA, Shimi SM, Kerr L, McPhillips G, Thompson AM. Reduction in gastric cancer surgical mortality over 10 years: An adverse events analysis. Ann Med Surg (Lond). 2014;3:26-30. [PMID: 25568781 DOI: 10.1016/j.amsu.2014.03.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
623 Baeza MR, Osvaldo Giannini T, Raúl Rivera S, González P, González J, Vergara E, del Castillo C, Madrid J, Vinés E. Adjuvant radiochemotherapy in the treatment of completely resected, locally advanced gastric cancer. International Journal of Radiation Oncology*Biology*Physics 2001;50:645-50. [DOI: 10.1016/s0360-3016(01)01467-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
624 Catarci M, Montemurro LA, Ghinassi S, Di Cintio A, Leone L, Cosentino LM, Viarengo MA, Grassi GB. Long-term results of tailored D(2) lymph node dissection after R(0) surgery for gastric cancer. Updates Surg. 2011;63:83-90. [PMID: 21445644 DOI: 10.1007/s13304-011-0065-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
625 Lou N, Zhang L, Chen XD, Pang WY, Arvine C, Huang YP, Zhuang CL, Shen X. A novel scoring system associating with preoperative platelet/lymphocyte and clinicopathologic features to predict lymph node metastasis in early gastric cancer. J Surg Res 2017;209:153-61. [PMID: 28032552 DOI: 10.1016/j.jss.2016.10.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
626 Deng JY, Liang H, Sun D, Zhan HJ, Zhang RP. Analysis of risk factors for the interval time, number and pattern of hepatic metastases from gastric cancer after radical gastrectomy. World J Gastroenterol 2008; 14(15): 2440-2447 [PMID: 18416477 DOI: 10.3748/wjg.14.2440] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
627 Narayan RR, Poultsides GA. Advances in the surgical management of gastric and gastroesophageal junction cancer. Transl Gastroenterol Hepatol 2021;6:16. [PMID: 33409410 DOI: 10.21037/tgh.2020.02.06] [Reference Citation Analysis]
628 Sastre J, García-Saenz JA, Díaz-Rubio E. Chemotherapy for gastric cancer. World J Gastroenterol 2006; 12(2): 204-213 [PMID: 16482619 DOI: 10.3748/wjg.v12.i2.204] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 58] [Article Influence: 3.7] [Reference Citation Analysis]
629 Cho J, Park I, Lee D, Sung K, Baek J, Lee J. Advanced Gastric Cancer Perforation Mimicking Abdominal Wall Abscess.J Gastric Cancer. 2015;15:214-217. [PMID: 26468420 DOI: 10.5230/jgc.2015.15.3.214] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
630 Jiao XG, Deng JY, Zhang RP, Wu LL, Wang L, Liu HG, Hao XS, Liang H. Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer. World J Gastroenterol 2014; 20(13): 3640-3648 [PMID: 24707149 DOI: 10.3748/wjg.v20.i13.3640] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
631 Loh J, Maclellan S, Okrainec A, Mackay H, Jacks L, Sykes J, Kassam Z, Conrad T, Khalili I, Ringash J. Gastric cancer recurrence after resection and adjuvant chemoradiation. J Radiat Oncol 2015;4:79-85. [DOI: 10.1007/s13566-015-0183-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
632 Park SS, Park JM, Kim JH, Kim WB, Lee J, Kim SJ, Kim CS, Mok YJ. Prognostic factors for patients with node-negative gastric cancer: Can extended lymph node dissection have a survival benefit? J Surg Oncol 2006;94:16-20. [PMID: 16788938 DOI: 10.1002/jso.20560] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
633 Back M, Premsenthil S, Wynne C, Shakespeare T. Introducing the Intergroup 0116 Protocol of Adjuvant Chemo-radiotherapy in Gastric Cancer into Clinical Practice. Clinical Oncology 2003;15:378-82. [DOI: 10.1016/s0936-6555(03)00154-7] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
634 Propper D, Jones K, Anthoney DA, Mansoor W, Ford D, Eatock M, Agarwal R, Inatani M, Saito T, Abe M, Evans TR. Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma. BMC Cancer 2016;16:779. [PMID: 27724887 DOI: 10.1186/s12885-016-2828-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
635 Vadthya G, Ramakrishnaiah VPN, Krishnamachari S. Short-Term Outcome in Patients Undergoing Gastrectomy with D2 Lymphadenectomy for Carcinoma Stomach. Indian J Surg Oncol 2017;8:304-11. [DOI: 10.1007/s13193-017-0620-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
636 Mönig SP, Lübke T, Baldus SE, Hölscher AH. Primärtherapie des Magenkarzinoms: Ausmaß der chirurgischen Intervention. Onkologe 2005;11:630-9. [DOI: 10.1007/s00761-005-0880-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
637 Beamish AJ, Chan DS, Blake PA, Karran A, Lewis WG. Systematic review and meta-analysis of enhanced recovery programmes in gastric cancer surgery. Int J Surg. 2015;19:46-54. [PMID: 26004350 DOI: 10.1016/j.ijsu.2015.05.021] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
638 Fujitani K, Ajani JA, Crane CH, Feig BW, Pisters PW, Janjan N, Walsh GL, Swisher SG, Vaporciyan AA, Rice D, Welch A, Baker J, Faust J, Mansfield PF. Impact of Induction Chemotherapy and Preoperative Chemoradiotherapy on Operative Morbidity and Mortality in Patients with Locoregional Adenocarcinoma of the Stomach or Gastroesophageal Junction. Ann Surg Oncol 2007;14:1305-11. [DOI: 10.1245/s10434-006-9309-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
639 Fuse N, Bando H, Chin K, Ito S, Yoshikawa T, Tsuburaya A, Terashima M, Kawashima Y, Fukunaga T, Gotoh M, Emi Y, Yoshida K, Oki E, Takahashi S, Kuriki H, Sato K, Sasako M. Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study. Gastric Cancer. 2017;20:332-340. [PMID: 26956689 DOI: 10.1007/s10120-016-0606-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
640 Yarema R, de Manzoni G, Fetsych T, Ohorchak M, Pliatsko M, Bencivenga M. On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer. World J Gastrointest Oncol 2016; 8(6): 489-497 [PMID: 27326318 DOI: 10.4251/wjgo.v8.i6.489] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
641 Edwards P, Blackshaw GR, Lewis WG, Barry JD, Allison MC, Jones DR. Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer. 2004;90:1888-1892. [PMID: 15138467 DOI: 10.1038/sj.bjc.6601790] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 3.7] [Reference Citation Analysis]
642 Villano AM, Zeymo A, Mcdermott J, Crocker A, Zeck J, Chan KS, Shara N, Kim S, Al-refaie WB. Evaluating Dissemination of Adequate Lymphadenectomy for Gastric Cancer in the USA. J Gastrointest Surg 2019;23:2119-28. [DOI: 10.1007/s11605-019-04138-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
643 Wu P, Wang P, Ma B, Yin S, Tan Y, Hou W, Wang Z, Xu H, Zhu Z. Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis. Cancer Manag Res 2018;10:4759-71. [PMID: 30464590 DOI: 10.2147/CMAR.S179368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
644 Shah MA. Recent developments in the treatment of gastric carcinoma. Curr Oncol Rep 2002;4:193-201. [DOI: 10.1007/s11912-002-0016-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
645 Hundahl SA. Low maruyama index surgery for gastric cancer. Scand J Surg 2006;95:243-8. [PMID: 17249272 DOI: 10.1177/145749690609500406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
646 Bouchbika Z, Quero L, Kouto H, Hennequin-baruch V, Gornet J, Munoz N, Cojean-zelek I, Houdart R, Panis Y, Valleur P, Sergent G, Maylin C, Hennequin C. Chimiothérapie adjuvante suivie d’une chimioradiothérapie conformationnelle dans les cancers de l’estomac. Cancer/Radiothérapie 2008;12:775-80. [DOI: 10.1016/j.canrad.2008.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
647 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
648 Van Cutsem E, Van de Velde C, Roth A, Lordick F, Köhne CH, Cascinu S, Aapro M. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group. Eur J Cancer. 2008;44:182-194. [PMID: 18093827 DOI: 10.1016/j.ejca.2007.11.001] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 5.6] [Reference Citation Analysis]
649 D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004;240:808-816. [PMID: 15492562 DOI: 10.1097/01.sla.0000143245.28656.15] [Cited by in Crossref: 378] [Cited by in F6Publishing: 377] [Article Influence: 21.0] [Reference Citation Analysis]
650 Deng J, Sun D, Pan Y, Zhang L, Zhang R, Wang D, Hao X, Liang H. Ratio between negative and positive lymph nodes is suitable for evaluation the prognosis of gastric cancer patients with positive node metastasis. PLoS One. 2012;7:e43925. [PMID: 22952812 DOI: 10.1371/journal.pone.0043925] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
651 Seevaratnam R, Bocicariu A, Cardoso R, Mahar A, Kiss A, Helyer L, Law C, Coburn N. A meta-analysis of D1 versus D2 lymph node dissection. Gastric Cancer. 2012;15 Suppl 1:S60-S69. [PMID: 22138927 DOI: 10.1007/s10120-011-0110-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 5.2] [Reference Citation Analysis]
652 Schumacher G, Schmidt SC, Schlechtweg N, Roesch T, Sacchi M, von Dossow V, Chopra SS, Pratschke J, Zhukova J, Stieler J. Surgical results of patients after esophageal resection or extended gastrectomy for cancer of the esophagogastric junction. Dis Esophagus. 2009;22:422-426. [PMID: 19191862 DOI: 10.1111/j.1442-2050.2008.00923.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
653 Disiena MR, Taneja C, Wanebo HJ. Radical Gastrectomy and Lymphadenectomy: Historic Overview, Surgical Trends, and Lessons from the Past. Surgical Oncology Clinics of North America 2005;14:511-32. [DOI: 10.1016/j.soc.2005.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
654 Eom BW, Joo J, Kim YW, Reim D, Park JY, Yoon HM, Ryu KW, Lee JY, Kook MC. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer. Surgery. 2014;155:408-416. [PMID: 24287148 DOI: 10.1016/j.surg.2013.08.019] [Cited by in Crossref: 25] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
655 Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, Gunderson LL, Goldman B, Martenson JA, Jessup JM, Stemmermann GN, Blanke CD, Macdonald JS. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol 2012;30:2327-33. [PMID: 22585691 DOI: 10.1200/JCO.2011.36.7136] [Cited by in Crossref: 466] [Cited by in F6Publishing: 253] [Article Influence: 46.6] [Reference Citation Analysis]
656 Moehler M, Lyros O, Gockel I, Galle PR, Lang H. Multidisciplinary management of gastric and gastroesophageal cancers. World J Gastroenterol 2008; 14(24): 3773-3780 [PMID: 18609699 DOI: 10.3748/wjg.14.3773] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
657 Mrena J, Mattila A, Böhm J, Jantunen I, Kellokumpu I. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer. World J Gastroenterol 2015; 21(47): 13294-13301 [PMID: 26715812 DOI: 10.3748/wjg.v21.i47.13294] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
658 Huang CM, Lin JX, Zheng CH, Li P, Xie JW, Wang JB. Impact of the number of dissected lymph nodes on survival for gastric cancer after distal subtotal gastrectomy. Gastroenterol Res Pract 2011;2011:476014. [PMID: 21811495 DOI: 10.1155/2011/476014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
659 Weitz J, D’angelica M, Gonen M, Klimstra D, Coit DG, Brennan MF, Karpeh MS. Interaction of Splenectomy and Perioperative Blood Transfusions on Prognosis of Patients With Proximal Gastric and Gastroesophageal Junction Cancer. JCO 2003;21:4597-603. [DOI: 10.1200/jco.2003.12.136] [Cited by in Crossref: 36] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
660 Chandran S, Vaughan R, Jacob A, Hamilton C, Joon DL, Lim K, Tog C, Bhatia K, Aly A, Sweeney T, Efthymiou M. A novel endoscopic marker for radiological localization and image-guided radiotherapy in esophageal and gastric cancers (with video). Gastrointest Endosc 2016;83:309-17. [PMID: 26239307 DOI: 10.1016/j.gie.2015.06.042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
661 Foukakis T, Lundell L, Gubanski M, Lind PA. Advances in the treatment of patients with gastric adenocarcinoma. Acta Oncol. 2007;46:277-285. [PMID: 17450463 DOI: 10.1080/02841860701218634] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
662 Ding YB, Xia TS, Wu JD, Chen GY, Wang S, Xia JG. Surgical outcomes for gastric cancer of a single institute in southeast China. Am J Surg. 2012;203:217-221. [PMID: 21803328 DOI: 10.1016/j.amjsurg.2010.10.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
663 Lordick F, Stein HJ, Peschel C, Siewert JR. Neoadjuvant therapy for oesophagogastric cancer. Br J Surg. 2004;91:540-551. [PMID: 15122603 DOI: 10.1002/bjs.4575] [Cited by in Crossref: 78] [Cited by in F6Publishing: 55] [Article Influence: 4.3] [Reference Citation Analysis]
664 Drognitz O, Henne K, Weissenberger C, Bruggmoser G, Göbel H, Hopt UT, Frommhold H, Ruf G. Long-term results after intraoperative radiation therapy for gastric cancer. Int J Radiat Oncol Biol Phys 2008;70:715-21. [PMID: 18164840 DOI: 10.1016/j.ijrobp.2007.07.2331] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
665 Persiani R, Rausei S, Biondi A, Boccia S, Cananzi F, D'Ugo D. Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer. Eur J Surg Oncol 2008;34:519-24. [PMID: 17624713 DOI: 10.1016/j.ejso.2007.05.009] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
666 Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2005;241:27-39. [PMID: 15621988 DOI: 10.1097/01.sla.0000149300.28588.23] [Cited by in Crossref: 405] [Cited by in F6Publishing: 383] [Article Influence: 23.8] [Reference Citation Analysis]
667 Arai H, Nakajima TE. Recent Developments of Systemic Chemotherapy for Gastric Cancer. Cancers (Basel) 2020;12:E1100. [PMID: 32354119 DOI: 10.3390/cancers12051100] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
668 Kim JA, Lee J, Han B, Park SH, Park JO, Park YS, Lim HY, Kang WK. Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer. Cancer Chemother Pharmacol 2011;68:177-84. [PMID: 20878159 DOI: 10.1007/s00280-010-1452-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
669 Larsen AC, Holländer C, Duval L, Schønnemann K, Achiam M, Pfeiffer P, Yilmaz MK, Thorlacius-ussing O, Bæksgaard L, Ladekarl M. A Nationwide Retrospective Study of Perioperative Chemotherapy for Gastroesophageal Adenocarcinoma: Tolerability, Outcome, and Prognostic Factors. Ann Surg Oncol 2015;22:1540-7. [DOI: 10.1245/s10434-014-4127-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
670 Sun L, Su XH, Guan YS, Pan WM, Luo ZM, Wei JH, Wu H. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: Initial results. World J Gastroenterol 2008; 14(29): 4627-4632 [PMID: 18698676 DOI: 10.3748/wjg.14.4627] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
671 Merchant SJ, Li L, Kim J. Racial and ethnic disparities in gastric cancer outcomes: More important than surgical technique? World J Gastroenterol 2014; 20(33): 11546-11551 [PMID: 25206261 DOI: 10.3748/wjg.v20.i33.11546] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
672 Schwarz RE, Zagala-Nevarez K. Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol. 2002;9:394-400. [PMID: 11986192 DOI: 10.1007/bf02573875] [Cited by in Crossref: 112] [Cited by in F6Publishing: 47] [Article Influence: 5.6] [Reference Citation Analysis]
673 Kung CH, Song H, Ye W, Nilsson M, Johansson J, Rouvelas I, Irino T, Lundell L, Tsai JA, Lindblad M. Extent of lymphadenectomy has no impact on postoperative complications after gastric cancer surgery in Sweden. Chin J Cancer Res 2017;29:313-22. [PMID: 28947863 DOI: 10.21147/j.issn.1000-9604.2017.04.04] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
674 Memon MA, Butler N, Memon B. The issue of lymphadenectomy during laparoscopic gastrectomy for gastric carcinoma. World J Gastrointest Oncol 2010; 2(2): 65-67 [PMID: 21160923 DOI: 10.4251/wjgo.v2.i2.65] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
675 Chen XZ, Hu JK, Yang K, Wang L, Lu QC. Short-term evaluation of laparoscopy-assisted distal gastrectomy for predictive early gastric cancer: a meta-analysis of randomized controlled trials. Surg Laparosc Endosc Percutan Tech. 2009;19:277-284. [PMID: 19692873 DOI: 10.1097/sle.0b013e3181b080d3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
676 Uslu A, Zengel B, İlhan E, Aykas A, Şimşek C, Üreyen O, Duran A, Okut G. Survival outcomes after D1 and D2 lymphadenectomy with R0 resection in stage II-III gastric cancer: Longitudinal follow-up in a single center. Turk J Surg 2018;34:125-30. [PMID: 30023977 DOI: 10.5152/turkjsurg.2018.3846] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
677 Dikken JL, Jansen EP, Cats A, Bakker B, Hartgrink HH, Kranenbarg EM, Boot H, Putter H, Peeters KC, van de Velde CJ, Verheij M. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol. 2010;28:2430-2436. [PMID: 20368551 DOI: 10.1200/jco.2009.26.9654] [Cited by in Crossref: 125] [Cited by in F6Publishing: 62] [Article Influence: 10.4] [Reference Citation Analysis]
678 D'Annibale A, Pende V, Pernazza G, Monsellato I, Mazzocchi P, Lucandri G, Morpurgo E, Contardo T, Sovernigo G. Full robotic gastrectomy with extended (D2) lymphadenectomy for gastric cancer: surgical technique and preliminary results. J Surg Res 2011;166:e113-20. [PMID: 21227455 DOI: 10.1016/j.jss.2010.11.881] [Cited by in Crossref: 74] [Cited by in F6Publishing: 63] [Article Influence: 6.2] [Reference Citation Analysis]
679 Lo CH, Chen JH, Wu CW, Lo SS, Hsieh MC, Lui WY. Risk factors and management of intra-abdominal infection after extended radical gastrectomy. Am J Surg 2008;196:741-5. [PMID: 18954604 DOI: 10.1016/j.amjsurg.2007.11.031] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
680 Ji X, Bu ZD, Li ZY, Wu AW, Zhang LH, Zhang J, Wu XJ, Zong XL, Li SX, Shan F, Jia ZY, Ji JF. Prognostic significance of the total number of harvested lymph nodes for lymph node-negative gastric cancer patients. BMC Cancer 2017;17:558. [PMID: 28830455 DOI: 10.1186/s12885-017-3544-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
681 Ajani JA. Operate on My Stomach Cancer? Oh, No—Not You, or Not Yet! JCO 2004;22:1763-4. [DOI: 10.1200/jco.2004.99.277] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
682 Hecht JR. Adjuvant therapy for gastric cancer: a reality at last. Curr Gastroenterol Rep 2000;2:478-81. [PMID: 11079050 DOI: 10.1007/s11894-000-0012-1] [Reference Citation Analysis]
683 Kim MS, Yoo SY, Cho CK, Yoo HJ, Yang KM, Kang JK, Lee DH, Lee JI, Bang HY, Kim MS, Kang HJ. Stereotactic body radiotherapy for isolated para-aortic lymph node recurrence after curative resection in gastric cancer. J Korean Med Sci 2009;24:488-92. [PMID: 19543514 DOI: 10.3346/jkms.2009.24.3.488] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
684 Haverkamp L, Ruurda JP, Offerhaus GJ, Weijs TJ, van der Sluis PC, van Hillegersberg R. Laparoscopic gastrectomy in Western European patients with advanced gastric cancer. Eur J Surg Oncol 2016;42:110-5. [PMID: 26603678 DOI: 10.1016/j.ejso.2015.09.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
685 Pang X, Wei W, Leng W, Chen Q, Xia H, Chen L, Li R. Radiotherapy for gastric cancer: a systematic review and meta-analysis. Tumour Biol. 2014;35:387-396. [PMID: 23929390 DOI: 10.1007/s13277-013-1054-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
686 Marcenaro M, Foppiano F, Durzu S, Barra S, Corvò R. Kidney-Sparing Radiotherapy by Multiple-Field Three-Dimensional Technique in the Postoperative Management of Patients with Gastric Cancer: Comparison with Standard Two-Field Conformal Technique. Tumori 2006;92:34-40. [DOI: 10.1177/030089160609200107] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
687 Pattison S, Mann GB, Crosthwaite G, Lade S, Mitchell C, Leong T, Busuttil RA, Boussioutas A. Predictors of outcome after surgery for gastric cancer in a Western cohort. ANZ J Surg. 2016;86:469-474. [PMID: 25388659 DOI: 10.1111/ans.12915] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]